Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),0.8503271872205237,2.187364942545835,0.0,0.0019669805236682573,0.002,6/22,4.62%,CYP26B1;ALDH1A2;NR2F2;RBP4;ABCA4;RBP1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8802512174326017,2.156106756352865,0.0,0.001475235392751193,0.002,4/15,2.81%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,cadherin binding (GO:0045296),-0.45638500907848945,-2.0985063479995896,0.0,0.003057806658805229,0.003,134/315,21.01%,DOCK9;FMNL2;SPTBN1;PTPRB;STXBP6;BSG;COBLL1;PTPRJ;MRTFB;PTPRM;TJP2;ITGA6;FXYD5;PROM1;LRRFIP1;ESYT2;STK38;HSPA8;KDR;FNBP1L;CDH11;CTNND2;IQGAP1;PKP4;CDH1;TES;CBL;HSP90AB1;HNRNPK;ITGB1;CDH2;EHD4;RPL6;AHNAK;F11R;PLEC;EEF2;SLK;NOTCH3;DAB2IP;CLINT1;RACK1;PKM;TAGLN2;SH3GLB1;BMPR2;RPL34;PACSIN2;CHMP5;SHTN1;RPL24;FLNA;EPS8L2;RPL23A;PPME1;CHMP2B;NCK1;TRIM25;EEF1D;EHD1;CTNNB1;CEMIP2;MPP7;SLC3A2;YWHAB;ATXN2L;RPL14;PCMT1;BAIAP2L1;MYH9;RPS2;TJP1;CTNNA3;TRPC4;LASP1;PAICS;RPL29;PLCB3;SEPTIN9;RTN4;PAK2;APC;RANBP1;HSPA5;LYPLA2;PPP1CA;RPL7A;CD2AP;PTPN1;TXNDC9;RSL1D1;PSMB6;RAB1A;DBNL;RANGAP1;MARK2;TBC1D10A;CDH13;EPN2;EEF1G;EIF4H;TMPO;JUP;ALDOA;PFKP;RPS26;TNKS1BP1;FASN;LDHA;DHX29;DIAPH3;RUVBL1;ARGLU1;DNAJB1;SERBP1;ACVR1;EIF2A;USP8;SCYL1;SNX1;PCBP1;S100A11;CKAP5;PSEN1;CIP2A;CTNNA1;ANK3;SNX2;DBN1;SH3GL1;ARFIP2;MAPRE1;ABI1;ADD1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8958255613578072,2.092425775484304,0.0,0.002950470785502386,0.007,4/13,2.81%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,retinoic acid binding (GO:0001972),0.8732444995233624,1.9584464128675916,0.0,0.03860199277698955,0.126,2/12,1.14%,CYP26B1;NR2F2
prerank,MHC class II protein complex binding (GO:0023026),-0.7896431683953969,-1.8637050215853561,0.0,0.11568701859146449,0.19,7/11,13.69%,HSPA8;HSP90AA1;HSP90AB1;ATP1B1;PKM;CD74;CD81
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8201766581669824,1.8460924725247494,0.002066115702479339,0.15696504578872694,0.498,3/10,3.73%,SLC6A13;SLC6A12;SLC6A1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.7484396687871843,1.8081477121923117,0.006276150627615063,0.21374521690528395,0.674,2/16,0.70%,SLC22A4;SLC22A2
prerank,anion channel activity (GO:0005253),-0.48899840594408217,-1.7786792815179986,0.0,0.238169163091385,0.462,18/61,16.89%,SLC26A7;LRRC8C;ANO1;ANO4;LRRC8D;CLIC4;LRRC8B;GABRB3;CLCN5;GABRB1;TTYH3;ANO3;LRRC8A;GABRG3;SLC1A4;ANO2;CFTR;GLRA3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.7194178163505756,-1.7705263560619773,0.0039447731755424065,0.20003151893017537,0.498,4/12,13.44%,ENTPD1;ENTPD7;ENTPD2;SLC25A42
prerank,amino acid:sodium symporter activity (GO:0005283),0.7818640519218953,1.7674604699208782,0.006535947712418301,0.28746015367323247,0.828,4/11,3.73%,SLC6A13;SLC6A12;SLC1A3;SLC6A1
prerank,ephrin receptor activity (GO:0005003),0.7213242339666499,1.7655251260738873,0.012295081967213115,0.22806046404975852,0.83,4/17,3.71%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7213242339666499,1.7655251260738873,0.012295081967213115,0.22806046404975852,0.83,4/17,3.71%,EPHA7;EPHA3;EPHA8;EPHA4
prerank,LRR domain binding (GO:0030275),0.7472811301347158,1.747866578019259,0.010660980810234541,0.2498065265058687,0.88,2/14,0.82%,ROBO1;PAWR
prerank,phospholipid transfer activity (GO:0120014),-0.6106804508827646,-1.7319114477949007,0.0020876826722338203,0.258282735780415,0.671,11/21,18.85%,PITPNC1;CERT1;PLTP;PITPNM2;TNFAIP8L3;GLTP;ABCA3;PRELID3B;MTTP;PITPNA;PITPNB
prerank,translation elongation factor activity (GO:0003746),-0.6800668383952782,-1.7213397099254126,0.007590132827324478,0.24717270492008928,0.715,11/14,28.81%,EEF1A1;EEF2;GFM1;EEFSEC;EEF1B2;EIF5A;EIF5AL1;GTPBP2;TUFM;EEF1A2;GTPBP1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.5426281300899457,-1.710370206474975,0.006787330316742082,0.21200792834382917,0.758,15/34,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.5426281300899457,-1.710370206474975,0.006787330316742082,0.21200792834382917,0.758,15/34,18.10%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;NDUFA13;NDUFS1;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6492918228066817,-1.7026934451123004,0.0,0.18326454575106005,0.787,5/16,6.03%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6492918228066817,-1.7026934451123004,0.0,0.18326454575106005,0.787,5/16,6.03%,PTPRB;PTPRG;PTPRM;PTPRN2;PTPRC
prerank,amyloid-beta binding (GO:0001540),-0.45198074429202,-1.701116093497092,0.0026041666666666665,0.17058854723819475,0.796,41/79,31.55%,APBB2;COL25A1;TGFB2;ITM2B;CST3;FZD4;FZD6;ITM2A;APBB1;CRYAB;GRIN1;ATP1A3;APBB3;CD74;CLU;ADRB2;APBA3;IAPP;C1QA;CACNA1B;GRIA2;PFDN6;ITM2C;PFDN5;INSR;MAPK8IP2;FCGR2B;AGER;PFDN4;SORL1;APBA2;TREM2;ITGB2;CLSTN1;APBA1;TLR4;GRIA1;CD36;TLR6;BCHE;GRIN2B
prerank,monocarboxylic acid binding (GO:0033293),0.6856691791957861,1.687336320514649,0.024163568773234202,0.42012915821441554,0.984,3/18,6.18%,CYP26B1;NR2F2;NAPEPLD
prerank,CoA-ligase activity (GO:0016405),0.7039571041007031,1.6865673588573746,0.010638297872340425,0.38864256846811984,0.985,2/14,1.86%,ACSS3;ACSL1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6402353628064765,-1.6847687472307131,0.005893909626719057,0.17108036229520535,0.844,7/16,20.32%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,intracellular chloride channel activity (GO:0061778),-0.6402353628064765,-1.6847687472307131,0.005893909626719057,0.17108036229520535,0.844,7/16,20.32%,ANO1;ANO4;TTYH3;TTYH2;ANO3;ANO2;ANO8
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6519548192651887,-1.6827252512912365,0.01348747591522158,0.1616997283144384,0.854,6/15,15.43%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,fatty acid synthase activity (GO:0004312),-0.7227951268978863,-1.6783616753464952,0.011650485436893204,0.15853028744427997,0.87,4/10,13.03%,ELOVL7;ELOVL5;ELOVL6;ELOVL1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6409513302197751,-1.677802843658605,0.011538461538461539,0.14925918753293022,0.872,6/16,15.43%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6584589921419749,1.6739616764164371,0.01968503937007874,0.4027014356725437,0.992,2/18,0.23%,ALDH1A1;ALDH1A2
prerank,rRNA binding (GO:0019843),-0.5031338477668981,-1.6552392052192435,0.004434589800443459,0.17951123796985993,0.927,21/42,27.58%,RPL11;CAVIN1;RPL23;RPS9;RPS3;RPS14;RPL5;RCC1L;RPLP0;ERAL1;RPS5;RPL12;NOP53;ANG;PPAN;MRPS11;MRPS27;MRPL11;MRPS18C;MRPL18;DDX28
prerank,acetyltransferase activity (GO:0016407),0.5883239418089158,1.6536067313080107,0.011342155009451797,0.44460784765344286,0.996,13/31,16.53%,PAFAH2;NAA80;PAFAH1B3;SPHK1;DBT;KAT8;KAT6B;SMARCE1;SAT2;ESCO1;CREBBP;NAT8;NAT14
prerank,poly(U) RNA binding (GO:0008266),0.6411743182976183,1.6476841888194804,0.023166023166023165,0.43607958209725267,0.997,7/20,5.90%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,sialyltransferase activity (GO:0008373),-0.5813219512465426,-1.6448913465039776,0.01642710472279261,0.18930088259973848,0.937,8/20,9.43%,ST3GAL4;ST6GALNAC3;ST6GAL1;ST3GAL6;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.46783208759083694,-1.631644788875939,0.007481296758104738,0.20261992544398857,0.956,23/57,18.29%,COX4I1;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFA4;NDUFB7;UQCRH;COX6A1;NDUFA13;NDUFS1;UQCR11;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;NDUFB4;NDUFS7;UQCRC1
prerank,semaphorin receptor binding (GO:0030215),-0.568390373946638,-1.6288400862874945,0.006224066390041493,0.199623811375668,0.959,10/23,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.7364477434450736,1.6230562669819188,0.02591792656587473,0.5013341609699472,0.999,1/11,0.28%,SLC22A4
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6067733416074068,-1.6196864957697354,0.017786561264822136,0.20875597523049663,0.968,5/17,1.76%,ATP10A;PITPNC1;ATP8B1;PLTP;PITPNM2
prerank,calcium:sodium antiporter activity (GO:0005432),0.7339597719686324,1.6163976173391987,0.0300187617260788,0.49747251538303955,0.999,3/10,3.07%,SLC24A3;SLC8A3;SLC8A1
prerank,metallopeptidase activity (GO:0008237),0.45785801364076173,1.5999708325575193,0.009230769230769232,0.5339259354801725,1.0,16/113,8.06%,ADAMTS12;ADAMTS9;PAPPA;ADAM12;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ACE;ADAMTS7;MMP19;NRDC;MMP9;ADAMTSL4
prerank,sodium:proton antiporter activity (GO:0015385),-0.6843711734846241,-1.595271163898356,0.01486988847583643,0.24999885955928808,0.981,3/11,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,acylglycerol lipase activity (GO:0047372),-0.6582082877745455,-1.5881274951087854,0.019230769230769232,0.2561023866845713,0.988,3/11,9.35%,ABHD2;MGLL;LIPE
prerank,phospholipase binding (GO:0043274),0.676267215873656,1.5825600328044873,0.04781704781704782,0.578240511313108,1.0,3/13,1.89%,ARHGAP6;PRKN;PDPK1
prerank,metalloendopeptidase activity (GO:0004222),0.4755623672009351,1.5741496729374078,0.008361204013377926,0.5824721075712628,1.0,13/76,8.06%,ADAMTS12;ADAMTS9;TRABD2B;ADAMTS5;THSD4;ADAMTS10;ADAMTS15;MMP2;ADAMTS7;MMP19;NRDC;MMP9;ADAMTSL4
prerank,phospholipase activator activity (GO:0016004),0.7092420227239609,1.574083835312869,0.055674518201284794,0.5552973349793936,1.0,2/10,1.89%,ARHGAP6;PDPK1
prerank,outward rectifier potassium channel activity (GO:0015271),0.7000751622350481,1.573006843854707,0.0423728813559322,0.534392844998417,1.0,4/11,4.07%,KCNK2;KCNA5;KCNT2;KCND3
prerank,diacylglycerol kinase activity (GO:0004143),-0.657406894917371,-1.568626008023405,0.028901734104046242,0.2915958405466208,0.998,7/11,24.15%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKE;DGKQ
prerank,poly-pyrimidine tract binding (GO:0008187),0.5853047234858434,1.5644952270561558,0.045368620037807186,0.5446398028252738,1.0,7/23,5.90%,ATXN1;RBMS1;RBMS3;HNRNPC;PABPC4L;HNRNPH1;RBMS2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6465007836473053,1.5577694468250822,0.051440329218107,0.5475172245152413,1.0,5/14,11.64%,SLC7A11;SLC1A3;SLC25A18;SLC25A22;SLC38A7
prerank,acid-thiol ligase activity (GO:0016878),0.6680365079440028,1.556286362295483,0.02564102564102564,0.5307306848961691,1.0,3/13,8.71%,ACSS3;ACSL1;AASDH
prerank,translation initiation factor activity (GO:0003743),-0.4916392069847456,-1.5553074066468981,0.013363028953229399,0.3121816744862884,1.0,19/36,24.23%,EIF3F;EIF1B;EIF4G3;EIF3I;EIF4G1;EIF3D;EIF3B;EIF2B5;EIF3C;EIF1;EIF2B2;EIF2A;EIF5B;EIF2D;EIF3A;EIF3G;EIF4E;EIF5;EIF3K
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.4879075679175783,1.5418551648827479,0.023688663282571912,0.5624807766720575,1.0,14/55,12.29%,SLC22A4;SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC16A6;SLC19A2;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.6244764720840188,1.5406983982967228,0.054901960784313725,0.5459099464484477,1.0,7/16,11.64%,SLC13A3;SLC25A18;SLC13A5;SLC1A5;SLC25A11;SLC25A22;SLC38A7
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.5457579317936261,-1.5388581147157936,0.030042918454935622,0.3441208570640038,1.0,9/20,17.93%,TJP2;DLG2;MAGI3;CMPK1;GUK1;AK2;CASK;LRGUK;AK6
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5641453648538869,-1.538072221507922,0.024193548387096774,0.333753934203667,1.0,10/19,30.72%,EFNA5;GAS6;PAK2;NRG3;GREM1;ABI1;AFAP1L2;DGKQ;ANGPT4;EGF
prerank,AMP binding (GO:0016208),0.6899590846722496,1.5378128282031223,0.041666666666666664,0.5362129406128503,1.0,3/11,6.95%,PRKAG2;PRKAG3;MPPED2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4802718705520727,1.530326624848502,0.03140495867768595,0.543429239849313,1.0,18/60,11.42%,EPHA7;EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,chloride channel activity (GO:0005254),-0.42340765703069794,-1.525885407921812,0.017369727047146403,0.3536134986146904,1.0,21/59,25.74%,SLC26A7;ANO1;ANO4;CLIC4;GABRB3;CLCN5;GABRB1;TTYH3;TTYH2;ANO3;GABRG3;SLC1A4;ANO2;CFTR;GLRA3;GABRA5;GABRE;BEST1;CLCN3;GABRG2;GLRA1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5003540666772613,1.5241237259150622,0.04222972972972973,0.5480663399114322,1.0,9/47,6.03%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;PDPN;SLC6A1;SLC38A9;SLC43A1
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7029254774565853,1.5215988944714667,0.06140350877192982,0.5391747419313232,1.0,1/10,0.08%,PRKAG2
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6113480228430123,-1.5203733448672754,0.04206500956022945,0.3570604350207163,1.0,7/13,16.92%,SH3BP4;ARHGDIB;ARHGDIA;CCDC88A;RANBP1;GDI2;GDI1
prerank,frizzled binding (GO:0005109),0.5228598115360071,1.5169750653711465,0.042328042328042326,0.5375081621630337,1.0,8/34,10.14%,WNT4;RNF43;WNT6;NDP;ZNRF3;WNT5B;RYK;DVL3
prerank,C-C chemokine receptor activity (GO:0016493),0.5849745883423635,1.5100750255445,0.05168986083499006,0.5442575503519654,1.0,4/21,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6263745674826319,-1.5084608348800315,0.03954802259887006,0.3795757332463557,1.0,3/12,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,GTPase activity (GO:0003924),-0.3523362979253952,-1.5054859116866504,0.0033444816053511705,0.37660341365543104,1.0,74/192,26.13%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;EEF2;RAB31;RAB3C;GNAL;ARHGDIB;RAB27A;GCH1;RERG;NRAS;RHOB;GBP4;GNAI1;RHOT1;GNA14;GNA12;ENTPD7;MRAS;GFM1;DNM2;RAB28;NKIRAS1;SEPTIN9;RHOA;RAB38;GPN3;BMS1;GNA11;RALB;RAB3B;ARL8A;GBP5;RHEB;RAB1A;DNM1;GSPT2;AGAP3;GBP3;RABL3;ATL2;TPPP;RHOG;RRAS;GNAZ;RRAGB;RAB1B;GNA13;RIT2;MTG1;RAB8A;RAP1GAP;MFN2;TSR1;RAB8B;GNAO1;GNG3;RAB7A;RAB3A;GEM;DRG2;RAB2A;RAB14;HRAS;RAB5B;RAB6B;RND1;GNB2;GNB1
prerank,cation:chloride symporter activity (GO:0015377),-0.6612785627870859,-1.5049252562391868,0.05128205128205128,0.36645901676618914,1.0,5/10,10.53%,SLC12A7;SLC12A2;SLC12A6;SLC12A8;SLC12A4
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.5782866253995751,-1.4992951716796783,0.044534412955465584,0.3707050052422258,1.0,8/15,23.86%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;CCKBR;PIK3R3;SOCS1
prerank,C-C chemokine binding (GO:0019957),0.5648868303339274,1.4982422755446023,0.050682261208576995,0.5675028072624638,1.0,4/22,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.38448254833581413,1.4918749403819285,0.0,0.5725318309962963,1.0,73/232,19.46%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;KCMF1;NEURL2;RNF138;RNF2;UFL1;RNF217;ZNRF3;LTN1;FBXO44;SH3RF1;RNF181;UBR2;RNF152;RNF145;TRIM56;RNF135;SIAH2;WWP2;AMFR;PIAS1;RNF216;RNF180;RC3H2;NHLRC1;FBXO6;MDM2;ITCH;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;MYCBP2;RNF14;GID4;TRIM26;TRIM43;RCHY1;TRIM24;RNFT2;BIRC2;TRIM62;UBR1;PPIL2;RNF122;CBX4;HECTD1;TRIM17;CBLB;TRIM69;TRIM39;NHLRC3;PELI3;DTX3L;TRIM9;TRAF6;MKRN2;SHPRH;RNF130;PIAS3;HACE1;XIAP
prerank,cytokine receptor activity (GO:0004896),0.4387346362698386,1.4892399562874552,0.03145695364238411,0.5661079223813004,1.0,7/83,4.03%,IL31RA;LEPR;ACKR2;CCR9;CNTFR;IL13RA1;GFRAL
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6601839860664084,1.4855528245316212,0.09368635437881874,0.5637791473919425,1.0,3/12,3.44%,IGF1;GNAS;IGF2
prerank,receptor antagonist activity (GO:0048019),0.5973985604976229,1.4840743515781138,0.08519269776876268,0.5545849823837292,1.0,3/17,2.62%,DKK3;PXDN;DKK1
prerank,lipase activator activity (GO:0060229),0.6743579041911401,1.4823878795382086,0.06866952789699571,0.5461649254052195,1.0,2/10,1.89%,ARHGAP6;PDPK1
prerank,NAD binding (GO:0051287),0.5497609889358019,1.48234575392489,0.06355140186915888,0.53268291306591,1.0,9/26,16.29%,ALDH1A1;CRYL1;SORD;NUDT6;PARP9;CRYZ;BDH2;ALDH2;SIRT3
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.5694498841512725,-1.4808685473036782,0.05084745762711865,0.4107653611661691,1.0,11/16,32.33%,RPS3;CD38;ADPRH;SMUG1;NEIL1;NEIL3;NTHL1;SARM1;MACROD2;NEIL2;BST1
prerank,pyridoxal phosphate binding (GO:0030170),0.5719919386746324,1.4806649053701666,0.07307692307692308,0.5253277252235956,1.0,6/20,13.02%,ABAT;CBS;ACCS;SRR;THNSL2;SHMT1
prerank,cAMP response element binding (GO:0035497),0.6598022779439046,1.479325955985813,0.09009009009009009,0.5160513902452507,1.0,1/10,0.08%,CREB5
prerank,ubiquitin protein ligase activity (GO:0061630),0.38143439095347137,1.4771792276723144,0.0028530670470756064,0.5103628302922499,1.0,65/228,17.79%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;TRIM5;MGRN1;NEDD4;KCMF1;NEURL2;RNF138;RNF2;RNF217;ZNRF3;LTN1;FBXO44;SH3RF1;RNF181;UBR2;RNF152;RNF145;TRIM56;RNF135;SIAH2;WWP2;AMFR;RNF216;RNF180;RC3H2;UBE4A;NHLRC1;FBXO6;MDM2;ITCH;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;MYCBP2;RNF14;GID4;TRIM26;TRIM43;RCHY1;TRIM24;RNFT2;BIRC2;TRIM62;UBR1;PPIL2;RNF122;HECTD1;TRIM17;CBLB;TRIM69;TRIM39;NHLRC3;PELI3;DTX3L;TRIM9;UBE4B
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6288916459460426,1.4768929062844425,0.09071274298056156,0.49956834890892676,1.0,2/13,1.28%,BMP6;BMP7
prerank,sulfotransferase activity (GO:0008146),0.5128084916699723,1.4744752560790093,0.04964539007092199,0.4950015764506929,1.0,9/33,11.73%,HS3ST3A1;UST;TPST1;GAL3ST3;GAL3ST2;CHST3;CHST15;SULT4A1;HS6ST1
prerank,MAP kinase activity (GO:0004707),0.6333123627741992,1.4743893928996472,0.0728744939271255,0.4845827561841419,1.0,2/14,4.54%,MAPK4;MAPK9
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6183473297561439,1.4742087097256737,0.08853118712273642,0.474711916595086,1.0,6/15,19.76%,KMT2A;ASH2L;SETD1A;KMT2B;WDR82;SETD4
prerank,ligand-gated anion channel activity (GO:0099095),-0.5358750990077817,-1.470175292890242,0.07889546351084813,0.4301314700052688,1.0,9/17,25.74%,GABRB3;GABRB1;GABRG3;CFTR;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,lysine-acetylated histone binding (GO:0070577),0.5670444018785153,1.4661967110282952,0.08151093439363817,0.47761498511438627,1.0,9/20,20.80%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;BRDT;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),0.5670444018785153,1.4661967110282952,0.08151093439363817,0.47761498511438627,1.0,9/20,20.80%,KMT2A;DPF2;PSME4;PHIP;TRIM24;ATAD2B;BRD7;BRDT;CARM1
prerank,copper ion binding (GO:0005507),0.4911152988789095,1.459282296871716,0.06759098786828423,0.488912678962982,1.0,10/42,11.56%,MOXD1;HEPH;SOD3;LOXL3;LACC1;COX17;CCS;DCT;ATP7B;PAM
prerank,disordered domain specific binding (GO:0097718),-0.5037131751260954,-1.4591101429881,0.06292134831460675,0.4529517678478338,1.0,7/23,10.74%,FN1;HSP90AA1;CALM1;HSP90AB1;FYN;GAPDH;KCNA1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.5324294723426981,-1.4518087630005652,0.05714285714285714,0.46500699460029066,1.0,8/18,23.86%,PIK3R6;SOCS2;SOCS5;PIK3R5;CISH;CCKBR;PIK3R3;SOCS1
prerank,death receptor binding (GO:0005123),-0.5488626130372324,-1.4515244134719123,0.07183364839319471,0.45368194585115473,1.0,11/15,32.31%,DAB2IP;NGF;EDA;TMBIM1;CASP8AP2;MADD;MYD88;BID;FADD;NTF3;PIDD1
prerank,sterol binding (GO:0032934),0.45675779945262546,1.4504453268498974,0.03547297297297297,0.5037784235324466,1.0,6/56,4.04%,RORA;SIDT1;OSBPL8;INSIG2;GRAMD1C;ABCA1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.5105862260798715,-1.4502832285077238,0.06223175965665236,0.4461522860894364,1.0,14/22,25.10%,ATP6V0A1;ATP2C1;ATP2A2;ATP2A3;ATP6V1A;ATP6V0C;TCIRG1;ATP6V1E1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,poly-purine tract binding (GO:0070717),0.5226772497653496,1.448084398031845,0.08061420345489444,0.5014098140670114,1.0,6/27,5.90%,ATXN1;RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,store-operated calcium channel activity (GO:0015279),-0.6302561472496884,-1.4459981658231793,0.07024029574861368,0.44768837657124216,1.0,6/10,17.03%,TRPC3;TRPC6;TRPC4;STIM2;TRPC1;ORAI1
prerank,BMP receptor binding (GO:0070700),0.6288924421083448,1.445798157612186,0.11555555555555555,0.49779452384834605,1.0,2/12,1.28%,BMP6;BMP7
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6613763844586807,1.4449203540091402,0.1,0.4909255556988692,1.0,4/10,11.74%,EHHADH;ECHDC3;ECHDC1;AUH
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.46727459616972133,-1.4447186169739656,0.05230125523012552,0.4400258362670939,1.0,10/31,13.73%,SLC12A7;SLC12A2;KCNK5;ABCC9;SLC12A6;SLC12A8;SLC12A4;KCNA1;HCN1;TMEM38B
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.32549915981050365,-1.4443178089604,0.0,0.4307381776756667,1.0,95/248,26.13%,DNM3;EEF1A1;RAP1A;RHOJ;KRAS;RAC1;HSP90AA1;MYL6;RASL12;EEF2;RAB31;RAB3C;GNAL;ARHGDIB;RAB27A;GCH1;RERG;NRAS;RHOB;GBP4;GNAI1;RHOT1;GNA14;SMCHD1;GNA12;ENTPD7;KIF26A;MRAS;MYH9;GFM1;DNM2;ABCB10;RAB28;NKIRAS1;SEPTIN9;RHOA;TOR1B;RAB38;GPN3;TOR3A;BMS1;GNA11;KIF1A;RALB;RAB3B;ARL8A;GBP5;RHEB;RAB1A;ATP2B1;DNM1;GSPT2;CLU;AGAP3;GBP3;ABCD2;RABL3;ATL2;CFTR;TPPP;DHX29;RHOG;RUVBL1;ABCA3;RRAS;GNAZ;RRAGB;RAB1B;GNA13;RIT2;MTG1;KIF15;ATAD1;RAB8A;RAP1GAP;VCP;MFN2;TSR1;RAB8B;GNAO1;GNG3;HSPA1B;RAB7A;RAB3A;GEM;DRG2;RAB2A;RAB14;HRAS;RAB5B;RAB6B;RND1;KIF14;GNB2;GNB1
prerank,N-acetyltransferase activity (GO:0008080),0.5690620708934131,1.440454643922053,0.0973630831643002,0.49403398098096923,1.0,11/19,25.01%,NAA80;AANAT;SMARCE1;SAT2;ESCO1;NAT8;NAT14;KAT2B;NAA50;NAA10;ATAT1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4512213644444933,1.4377550478413628,0.059602649006622516,0.49246518628733577,1.0,17/60,11.42%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;EPHA8;EPHA4;PDGFRA;DDR1;IGF1R;DDR2;RYK;MUSK;AXL;EPHA2;ERBB2
prerank,androgen receptor binding (GO:0050681),-0.4859367405427523,-1.4293406758692477,0.066,0.46547402603843624,1.0,8/25,9.16%,FOXP1;CALR;KDM4C;KDM3A;ARID5A;DDX5;TMF1;ZBTB7A
prerank,leucine zipper domain binding (GO:0043522),0.6416778325188053,1.4272367364934602,0.1279317697228145,0.5123294095551015,1.0,1/10,0.82%,PAWR
prerank,leak channel activity (GO:0022840),0.5655022594086108,1.4262998822070563,0.102,0.5060735666282684,1.0,3/18,5.96%,KCNK2;NALCN;TMEM175
prerank,chemokine receptor activity (GO:0004950),0.5320985503606344,1.42372472762702,0.08560311284046693,0.5042971337503033,1.0,4/24,4.02%,ACKR2;CCR9;CXCR5;CXCR6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6094315877822438,1.4235229549725057,0.12317327766179541,0.4964494926695043,1.0,3/14,5.55%,ALDH4A1;AASS;MTHFR
prerank,ankyrin binding (GO:0030506),-0.5219874137704088,-1.422287201471167,0.07520325203252033,0.47690201276381244,1.0,7/19,14.99%,SPTBN1;CDH1;PLEC;NRCAM;PTPRC;SPTBN4;KCNQ2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.583708848321079,-1.4222386954553994,0.07945736434108527,0.4664853936155087,1.0,6/12,18.64%,PIK3R6;PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,hydro-lyase activity (GO:0016836),0.4759029432697175,1.4212769116090738,0.06412478336221837,0.4938733393525087,1.0,13/41,16.17%,GMDS;CBS;HACD1;EHHADH;HACD3;ECHDC3;ECHDC1;L3HYPDH;AUH;ENO2;FAHD2A;ACO2;HACD4
prerank,peptidase inhibitor activity (GO:0030414),0.4921176994935185,1.4196360079422314,0.07945736434108527,0.489825738631872,1.0,9/33,11.22%,TFPI;ITIH2;SERPIND1;PROS1;A2ML1;GPC3;SIMC1;CST7;RENBP
prerank,RNA binding (GO:0003723),-0.28183930511086275,-1.4145159664395996,0.0,0.47961032702782014,1.0,387/1321,22.06%,SPTBN1;MSI2;SORBS2;TMSB4X;SYNE1;EEF1A1;MBNL1;ACTN4;MSN;LRRFIP1;HSPA8;RPL37A;TFRC;FAU;RPL41;NOVA2;RPL11;TPT1;RPL13;RPL27A;HSP90AA1;RPS21;CAVIN1;TES;RPL17;RPL23;HSP90AB1;RPS24;HNRNPK;RPL19;RPL21;RPS9;PPARGC1A;TARDBP;ADARB1;RPL6;RPS15;AHNAK;RPL38;CMSS1;RPL37;PLEC;SUCLG1;EEF2;RPL4;MAP4;RPSA;RPS7;VIM;RPS8;RPS3;RACK1;PPIA;RBFOX1;RPL8;RPS23;SMC1A;RPS19;PKM;RPS11;ADARB2;RPL34;IREB2;PSTK;RPL28;RPL18A;RPL26;CDK11B;QKI;UCHL5;RPL24;LUC7L2;SRSF2;RBFOX3;RPS14;FLNA;ACTN1;RPL18;CKAP4;RPS6;RPL23A;ATP5F1A;RPS12;HSPB1;HNRNPAB;RFTN1;G3BP1;RBFOX2;RBM47;RPS20;PABPC1;PINX1;SRP9;CALR;YBX3;TRIM25;RPS25;RPS18;EIF1B;HSP90B1;RTCB;SRSF1;RPL3;SARS1;SLC3A2;TFB2M;RPL32;LGALS1;ATXN2L;GNL3;RPL36;RPS27A;UBC;COL14A1;RPL14;KCTD12;SRRM3;ARF1;MYH9;TCF20;RPL5;GFM1;PUM2;EIF4G3;DCAF13;RPS2;HNRNPU;HNRNPA3;EIF3I;YBX1;PPIE;MTHFSD;CISD2;JUN;SF3B1;SF3B2;RPL27;MRPL32;RCC1L;LARP7;CPSF7;RPL31;MAK16;RPS27;TIAL1;PATL1;PHF5A;RPL29;SFPQ;KHDC4;RBM14;DDX5;DIDO1;DDX52;CPNE3;GRN;STAU1;LLPH;RALYL;DDX20;PDAP1;CCDC47;PPP1R10;PYM1;SRSF5;ZC3H12C;PPIB;RTN4;IMP3;RPLP0;APEH;RPL35A;DDX39B;EIF4G1;ANKHD1;PDCD11;ZFP36L1;BMS1;ADAR;ZC3H8;STRBP;YWHAG;SSB;EIF3D;MRPS14;NUDT4;MEPCE;RPL7A;RPS28;RPL7;STAT3;CPSF3;TUBB4B;POP5;PTPN1;TUBA1B;RPN1;RSL1D1;KIN;S100A16;HNRNPH2;ALDH18A1;RPS17;SRSF9;YTHDF3;RPS10;CPSF6;LBR;CLNS1A;DGCR8;RPUSD4;CWC15;DDX54;RALY;RPL30;MYO5A;DNM1;RANGAP1;TASOR;ZRANB2;RPS4X;RBM8A;GSPT2;MARK2;YARS1;OAS2;MYBBP1A;HSPD1;DHX37;RRBP1;STRAP;CANX;KHDRBS3;ERAL1;RNPS1;SHFL;SNRPC;SRSF6;BUD23;EIF4H;WDR3;FBL;PRPF40B;ZCCHC9;PPRC1;RPS27L;SRPK1;HNRNPDL;RSL24D1;POP4;EIF3B;ALDOA;GRSF1;MTCL1;SAMSN1;GDI2;RPP21;NUDT1;FUS;SF3B5;TENT5A;RPF1;RPS26;NELFCD;LARP1B;AGFG1;RTRAF;RPS16;ALKBH8;NUFIP2;MRPS5;HNRNPA0;RPS5;RCC2;TBL2;FASN;MRPL23;DHX32;RPL13A;RIDA;EIF3C;IFIH1;RBM42;EIF1;LIN28B;AKAP1;DHX29;SAFB2;AKAP8;GLRX3;POLR2G;RBM28;IMMT;YTHDC2;TOP2A;CPSF2;BTF3;SERBP1;ZC3H7A;SPEN;RPL36A;EIF2A;COA6;RPL12;RPP30;N4BP1;ZC3H12A;CSTF2T;TBL3;UTP18;NELFE;PCBP1;DSP;UTP15;SMG5;EIF5A;PCF11;CSTF2;ZBED4;FASTKD3;DDX17;EIF5B;MTREX;RPL9;EBNA1BP2;NOLC1;BST2;HNRNPUL1;DALRD3;DCN;KRI1;MRPS35;MRPS28;YTHDC1;MRPL13;SUPV3L1;EDC3;R3HDM1;CTNNA1;EXOSC10;PRKRIP1;THUMPD1;MEX3A;PPP1CC;PCBP4;FKBP4;HSPA9;NOP53;HNRNPLL;PTBP1;ANG;AGO3;DDX24;RPL35;NOC2L;RBM22;TRUB2;NKAP;SNIP1;MEX3B;TSN;MAGOH;FARSA;METTL3;MAPRE1;FMR1;ADD1;NHP2;UBA1;LRRC47;SLTM;CCDC124;CCDC137;RPL22;ELP5;EIF3A;TRA2B;PWP2;MAZ;TSNAX;PPAN;RO60;EIF4B;VCP;EIF3G;PUM3;TRMT10C
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6097753132911807,-1.412585383893433,0.09215686274509804,0.4757166444507198,1.0,6/10,18.17%,CD200;CXADR;JUP;CD47;DSG2;DSP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.44605110999973135,1.4124843444060016,0.06506849315068493,0.5008931514477755,1.0,16/53,12.76%,SLC7A11;SLC22A2;SLC38A3;SLC6A9;SLC1A3;SLC25A18;SLC38A9;SLC43A1;SLC1A5;SLC25A22;SLC36A2;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,metal ion:proton antiporter activity (GO:0051139),-0.580469130013692,-1.4112868680668216,0.0735009671179884,0.46990419133820066,1.0,3/13,5.56%,SLC9A2;SLC9B2;SLC9A8
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3261518417320454,1.4070886228158297,0.0,0.5076961136011866,1.0,141/830,13.94%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;OSR1;AEBP1;ARNT2;RBPJ;ZIC1;HOXC6;EPAS1;HLF;PPARA;NR2F2;NPAS3;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;CUX1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;BBX;HOXC5;PKNOX2;VSX2;STAT5B;NFAT5;ZFP90;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;ZFP37;THAP1;SALL1;RFXAP;ZNF23;SMAD3;EN1;PBX4;NR6A1;RBL2;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;HOXC8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;ZNF177;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;HOXB9;TFDP2;MLXIP;CLOCK;ZNF148;SRF;DMRTA2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.522389443837509,1.406376001900362,0.0898876404494382,0.5015043804383416,1.0,3/25,1.11%,CYP26B1;MICAL3;CYP27A1
prerank,GTPase regulator activity (GO:0030695),0.36274033323451016,1.4013967189318983,0.025714285714285714,0.5069594272402863,1.0,34/212,9.48%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;ASAP1;SMAP2;PLCB1;ARHGAP20;ALS2;ARFGAP3;SYDE2;LLGL2;ARHGAP26;CPEB2;WASL;NPRL2;ARHGAP40;LRRK2;HACD3;TBC1D9B;ASAP3;GNAQ;ARHGAP35;ARHGAP9;MYO9B;TBC1D4;SIRPA;ARHGEF10L;GNB5
prerank,GTP binding (GO:0005525),-0.3289274647886703,-1.3982000209794267,0.020134228187919462,0.5008770512746333,1.0,62/172,25.17%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;GCH1;TGM2;RERG;NRAS;RHOB;TUBB3;GBP4;GNAI1;RHOT1;ARF5;GNL3;SCG5;ARF1;MRAS;DNM2;RAB28;RHOA;RAB38;BMS1;ARHGEF5;RALB;ARL8A;TUBB4B;TUBA1B;GBP5;RHEB;GBP3;TUBB2A;TUBA1A;RABL3;ATL2;RHOG;EIF2B2;RRAS;TUBB4A;RRAGB;RAB1B;RAB39A;RIT2;ARFIP2;INSR;RAB8A;TUBD1;TSR1;RAB7A;ARL4A;GEM;SEPHS1;DRG2;TUBB2B;RAB2A;RAB14;NUDT16;HRAS
prerank,histone methyltransferase binding (GO:1990226),-0.591717546618511,-1.3906047390617478,0.10559006211180125,0.5144861630328423,1.0,3/11,6.01%,HSP90AB1;LCORL;CTNNB1
prerank,FAD binding (GO:0071949),0.5243321637323503,1.3902425118481154,0.09140767824497258,0.5286627131336739,1.0,7/24,11.85%,MICAL3;DDO;SQOR;MTHFR;NDOR1;PRODH;CRY1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.3062865393503728,-1.390093048990085,0.0036900369003690036,0.506057009200047,1.0,91/254,23.48%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;RPL23;HSP90AB1;ATXN3;FBXO7;PPARGC1A;MID1;UBB;NFKBIA;DNAJA1;TRIB2;FZD4;UBXN1;FZD6;CALR;NKD2;FAF1;NEDD8;ARRB1;BAG6;RPS27A;UBC;GSK3B;TNFRSF1B;UCHL1;RPL5;CUL3;APBB1;MAP1LC3B;SMAD5;BAG1;JUN;FOXO1;DERL1;CHEK2;UBE2B;RTN4;RBX1;APC;HSPA5;ATP6V0C;RALB;ISG15;TUBA1B;CAMLG;HSPD1;CLU;OTUB1;ELOB;RNF34;PRKAR1A;CUL1;TPI1;CKB;TRAF1;ERLIN2;CASP8;UBE2G1;UBA52;WFS1;LAPTM5;HERC2;SPOPL;PER1;AUP1;CD40;SMG5;UQCRC1;UBE2D1;PINK1;TMBIM6;ARRB2;SCAMP3;JAK1;HSPA9;DIO2;GABARAPL1;ARIH1;KCNH2;CDKN1A;VCP;HDAC6;MFN2;UBOX5;TRIB3;RELA;HSPA1B
prerank,phosphatidylglycerol binding (GO:1901611),-0.5614817921676613,-1.3891256064039004,0.10058027079303675,0.49940255162204883,1.0,6/13,18.80%,PITPNC1;PLTP;STOML2;PLEKHN1;UQCC3;PITPNA
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.32343402483280215,1.3885361045898932,0.0,0.5254296723848833,1.0,129/730,13.94%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;ARNT2;RBPJ;ZIC1;HOXC6;HLF;PPARA;NR2F2;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;SCX;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;HOXC5;PKNOX2;STAT5B;NFAT5;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;THAP1;SALL1;ZNF23;SMAD3;EN1;PBX4;NR6A1;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;CREB3L2;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;HOXB9;MLXIP;CLOCK;TRIM24;ZNF148;SRF;DMRTA2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5806216723306798,-1.384709079182067,0.1,0.5044611727491821,1.0,7/12,23.57%,CISD2;ISCU;CISD1;XDH;CIAPIN1;ISCA2;ISCA1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5625133358295956,1.3784006236902668,0.14591439688715954,0.5451529281792743,1.0,2/15,1.52%,ACKR2;CCR9
prerank,poly(A) binding (GO:0008143),0.5227482372649395,1.3767933738404778,0.10848126232741617,0.5417064362182381,1.0,5/21,5.90%,RBMS1;RBMS3;RBPMS;PABPC4L;RBMS2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.6268952617361871,1.3753851118354978,0.13566739606126915,0.5381076929784563,1.0,4/10,7.94%,KDM7A;KDM2B;PHF8;KDM2A
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.6008385733082187,-1.3752781528362887,0.11172161172161173,0.5244893433840796,1.0,5/10,18.74%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,phosphatidic acid binding (GO:0070300),-0.5068286028859792,-1.3719384052611132,0.09274193548387097,0.5250902658823475,1.0,8/19,19.26%,PITPNC1;PLTP;PACSIN2;MARK1;PLEKHN1;ATP13A2;UQCC3;JPH2
prerank,histone demethylase activity (GO:0032452),0.49978323687460924,1.3711944993016372,0.10218978102189781,0.5421490068360635,1.0,13/27,18.39%,KDM7A;JARID2;KDM2B;PHF8;KDM2A;KDM5B;KDM6B;KDM3B;KDM5C;KDM6A;PHF2;RIOX2;KDM4D
prerank,chemokine binding (GO:0019956),0.4794170306825944,1.3699516742287412,0.09541284403669725,0.5378075035911861,1.0,5/30,4.02%,ACKR2;CCR9;CXCR5;PDPN;CXCR6
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31899655159600193,1.3689143460758422,0.0022935779816513763,0.5333441109108592,1.0,126/731,13.94%,GLIS3;CREB5;RORA;SOX5;MAF;TCF4;TCF7L2;ARNT2;RBPJ;ZIC1;HOXC6;HLF;PPARA;NR2F2;IKZF2;HOXC4;ZEB2;ZKSCAN2;KCNIP3;PRRX1;MEIS1;HOXB4;ESRRG;MXI1;SATB1;PRDM5;ZEB1;ZIC2;EBF1;MYBL1;DMRT1;NR1I2;ASCL2;SOX6;ZBTB20;HOXB3;HIF3A;PAX5;NFYB;ZIC5;HOXA3;HOXC5;PKNOX2;STAT5B;NFAT5;HOXA7;FOXD1;NFIB;TEAD1;ELF4;MGA;TEF;ZNF367;IKZF4;GMEB1;SOX1;SIX5;SALL4;ZFHX2;IRF8;ZNF250;GLI3;ZNF569;HIVEP2;MXD1;MYNN;ZBTB32;TCF7L1;THAP1;SALL1;ZNF23;SMAD3;EN1;PBX4;NR6A1;ZKSCAN5;TCF12;TEAD3;NFIA;ARNT;ZNF628;MITF;KDM6B;CEBPG;EBF4;NFYC;HOXB6;NSD1;BATF2;IRF3;ZSCAN29;IRX1;ATOH8;NEUROD2;HDAC1;ZBTB11;TFAP2A;ZNF8;TFAP2B;ZIC4;ZNF568;RXRA;ZBTB38;MYB;ZBTB39;NPAS2;ZBTB37;E2F6;SOX13;GMEB2;HSF1;AR;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;HOXB9;MLXIP;CLOCK;ZNF148;SRF;DMRTA2
prerank,Wnt-activated receptor activity (GO:0042813),-0.5305983499415441,-1.3680961989275373,0.10714285714285714,0.5272168314223349,1.0,5/15,6.14%,ROR1;PKD1;FZD4;FZD6;LRP5
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.5488419954126816,-1.3675841828712278,0.10638297872340426,0.5192906746883266,1.0,5/14,17.58%,SLC26A7;SLC26A2;SLC26A6;SLC25A30;SLC26A11
prerank,glutamate receptor binding (GO:0035254),-0.5231600268934385,-1.3667439164865125,0.09533898305084745,0.5128328386049091,1.0,5/17,8.94%,HIP1;SHANK3;NSF;HOMER1;SYNDIG1
prerank,ion gated channel activity (GO:0022839),-0.467546971870326,-1.3645948871013596,0.09761388286334056,0.5100490609862461,1.0,9/24,20.32%,ANO1;ANO4;TTYH3;TTYH2;KCNT1;ANO3;ANO2;TRPM4;ANO8
prerank,alkali metal ion binding (GO:0031420),0.5662358537740876,1.3640338851121057,0.15611814345991562,0.5385330409733866,1.0,1/13,0.21%,ATP1A2
prerank,potassium:proton antiporter activity (GO:0015386),-0.606444740943537,-1.3630459095397038,0.13099630996309963,0.5058291726254693,1.0,2/10,5.56%,SLC9A2;SLC9A8
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.575735964729127,-1.3608151581508703,0.12790697674418605,0.5044712613988451,1.0,5/11,16.21%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5749209081982897,-1.360227663809101,0.09437751004016064,0.49814300843256576,1.0,2/11,0.97%,SGMS1;SGMS2
prerank,double-stranded RNA binding (GO:0003725),-0.3609223656262848,-1.356725255583374,0.05714285714285714,0.5005257386426316,1.0,20/70,13.36%,MBNL1;MSN;LRRFIP1;TFRC;HSP90AB1;ADARB1;VIM;ADARB2;ACTN1;RFTN1;SLC3A2;HNRNPU;ADAR;STRBP;TUBB4B;TUBA1B;DGCR8;OAS2;HSPD1;EIF4H
prerank,ATPase binding (GO:0051117),-0.3708983051097471,-1.3547698707348248,0.04714640198511166,0.49811988993464135,1.0,28/71,19.26%,CAV1;PDE4D;ESR1;ATXN3;ATP1B1;UBXN1;ATP6V0A1;NKD2;DERL1;S100A1;RALB;PIH1D1;TCIRG1;ATP6V1E1;SVIP;FBL;PPP3CA;BBC3;NR1H2;TRPC1;DNAJC10;ATP5IF1;WFS1;ATP6V0A4;PLN;DNAJB1;ATP6V0A2;PSEN1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.5306307179797995,-1.3522058158308103,0.12593984962406016,0.4980304588905336,1.0,6/14,19.16%,IREB2;ISCU;NDUFS1;RSAD2;RSAD1;ISCA2
prerank,PDZ domain binding (GO:0030165),0.4244663018216278,1.3507310009832085,0.10862068965517241,0.5664256875097585,1.0,11/61,8.27%,TGFBR3;SLC22A4;ARHGAP29;PLEKHA2;PRKN;SDC2;LLGL2;SSTR2;SYNJ2;PTEN;SRR
prerank,CARD domain binding (GO:0050700),-0.534615719836006,-1.3495262718048997,0.1442687747035573,0.4979591813460394,1.0,9/14,32.29%,NOD1;CARD10;CARD14;CARD16;CARD19;CASP1;CARD11;MAVS;NOD2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5519406690453035,-1.3488266150750994,0.13148148148148148,0.49233729800454534,1.0,4/13,10.64%,PIP5K1B;PIK3C2B;PIK3CD;PIK3C2A
prerank,triglyceride lipase activity (GO:0004806),0.5229336032967017,1.3471045211296937,0.14119922630560927,0.5687511411585964,1.0,4/20,7.58%,CEL;LIPH;LIPC;DAGLB
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.2957072236762485,-1.3429500980215012,0.00398406374501992,0.501840034003917,1.0,93/269,23.48%,ACTG1;PRR5L;HSPA8;RPL11;HSP90AA1;RPL23;HSP90AB1;ATXN3;FBXO7;PPARGC1A;MID1;UBB;NFKBIA;DNAJA1;TRIB2;FZD4;UBXN1;FZD6;CALR;NKD2;FAF1;NEDD8;ARRB1;BAG6;RPS27A;UBC;GSK3B;TNFRSF1B;UCHL1;RPL5;CUL3;APBB1;MAP1LC3B;SMAD5;BAG1;JUN;FOXO1;DERL1;CHEK2;UBE2B;RTN4;RBX1;APC;HSPA5;ATP6V0C;RALB;ISG15;TUBA1B;HGS;CAMLG;HSPD1;CLU;OTUB1;ELOB;RNF34;PRKAR1A;CUL1;TPI1;CKB;TRAF1;ERLIN2;CASP8;UBE2G1;UBA52;WFS1;LAPTM5;HERC2;SPOPL;PER1;SUMO3;AUP1;CD40;SMG5;UQCRC1;UBE2D1;PINK1;TMBIM6;ARRB2;SCAMP3;JAK1;HSPA9;DIO2;GABARAPL1;ARIH1;KCNH2;CDKN1A;VCP;HDAC6;MFN2;UBOX5;TRIB3;RELA;HSPA1B
prerank,deubiquitinase activity (GO:0101005),-0.34845999522719007,-1.3422083657073722,0.04381443298969072,0.4967532479338272,1.0,39/88,29.66%,USP53;ATXN3;USP38;OTUD7A;MINDY2;PAN2;UCHL5;MINDY1;EIF3F;USP29;USP31;UCHL1;ZRANB1;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5749207668858216,-1.341229669998777,0.13799621928166353,0.49258353076534317,1.0,2/10,4.53%,MECOM;PRDM16
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4150521383939012,1.333646605002315,0.09933774834437085,0.598390780078514,1.0,10/60,7.48%,LRRK1;PPM1M;CTDSPL;SSU72;PPM1E;CDC14B;MTMR3;LRRK2;LRRC40;PTEN
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.4489061901823832,-1.3329440043979455,0.1075050709939148,0.5089166481438749,1.0,11/27,17.58%,SLC26A7;SLC26A2;ANO1;SLC39A8;LRRC8A;SLC26A6;SLC25A30;SLC39A14;XPR1;ANKH;SLC26A11
prerank,ephrin receptor binding (GO:0046875),-0.47079904710915954,-1.3312653878565963,0.12127659574468085,0.5060245324953375,1.0,8/21,11.86%,EFNA5;CBL;FYN;CHN1;ANKS1A;PTPN1;CRK;EFNB3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.5483643753239524,-1.3284259292831364,0.14722753346080306,0.5073166536120054,1.0,5/12,16.21%,SLC25A25;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,P-type ion transporter activity (GO:0015662),-0.545759139968058,-1.3262921860521641,0.11281070745697896,0.5056951066278161,1.0,7/12,20.29%,ATP2C1;ATP2A2;ATP2A3;ATP2B1;ATP6V1E1;ATP2B2;ATP2B4
prerank,transferrin receptor binding (GO:1990459),-0.5713940157658052,-1.3251714785815039,0.1425891181988743,0.5021462143830862,1.0,5/10,20.52%,IKBKB;CHUK;CD81;SNX1;SNX2
prerank,fibroblast growth factor binding (GO:0017134),0.5048541719032185,1.3241433020610176,0.16533864541832669,0.6180551587217362,1.0,4/21,3.19%,FGFR2;FGFR4;KL;CXCL13
prerank,guanyl ribonucleotide binding (GO:0032561),-0.3091036351310318,-1.3230390151676235,0.03007518796992481,0.5012120633897763,1.0,68/196,25.20%,EEF1A1;RAP1A;RHOJ;KRAS;RAC1;RASL12;RAB31;RAB27A;GCH1;TGM2;RERG;NRAS;RHOB;TUBB3;GBP4;GNAI1;RHOT1;ARF5;GNL3;SCG5;ARF1;MRAS;PDE2A;DNM2;RAB28;RHOA;RAB38;BMS1;ARHGEF5;RALB;RAB3B;ARL8A;MIEF1;TUBB4B;TUBA1B;GBP5;RHEB;GBP3;TUBB2A;TUBA1A;PDE11A;RABL3;ATL2;RHOG;EIF2B2;RRAS;TUBB4A;RRAGB;RAB1B;RAB39A;RIT2;ARFIP2;INSR;RAB8A;TUBD1;TSR1;RAB8B;RAB7A;ARL4A;GEM;SEPHS1;DRG2;TUBB2B;RAB2A;RAB14;NUDT16;HRAS;RAB5B
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5342310947220382,-1.322207398004921,0.11860940695296524,0.49705904778413995,1.0,5/13,13.66%,GSK3B;CSK;KCNQ1;RYR2;PRKAR1A
prerank,Tat protein binding (GO:0030957),-0.5712297727709048,-1.3208351061825896,0.14624505928853754,0.49433234229035466,1.0,5/10,22.46%,ACTB;DNAJA1;MDFIC;GABARAPL1;DLL1
prerank,estrogen receptor binding (GO:0030331),-0.41963278850675556,-1.3140671535195134,0.12742980561555076,0.5062153766169752,1.0,9/32,11.82%,LEF1;ESR1;RERG;CTNNB1;DCAF13;ARID5A;WBP2;DDX54;NRIP1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.5332603062906314,-1.3120988304721395,0.16981132075471697,0.5046527664525678,1.0,6/12,24.99%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,protein tyrosine kinase activity (GO:0004713),0.3681217202867855,1.3054753609171286,0.10060975609756098,0.6649623532826003,1.0,23/108,11.42%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;EPHA8;EPHA4;PDGFRA;BAZ1B;DDR1;IGF1R;TTK;DDR2;RYK;MUSK;FRK;AXL;ABL1;EPHA2;JAK2;ERBB2
prerank,TBP-class protein binding (GO:0017025),-0.4626956851484728,-1.2986921606051787,0.13821138211382114,0.5351790831234007,1.0,10/21,36.61%,ESR1;AHR;HHEX;YEATS2;RUVBL1;THRA;TAF11;PSMC5;PSMC1;TAF1B
prerank,insulin-like growth factor binding (GO:0005520),0.5281725681251475,1.2918226968887947,0.16913319238900634,0.6984723555835813,1.0,4/15,5.73%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,kinesin binding (GO:0019894),-0.43071838104930776,-1.2895616508292858,0.11883408071748879,0.5552032204154242,1.0,15/27,31.71%,ACTB;AP1AR;TOR1B;ARHGEF10;TTBK2;SPAG9;MAPK8IP2;ATCAY;KLC2;KIF1B;CLSTN1;MAPK8IP3;MAPK8IP1;SPTBN5;FAM83D
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.3070645640967977,-1.2886156156106106,0.028070175438596492,0.5513385050350182,1.0,29/147,6.96%,DOCK9;RAPGEF5;FGD5;ARHGEF28;ELMO1;CYTH3;FGD6;RAP1A;TIAM1;RASGEF1B;DOCK1;CYTH1;RASGRF2;DOCK10;ARHGEF15;PREX1;DENND3;RIN3;EPS8L2;DENND1B;SPATA13;ARHGEF17;ARHGEF6;DOCK2;DENND5B;EEF1D;CCDC88A;ABR;BCR
prerank,glutathione transferase activity (GO:0004364),0.4938825752652335,1.2864982768069992,0.18994413407821228,0.7067576909646305,1.0,3/23,5.01%,GSTM2;GSTT4;GSTT1
prerank,potassium ion leak channel activity (GO:0022841),0.532131539397517,1.2850489004999623,0.1970954356846473,0.7033614271350849,1.0,2/15,5.96%,KCNK2;TMEM175
prerank,sequence-specific DNA binding (GO:0043565),0.30461176263906187,1.284656586101501,0.016646848989298454,0.6963345218133687,1.0,94/590,14.06%,CREB5;RORA;MAF;TCF4;TCF7L2;OSR1;ARNT2;RBPJ;ZIC1;EPAS1;HLF;PPARA;NR2F2;HOXC4;ZEB2;KMT2A;HOXB4;ESRRG;BCL2;CUX1;SATB1;PRDM5;DMRT1;SCX;NR1I2;ASCL2;ZBTB20;ZIC5;BBX;PKNOX2;VSX2;NFAT5;MYRFL;HOXA7;FOXD1;NFIB;TEAD1;ELF4;TEF;GMEB1;KDM2B;IRF8;ZNF250;ACD;GLI3;TET1;ZBTB32;TCF7L1;CXXC5;THAP1;ZNF23;XRCC5;SMAD3;EN1;PBX4;NR6A1;KDM2A;TCF12;ARNT;KDM5B;CEBPG;HOXB6;IRF3;ZSCAN29;IRX1;ABL1;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;RXRA;ZBTB38;NPAS2;KMT2B;ZBTB37;ZNF177;SOX13;GMEB2;HSF1;HIVEP1;KLF5;HOXD4;NFATC4;HOXA6;NR1I3;FOXK2;SNAI1;HOXB9;CLOCK;ZNF148;SRF;DMRTA2;BATF
prerank,MHC protein binding (GO:0042287),-0.46527448112125636,-1.2841044542305242,0.1393939393939394,0.5572488611070291,1.0,7/20,18.49%,ATP5F1A;DERL1;TUBB4B;CD74;CD81;TAPBP;ATP5F1B
prerank,insulin-like growth factor I binding (GO:0031994),0.5481372156821951,1.283365684240118,0.1767337807606264,0.6922267281735343,1.0,4/13,5.73%,IGFBP2;IGFBP4;IGF1R;LRP2
prerank,MHC class I protein binding (GO:0042288),-0.5196938569892726,-1.283021757909137,0.15738963531669867,0.55372681601431,1.0,5/13,18.49%,ATP5F1A;DERL1;TUBB4B;TAPBP;ATP5F1B
prerank,GTPase activator activity (GO:0005096),0.32408397934004773,1.2828380783218372,0.05952380952380952,0.6856985592973763,1.0,52/313,9.87%,ARHGAP28;RANBP3L;ALDH1A1;ARHGAP24;ERRFI1;GMIP;NPRL3;RIN2;ARHGAP29;DENND4A;ASAP1;DOCK11;FGD4;SBF2;SMAP2;DENND2A;FNIP1;PLCB1;RAB3IL1;ARHGAP20;ALS2;RAB3IP;ARFGAP3;SYDE2;LLGL2;RCBTB2;ARHGAP26;IQSEC2;AKAP13;NPRL2;ARHGAP40;LRRK2;HACD3;TBC1D9B;ASAP3;ARHGEF11;GNAQ;RABIF;ARHGAP35;EPS8L1;RAPGEF4;ARHGAP9;RGL1;RALGPS1;MYO9B;TBC1D4;FARP1;ARHGEF10L;ARFGEF2;GNB5;ARHGEF18;RIC1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.43719812267666514,-1.2809621939933409,0.15436241610738255,0.5529178149092306,1.0,10/24,30.45%,KCNJ2;ABCC9;KCNN2;KCNJ8;KCNJ15;KCNH2;KCNJ6;KCNJ16;KCNJ10;ABCC8
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5606688611384559,1.2805086267408115,0.18354430379746836,0.6843961773788716,1.0,1/12,0.68%,B3GALT1
prerank,neurexin family protein binding (GO:0042043),0.5884905498481836,1.278876582800748,0.22474226804123712,0.6810446542687288,1.0,3/10,8.59%,CEL;NLGN2;SYTL3
prerank,ubiquitin-protein transferase activity (GO:0004842),0.31637943713232813,1.2788220541683746,0.04730617608409987,0.6735140221182957,1.0,85/346,17.74%,ASB2;PDZRN3;RNF220;TRIM63;RNF43;PRKN;PELI2;UBE2E2;TRIM5;MGRN1;NEDD4;RNF213;KCMF1;NEURL2;RNF138;DDB2;RNF2;RNF217;ZNRF3;LTN1;BCOR;FBXO44;SH3RF1;UBE2L3;RNF181;UBR2;RNF152;RNF145;TTC3;TRIM56;RNF135;SIAH2;WWP2;AMFR;BIRC6;RNF216;RNF180;TRAF7;RC3H2;NHLRC1;FBXO6;MDM2;ITCH;UBA7;RNF149;SMURF2;TRIM35;DTX1;SH3RF2;RBBP6;TRIM45;FBXO4;MYCBP2;CUL4B;RNF14;GID4;TRIM26;TRIM43;RNF20;FBXO11;RCHY1;RNF214;TRIM24;RNFT2;UBE2A;CHFR;BIRC2;TRIM62;UBR1;PPIL2;RNF122;UBE2H;PML;HECTD1;TRIM17;CBLB;TRIM69;OBI1;TRIM39;UBE2E1;NHLRC3;PELI3;KLHL13;DTX3L;TRIM9
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.46172008997742336,1.2787083412744122,0.174573055028463,0.6663146523926222,1.0,8/32,8.89%,KDM7A;KDM2B;TET1;PHF8;BBOX1;KDM2A;PHYH;TMLHE
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.5536336189942351,-1.2776619612204037,0.16666666666666666,0.555700710499807,1.0,5/10,18.74%,ANKRD13A;IDE;LAPTM5;FAAP20;ANKRD13B
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5433774363595185,-1.2772972808767775,0.19378427787934185,0.5503125377770985,1.0,6/11,12.13%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11C;ATP11A
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.5528058597939332,-1.2733655475131536,0.1954459203036053,0.5548831102088845,1.0,5/10,18.64%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PIK3R3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5320175396219585,-1.2733372658821889,0.1688073394495413,0.5488196692063013,1.0,6/12,18.27%,DAB2IP;ITGA5;CCDC88A;VEGFA;CADM4;GREM1
prerank,protein tyrosine kinase binding (GO:1990782),-0.3454812752083043,-1.2722780682481198,0.0819277108433735,0.5453984602095348,1.0,21/71,14.69%,GRB14;TJP2;PITPNM2;HSP90AA1;PTPN14;GAS6;CBL;ITGB1;RACK1;BMPR2;NCK1;TOB1;SOCS5;CEACAM1;CPNE3;PTPN1;CRK;DUSP3;PITPNM3;NEDD9;NRG3
prerank,peptidoglycan binding (GO:0042834),-0.5465114247152071,-1.2666972366461637,0.19433962264150945,0.5552688838139828,1.0,3/10,6.99%,NOD1;PGLYRP1;HK1
prerank,histone acetyltransferase activity (GO:0004402),0.45444170126037087,1.264905528938742,0.1867145421903052,0.6997154947464505,1.0,11/30,14.11%,BAZ1A;NCOA3;KAT8;BRCA2;KAT6B;TADA2A;NAA60;EPC2;SRCAP;CLOCK;CREBBP
prerank,calcium activated cation channel activity (GO:0005227),-0.47774389982271037,-1.2642287677827369,0.18309859154929578,0.5557207406262334,1.0,10/17,37.94%,ANO1;KCNMA1;KCNMB4;KCNN2;TRPM4;KCNN4;KCNMB2;TMEM63A;TMEM63B;KCNMB1
prerank,omega peptidase activity (GO:0008242),-0.32597564802853357,-1.2617735066177564,0.07957559681697612,0.5561196103196587,1.0,38/89,29.66%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;APEH;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;GGT1;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,cation transmembrane transporter activity (GO:0008324),0.4095271750099081,1.259639186969695,0.1555944055944056,0.707642623612739,1.0,14/48,12.76%,SLC22A2;SLC38A3;SLC6A9;SLC41A1;MMGT1;CHRNE;SLC38A9;SLC1A5;SLC36A2;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,flavin adenine dinucleotide binding (GO:0050660),0.40259824305249114,1.2581695522712937,0.15110356536502548,0.7045068575605142,1.0,12/53,13.77%,MICAL3;DPYD;DDO;SQOR;ACADL;MTHFR;GCDH;NDOR1;PRODH;CRY1;MTO1;ACOX1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5356705536945114,-1.258056071010461,0.192090395480226,0.5608661161019064,1.0,2/11,5.27%,LEF1;GATA2
prerank,GDP binding (GO:0019003),-0.34875756329745533,-1.2578749224322685,0.11691542288557213,0.5556501863955307,1.0,24/63,25.20%,RAP1A;KRAS;RASL12;RAB31;RAB27A;RERG;NRAS;GNAI1;MRAS;RAB28;RALB;RAB3B;MIEF1;RHEB;RRAS;RIT2;RAB8A;RAB8B;RAB7A;GEM;RAB2A;RAB14;HRAS;RAB5B
prerank,GTPase binding (GO:0051020),-0.290608588033355,-1.2576990350320478,0.04421768707482993,0.5503526589516284,1.0,53/195,18.47%,SPTBN1;UNC13B;FGD5;CAV1;FGD6;FNBP1L;TBC1D30;HSP90AA1;IQGAP1;RASIP1;EXOC4;SH3BP4;ARHGDIB;RABGAP1L;NCKAP1;RIN3;FLNA;YBX3;EHD1;SOD1;PEX5L;SGSM1;YBX1;PAK1;CYRIB;EPS8;EXOC5;PAK2;RANBP1;LAMTOR1;KCTD13;STOML2;EVI5;MYO5A;RANGAP1;WHAMM;ARHGEF2;MLPH;PPP6R1;CDC42EP5;IARS1;RCC2;DMXL2;BICDL1;RAF1;TRIP11;BICD1;RABGAP1;RTKN;KIF3B;CDC42EP2;RABGGTB;RRAGB
prerank,vinculin binding (GO:0017166),-0.5387123442314167,-1.2562348807973458,0.20889748549323017,0.5487306854146431,1.0,5/11,6.08%,UTRN;CORO2B;ACTN1;PXN;RTCB
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.3276787248504037,-1.2554041212674898,0.08571428571428572,0.5452264889910723,1.0,36/83,29.66%,USP53;ATXN3;USP38;OTUD7A;PAN2;UCHL5;USP29;USP31;UCHL1;ZRANB1;USP50;USP37;USP39;OTUD3;UCHL3;OTUB1;OTUD1;MYSM1;USP28;USP9X;ZC3H12A;USP8;OTUD6B;OTUD7B;TNFAIP3;USP5;OTULIN;JOSD2;USP49;USP33;YOD1;USP22;USP2;USP10;USP32;USP9Y
prerank,general transcription initiation factor binding (GO:0140296),-0.4288617256115922,-1.254495840042816,0.17154811715481172,0.54231220362797,1.0,13/25,37.11%,ESR1;AHR;HHEX;YEATS2;RUVBL1;RELA;THRA;THAP7;TAF11;PSMC5;PSMC1;TAF1B;TBP
prerank,metalloexopeptidase activity (GO:0008235),0.4049845492359825,1.2527492637156745,0.1579861111111111,0.7127374852836651,1.0,6/51,8.19%,CPQ;AEBP1;ACE;NPEPPS;AGBL2;CPXM1
prerank,ribosome binding (GO:0043022),-0.3724677210010023,-1.252283166632505,0.14386792452830188,0.5426849936542943,1.0,24/46,29.99%,EEF2;RPSA;RACK1;NOMO1;BAG6;CCDC47;PYM1;CPEB1;YTHDF3;TMEM147;SHFL;EIF3C;SERBP1;EIF2A;ZC3H12A;FMR1;EIF6;GTPBP6;NAA16;MRPS27;ETF1;CPEB3;SEC61B;MTIF3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3787236248639385,1.2520371820034666,0.15286624203821655,0.7073469013692493,1.0,10/72,4.92%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SNX18
prerank,gap junction channel activity (GO:0005243),0.46628009884780847,1.2509960815769088,0.21739130434782608,0.7030726009286727,1.0,3/22,5.06%,GJB6;GJA3;GJA1
prerank,microtubule minus-end binding (GO:0051011),0.5339568552573914,1.2507473696173887,0.22626262626262628,0.6966254166993555,1.0,4/13,9.86%,MACF1;HAUS4;TUBGCP6;TUBGCP2
prerank,wide pore channel activity (GO:0022829),0.46071234777346404,1.2457173332981508,0.19962335216572505,0.7040485644793193,1.0,3/23,5.06%,GJB6;GJA3;GJA1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37372548647671155,1.2457090810228204,0.1487603305785124,0.6969369628179121,1.0,11/71,7.48%,EYA4;EYA1;PTPN13;EYA2;PTPN4;CDC14B;PTPRA;MTMR3;PTPN9;PTPRD;PTEN
prerank,DNA binding (GO:0003677),0.2930582174060554,1.245506942566905,0.029069767441860465,0.6905675222494517,1.0,140/694,15.90%,RORA;TCF4;TCF7L2;RBPJ;DENND4A;APLP2;EPAS1;HLF;PPARA;NR2F2;POLR2D;ZEB2;RBMS1;MEIS1;ARID5B;BCL2;CUX1;SATB1;PRDM5;ZIC2;SCX;SOX6;TSHZ3;NFYB;RAD51B;SSBP2;MYRFL;HOXA7;FOXD1;NFIB;ZDHHC1;TEAD1;SPHK1;ARID4A;RAD51AP2;COLEC11;RNF138;DDB2;RAD51C;KDM2B;CAMTA1;SOX1;TDP2;DMC1;DDX60;GTF3C5;PDS5B;MTERF2;TET1;HIVEP2;ZBTB32;TCF7L1;PARP4;CXXC5;THAP1;XRCC5;SMAD3;BLM;XRCC4;RBM5;PBX4;CHD4;NR6A1;WDR48;MTF2;POLR2A;AUNIP;LYAR;CCNT1;ARNT;SSBP1;MAU2;KDM5B;NUPR1;BRCA2;CEBPG;FUBP1;RC3H2;CLSPN;TIGD4;NFYC;IRF3;MBD4;IRX1;NHEJ1;ABL1;ZMYM4;PRKDC;DCLRE1A;RFC1;SMARCA5;TSHZ1;TFAP2A;ZNF8;DCLRE1B;TFAP2B;ARID3A;GTF3C3;ZIC4;RXRA;PCBP2;NPAS2;BCLAF3;CUL4B;CRY1;SOX13;TRIM26;HSF1;MPG;EZH1;INO80;SMARCB1;CGGBP1;SPO11;FOXK2;ZBP1;MRE11;CLOCK;ZNF148;POLR3C;APEX1;BATF;CREBBP;RAD23B;GLI2;BANF2;CENPX;MLH1;SOX12;SMARCA2;WRN;BARX2;MEIS2;PATZ1;STN1;SMAD4;MCM2;PSIP1;POU3F1;RAD18
prerank,carbohydrate kinase activity (GO:0019200),0.5398683904541337,1.2432611137313276,0.25,0.690001187659073,1.0,3/11,9.67%,HK2;GALK2;GALK1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.47607348927077475,-1.2405226321866065,0.19114688128772636,0.5630916326839325,1.0,10/16,25.10%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.47607348927077475,-1.2405226321866065,0.19114688128772636,0.5630916326839325,1.0,10/16,25.10%,ATP6V0A1;ATP6V1A;ATP6V0C;TCIRG1;ATP6V0A4;ATP6V0A2;ATP5F1B;ATP6V0D2;ATP6V0E2;ATP6V1B2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5392726147836976,-1.2399210472570033,0.20857699805068225,0.5594120073011014,1.0,4/10,9.15%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.48530490176900654,1.2383544036656506,0.2084130019120459,0.6969667655531193,1.0,2/20,1.78%,AGPAT4;LPGAT1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.4002941090782274,-1.2381452283603613,0.18259023354564755,0.5590058865205012,1.0,11/30,21.22%,SLC39A10;SLC40A1;SLC30A5;SLC31A1;SLC39A8;SLC30A1;SLC39A7;SLC39A14;TMEM165;SLC39A6;SLC11A1
prerank,hormone activity (GO:0005179),0.3973694459334931,1.2377740581678687,0.16407599309153714,0.6920047548146099,1.0,1/54,0.03%,IGF1
prerank,syntaxin-1 binding (GO:0017075),0.4716423540668128,1.2342284333084779,0.20656370656370657,0.6950155460913394,1.0,3/22,5.48%,UNC13C;DAPK1;LRRK2
prerank,endopeptidase regulator activity (GO:0061135),0.41262957452139337,1.2310035031145494,0.1902071563088512,0.6979408892410311,1.0,5/40,3.76%,TFPI;ITIH2;SERPIND1;PROS1;A2ML1
prerank,receptor ligand activity (GO:0048018),0.31401663596547696,1.2223020363465806,0.10107816711590296,0.7173448074877893,1.0,30/245,11.42%,IGF1;EPHA7;BMP6;IL34;WNT4;WNT6;IL18;BMP7;SEMA3B;DKK1;CXCL13;IGF2;ARTN;TAFA4;NDP;FGF1;TAFA5;PTN;IL6;NBL1;WNT5B;CSF1;VEGFB;GDF1;IL17D;CCL4;FGF9;TNFSF13;APLN;TGFA
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.3561856537427853,-1.2219726486166995,0.16666666666666666,0.5966665439796329,1.0,19/49,22.67%,OTUD7A;MINDY2;UBXN1;MINDY1;BAG6;ZRANB1;UBQLN4;AGAP3;TAB3;ZFAND2B;FAAP20;SPRTN;SHARPIN;RNF168;OTUD7B;VCP;HDAC6;TNFAIP3;UBL7
prerank,tropomyosin binding (GO:0005523),0.4895315929965704,1.2215132126230455,0.2549407114624506,0.7129752908430985,1.0,3/16,3.73%,TNNT2;CALD1;NEBL
prerank,anion:anion antiporter activity (GO:0015301),-0.4722622320487553,-1.2197987429374653,0.19919517102615694,0.5966628594421318,1.0,6/17,21.40%,SLC26A7;SLC26A2;SLC4A2;SLC26A6;SLC26A11;SLC25A4
prerank,transcription corepressor binding (GO:0001222),0.4388343946013928,1.214519347308344,0.21828358208955223,0.7265716437125892,1.0,4/27,8.09%,RORA;USP11;MTF2;PER3
prerank,N-acyltransferase activity (GO:0016410),0.42183962515714346,1.21262355036447,0.21388367729831145,0.7251030083649183,1.0,10/32,16.53%,NMT2;NAA80;CERS6;CERS5;CERS1;SMARCE1;SAT2;ESCO1;NAT8;NAT14
prerank,phospholipase inhibitor activity (GO:0004859),0.5401915139848252,1.2122402575336755,0.2505643340857788,0.7196824103279669,1.0,4/10,18.24%,ANXA1;APOC1;ANXA5;SNCA
prerank,protein phosphatase binding (GO:0019903),-0.2995643595887937,-1.2087788541846167,0.12352941176470589,0.6212726992052142,1.0,36/117,22.73%,MAP3K5;IQGAP1;PTK2;DAB2IP;RACK1;PPP1R16B;PXN;PPME1;CTNNB1;HSP90B1;SOD1;AKAP11;MET;GRIN3A;CEACAM1;KCNQ1;FLT4;FOXO1;CDKN1B;MAP2K7;STAT3;MTMR9;MASTL;PPP6R1;JUP;VRK3;PPP1R16A;FBXL2;BOD1;SMG5;JAK3;JAK1;ATP2B4;VCP;ANAPC7;STRN4
prerank,mRNA 3'-UTR binding (GO:0003730),0.36231068141080497,1.2083728103696405,0.1771523178807947,0.7239905970719849,1.0,10/79,5.90%,CELF2;IGF2BP1;CSDC2;RBMS1;RBMS3;CPEB2;HNRNPC;CPEB4;PABPC4L;RBMS2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.42674836251840714,1.2074908662709223,0.21042830540037244,0.7199324339886864,1.0,9/29,11.64%,SLC13A3;SLC25A18;SLC13A5;ABCC2;SLC1A5;SLC25A11;SLC25A22;SLC19A1;SLC38A7
prerank,heme binding (GO:0020037),0.36928843710458803,1.2064335433406987,0.1983739837398374,0.7164421936584068,1.0,6/65,7.03%,CYP26B1;CYP27A1;CBS;PXDN;FLVCR2;PGRMC1
prerank,gated channel activity (GO:0022836),-0.48046433731129534,-1.205830756451989,0.23622047244094488,0.6237832073055669,1.0,4/14,10.76%,PIEZO2;PIEZO1;TMC6;TMEM266
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.4217297484529788,-1.2054040202093395,0.21961620469083157,0.619428234346881,1.0,12/21,26.39%,REV3L;POLQ;POLK;POLA1;POLN;POLE4;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5287005303894116,1.2034102381432534,0.27571115973741794,0.7188278561100286,1.0,5/12,14.82%,CDK8;CDK7;CDK1;MAPK1;CDK4
prerank,pyrophosphatase activity (GO:0016462),-0.3456579856049341,-1.2032353916241216,0.18701298701298702,0.6200368739414578,1.0,13/50,17.32%,ENTPD1;PLPP1;NUDT3;ENTPD7;PRUNE1;ALPL;ENTPD2;BNIP2;NUDT4;NUDT1;PRUNE2;DHX29;DCPS
prerank,cytokine receptor binding (GO:0005126),0.3497015571826244,1.203100463248696,0.17711598746081506,0.713423835934477,1.0,10/83,8.79%,TGFBR3;IL34;IL18;PXDN;IL13RA1;IL6;SMAD3;CCL19;CSF1;VEGFB
prerank,histone acetyltransferase binding (GO:0035035),0.45920717762770463,1.2005025736531016,0.25862068965517243,0.7146074155944083,1.0,4/21,10.66%,EPAS1;KANSL1L;GLI3;KANSL1
prerank,cytokine activity (GO:0005125),0.33039925405298676,1.2002040020546354,0.1581259150805271,0.7094915560670751,1.0,15/131,10.07%,BMP6;IL34;WNT4;WNT6;IL18;BMP7;CXCL13;NDP;IL6;WNT5B;CCL19;CSF1;GDF1;IL17D;CCL4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.528486792468799,-1.1996105990100128,0.27091633466135456,0.624256689764121,1.0,4/10,17.59%,FAP;NAALAD2;DPP4;PRCP
prerank,amino acid binding (GO:0016597),-0.3825034309479978,-1.199033429965099,0.20634920634920634,0.6205363100073914,1.0,16/31,32.68%,NOS3;GRM7;GRIN3A;DDAH1;GRIN1;NOS1;GLRA3;DDAH2;AARS2;CASTOR1;GLRA1;GLDC;GNMT;GRIN2B;AGXT;NOS2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.34821064359077014,1.1926734679878093,0.19846153846153847,0.7250740282055934,1.0,12/91,5.75%,FRMPD4;TULP3;ADAP2;SNX21;PARD3;GSDMA;PLCB1;AVIL;TULP1;SH3PXD2B;SNX18;WIPI1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.430488767019401,1.1900286314100696,0.23837209302325582,0.726741451127078,1.0,4/26,3.73%,SLC6A13;SLC16A12;SLC6A12;SLC6A1
prerank,DNA polymerase activity (GO:0034061),-0.40986542900264405,-1.187010566329508,0.22435897435897437,0.6485321812761323,1.0,12/22,26.39%,REV3L;POLQ;POLK;POLA1;POLN;POLE4;POLE;POLD3;POLB;POLD1;POLI;POLL
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5535337953599164,1.1853006601351848,0.28227571115973743,0.7342656337331787,1.0,3/10,9.85%,B3GALT1;B4GALT1;B3GALT6
prerank,lipid phosphatase activity (GO:0042577),0.4903984098820946,1.1821034398744967,0.24660633484162897,0.7370487350670976,1.0,6/14,18.65%,PLPP3;EPHX2;SGPP1;PLPP2;PLPPR3;PLPP7
prerank,syntaxin binding (GO:0019905),0.36805286213962585,1.1810413270527995,0.21929824561403508,0.7339981297562235,1.0,11/61,11.30%,UNC13C;STXBP4;DAPK1;ABCA1;SYT12;LRRK2;STX16;SNAP47;GOLGA2;ABL1;STX8
prerank,ADP binding (GO:0043531),0.43261348616458273,1.1810302715209822,0.2804642166344294,0.7281026279887461,1.0,5/25,12.27%,PRKAG2;MYO18A;MYO9B;MYH10;PRKAG1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4095035280982505,-1.1791522055300514,0.24183006535947713,0.665148285555644,1.0,8/23,19.26%,HIP1;CLVS2;CLVS1;HIP1R;SNX14;ATP13A2;GBF1;JPH2
prerank,chloride channel regulator activity (GO:0017081),-0.46202112503073434,-1.178687698216375,0.2702702702702703,0.6607322687227528,1.0,8/14,17.13%,STX7;STX1A;VTI1B;VAMP8;WNK3;CFTR;WNK2;SGK1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4640960219742559,-1.177658560987058,0.255859375,0.658151502733383,1.0,6/14,13.61%,MAL;RACK1;NOD1;ATP2A3;CASP8AP2;RPS27L
prerank,cell adhesion mediator activity (GO:0098631),-0.4115201070044496,-1.176710599252038,0.26126126126126126,0.6553207908952472,1.0,14/24,27.65%,BSG;ESAM;ROBO4;BCAM;CNTN6;CD47;NTNG1;NPTN;DSCAML1;PLXNB3;JAM3;VSTM2L;CNTN2;EMB
prerank,E-box binding (GO:0070888),0.41298287449625976,1.1739172394925343,0.24954792043399637,0.7424241084616569,1.0,9/34,13.72%,TCF4;ZEB1;SCX;ASCL2;MITF;ATOH8;NEUROD2;SNAI1;CLOCK
prerank,mechanosensitive ion channel activity (GO:0008381),-0.48260185029840463,-1.1732613120793856,0.2704761904761905,0.6590900968862845,1.0,3/12,8.36%,PIEZO2;PIEZO1;TMC6
prerank,metal ion binding (GO:0046872),-0.24643122637607903,-1.1723127736896115,0.03821656050955414,0.656324223683,1.0,97/477,15.71%,CSGALNACT1;SLIT2;SPOCK2;LTBP4;ADGRL3;MAP3K5;ITPR2;ACER3;RASGRP3;ESYT2;STK38;TPD52;PITPNM2;THBS1;TPT1;CDH11;IQGAP1;CDH1;CALM1;GSN;SPARCL1;S100A6;AGRN;CDH2;CDC42BPA;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F;MCTP1;ASPN;TGM2;STK38L;CALR;NUDT3;CAMKK2;HPRT1;HSP90B1;CEMIP2;GNAI1;ADPRH;CLEC3B;MT2A;PDE2A;ATP2A2;CHP1;RPH3A;NOTCH4;RYR2;MARK1;NRXN1;NUCB1;SNN;CCDC47;DYSF;C2CD5;BNIP2;CERK;IDS;S100A1;HSPA5;PIR;STIM2;GRIN1;MAP2K7;SYT10;S100A16;RHEB;PCLO;CALU;MSH2;S100A10;MARK2;CDH13;SYT4;TKT;CANX;SDF4;IRAK3;PITPNM3;PPP3CA;SRPK1;RET;MT3;SPOCK1;ITPR3;SPARC;KCNIP2;PLA2G4A;AASDHPPT;TPM4;CALM2;TPPP
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.47075695955671204,1.1710703317559736,0.298989898989899,0.7444391848316781,1.0,2/17,6.82%,DPYD;PTGR1
prerank,SH3 domain binding (GO:0017124),-0.3266246258160509,-1.1708921742230403,0.20823244552058112,0.6547412682156893,1.0,16/62,10.85%,AFAP1L1;SHANK3;ELMO1;SGIP1;CBL;ADAM15;ARHGAP27;DAB2IP;PTPN12;WIPF1;SYNJ1;DNM2;ABI3;MICAL1;CD2AP;CRK
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4689273645720492,-1.1697464988613657,0.2725490196078431,0.6524741164828195,1.0,1/12,0.80%,SLC2A1
prerank,actin binding (GO:0003779),-0.2755912527565844,-1.1686387552970086,0.1174496644295302,0.6503432698727218,1.0,33/170,9.36%,UTRN;MYRIP;TMSB4X;SYNE1;NOS3;ACTN4;KLHL2;FXYD5;PARVB;MICAL2;ABLIM1;MAP1B;GSN;PTK2;ITGB1;CORO2B;KCNMA1;TMSB10;EPS8L2;FERMT2;CCDC88A;SMTN;CAP2;PDLIM7;CEACAM1;MYH9;ADD2;HNRNPU;MICAL1;EPS8;SSH2;LDB3;SSH1
prerank,voltage-gated calcium channel activity (GO:0005245),0.4032453152710789,1.1685166248656118,0.25918762088974856,0.7455948951660288,1.0,6/37,7.35%,CACNA2D3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,anion transmembrane transporter activity (GO:0008509),-0.4864433745012573,-1.1678479439957328,0.27171903881700554,0.6472604025115595,1.0,4/12,11.07%,ABCG2;SLCO2B1;SLC39A8;SLC4A2
prerank,kinase binding (GO:0019900),-0.24822915953552657,-1.1647118920721273,0.054455445544554455,0.6504892490654088,1.0,91/435,12.99%,UTRN;FRMD5;SLC12A7;SLC12A2;CAV1;PTPRJ;ACTB;EEF1A1;TIAM1;ESR1;DLG2;MSN;TFRC;NSF;BCAR3;ADAM10;RAC1;ACVRL1;IQGAP1;CALM1;GSN;HSP90AB1;FBXO7;PTK2;UNC5C;TTC28;PLCG2;NBEA;EEF2;CSPG4;PDE8A;CAV2;DAB2IP;RPS7;RPS3;PIK3IP1;RPS19;PKD1;LIMS1;TRIM14;FLNA;RPS6;HSPB1;BCAR1;CIT;AP2A2;STX1A;WARS1;IKBKB;RHOB;MTCP1;FERMT2;CTNNB1;PTPRC;FAF1;BCL2L1;GSK3B;SPRED2;CEACAM1;ACTA2;CDC37;ADD2;CHP1;LRRC14;PDCD10;EMP2;CHEK2;SRCIN1;RHOA;PAK2;MAP3K1;APC;CDKN1B;MAP2K7;SLC12A4;STAT3;ATF4;PTPN1;CRK;PIH1D1;DUSP3;TOLLIP;CEP68;USP37;PTPN23;DNM1;MSH2;IBTK;PFKM;IRAK3;MAP3K12
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.4612838056239569,-1.1645586304567834,0.2874015748031496,0.6457958232426959,1.0,6/13,25.74%,GABRG3;GLRA3;GABRA5;GABRE;GABRG2;GLRA1
prerank,kinase activator activity (GO:0019209),0.4135835367701191,1.1629060113276017,0.2555970149253731,0.7564201716175908,1.0,1/30,0.08%,PRKAG2
prerank,MAP-kinase scaffold activity (GO:0005078),0.5248088027551419,1.1613549137349806,0.32179226069246436,0.754698156157294,1.0,3/11,6.66%,KSR1;AKAP13;SH3RF1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3507295018178233,-1.1609537764857811,0.20884520884520885,0.6503738068318649,1.0,15/42,20.76%,STXBP6;BSG;ESAM;CD200;ROBO4;BAIAP2L1;PPP1CA;CNTN6;CD47;NTNG1;S100A11;NPTN;DSCAML1;PLXNB3;JAM3
prerank,transcription cis-regulatory region binding (GO:0000976),0.28143960859654643,1.1608913042349702,0.1371069182389937,0.750151479247343,1.0,62/406,13.66%,RORA;SOX5;TCF7L2;OSR1;AEBP1;EPAS1;NPAS3;ARID5B;MXI1;CUX1;SMAD6;SATB1;PRDM5;DMRT1;SCX;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;HIF3A;NFYB;BBX;VSX2;ZFP90;ASH2L;TEAD1;ARID4A;GLI3;ZFP37;BCOR;RFXAP;XRCC5;SMAD3;GABPB1;GABPB2;RBL2;TCF12;PER3;ARNT;NFYC;CREB3L2;AGO2;HDAC1;TFAP2A;HOXC8;TFAP2B;ZNF568;RXRA;ZNF177;E2F6;SOX13;HSF1;PSPC1;AR;HOXD4;NONO;NR1I3;FOXK2;SNAI1;TFDP2;MLXIP
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4052990932569116,-1.1603079219904384,0.2651356993736952,0.6371841834558546,1.0,13/22,40.54%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4052990932569116,-1.1603079219904384,0.2651356993736952,0.6371841834558546,1.0,13/22,40.54%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.4052990932569116,-1.1603079219904384,0.2651356993736952,0.6371841834558546,1.0,13/22,40.54%,CHRM3;HTR2A;HRH1;HRH2;HTR2C;CHRM1;HTR1A;HTR1B;HTR1F;HRH3;CHRM5;HTR6;HTR1D
prerank,hormone receptor binding (GO:0051427),-0.4583857202414784,-1.1596051287524751,0.2759295499021526,0.6341330801508523,1.0,5/14,25.78%,SOCS2;PTHLH;JAK1;ADCYAP1;NPPC
prerank,RNA methyltransferase activity (GO:0008173),0.4585587807197895,1.1593435566202779,0.2777777777777778,0.7487765281925606,1.0,6/19,9.45%,TRMT9B;METTL4;FTSJ3;METTL8;LCMT2;TRDMT1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.42161496062844683,-1.1579115003181428,0.2717842323651452,0.6336532126975148,1.0,6/20,13.34%,SLC39A10;SLC30A5;SLC39A8;SLC30A1;SLC39A7;SLC39A14
prerank,single-stranded DNA binding (GO:0003697),0.33620031060447336,1.1564876565080207,0.22204213938411668,0.7508084779789749,1.0,23/93,17.59%,POLR2D;RBMS1;RAD51B;SSBP2;RAD51AP2;RNF138;TDP2;DMC1;BLM;WDR48;SSBP1;BRCA2;FUBP1;PCBP2;POLR3C;RAD23B;MLH1;STN1;MCM2;RAD51;REXO4;XPC;PURA
prerank,clathrin adaptor activity (GO:0035615),-0.450337989129968,-1.1560336023510982,0.29563492063492064,0.6338319737422187,1.0,5/15,9.34%,HIP1;STON2;AP2A2;HIP1R;AP2M1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.3736748577908816,-1.1559583800429944,0.25054945054945055,0.6293528983653875,1.0,8/34,10.42%,CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;FERMT2;HIP1R;OGT
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3745924748643268,1.1545411362768017,0.2436548223350254,0.7506936464477094,1.0,14/51,12.24%,SLC22A4;SLC5A5;SLC20A2;SLCO1B1;SLC28A3;MCU;SLC25A11;SLC20A1;SLC35E2B;SLC35E2A;SLC22A6;SLC35A1;CLCN4;SLC46A2
prerank,calcium ion binding (GO:0005509),-0.2504035885209928,-1.1515995389400737,0.08629441624365482,0.6359331833527082,1.0,76/323,18.96%,SLIT2;SPOCK2;LTBP4;ADGRL3;ITPR2;ACER3;RASGRP3;ESYT2;TPD52;PITPNM2;THBS1;TPT1;CDH11;IQGAP1;CDH1;CALM1;GSN;SPARCL1;S100A6;AGRN;CDH2;MCTP1;ASPN;TGM2;CALR;CAMKK2;HSP90B1;CEMIP2;CLEC3B;ATP2A2;CHP1;RPH3A;NOTCH4;RYR2;NRXN1;NUCB1;CCDC47;DYSF;C2CD5;BNIP2;IDS;S100A1;HSPA5;STIM2;GRIN1;SYT10;S100A16;PCLO;CALU;S100A10;CDH13;SYT4;TKT;CANX;SDF4;PITPNM3;PPP3CA;RET;SPOCK1;ITPR3;SPARC;KCNIP2;PLA2G4A;TPM4;CALM2;AOC3;DSG2;TUBB4A;SYT2;CETN2;SYT7;DSPP;S100A11;TRPM4;LETM1;PADI2
prerank,histone deacetylase binding (GO:0042826),-0.2970584721612037,-1.1499991153048663,0.18232044198895028,0.6352968064876049,1.0,28/88,23.48%,LEF1;MEF2C;MEF2D;HSP90AA1;HSP90AB1;HES1;HDAC5;YWHAB;SFPQ;SP2;HEY2;MAPK8;MEF2B;TAL1;KCTD21;AKAP8;BRMS1;TOP2A;RAD9A;SMG5;SPI1;TFAP4;HDAC9;NACC1;HDAC6;SATB2;RELA;HSPA1B
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.442199124937267,-1.1430440886692381,0.305019305019305,0.6485302886651897,1.0,6/15,18.64%,PIK3C2B;PIK3CD;PIK3C2A;PIK3C3;PI4KB;PIK3R3
prerank,phosphoric ester hydrolase activity (GO:0042578),0.36524216002719595,1.1422403287411729,0.25041736227045075,0.7809208465507894,1.0,8/49,8.83%,ATP1A2;PXYLP1;LHPP;DUSP10;EPHX2;ACP3;MPPED2;HDHD2
prerank,O-acyltransferase activity (GO:0008374),-0.3740082755843553,-1.1411401883503705,0.27450980392156865,0.6485726099428645,1.0,15/30,31.35%,MBOAT1;LPCAT3;GPAT4;GPAT3;DGAT1;LPCAT1;PLA2G4A;LCAT;GPAM;PRDX6;PIGW;PLAAT1;PLA2G15;MBOAT2;LPCAT4
prerank,myosin V binding (GO:0031489),-0.44248329799869784,-1.1406279626624323,0.296875,0.6452998651834986,1.0,6/15,25.58%,RAB3C;RAB3B;RAB8A;RAB3A;RAB14;RAB6B
prerank,Hsp90 protein binding (GO:0051879),-0.37458018057479253,-1.134152329557936,0.2947845804988662,0.6574284316431241,1.0,5/33,7.41%,SLC12A2;KDR;RPS3;AHR;CHORDC1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.3970349735868603,1.1318953162244492,0.289568345323741,0.8049794398316683,1.0,8/34,10.65%,LTF;ALS2;IGF2;FAM20A;RICTOR;CCNT2;CCNT1;MLST8
prerank,chemorepellent activity (GO:0045499),-0.3884669917024293,-1.1305299665919837,0.2673913043478261,0.6627199552229006,1.0,11/25,11.39%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;DPP4;SEMA3G
prerank,protein kinase binding (GO:0019901),-0.23782834623313784,-1.12884108652565,0.07881773399014778,0.6626109114733059,1.0,93/480,12.08%,UTRN;FRMD5;SLC12A7;SLC12A2;CAV1;PTPRJ;ACTB;EEF1A1;TJP2;ESR1;MSN;STK38;TFRC;NSF;ADAM10;RAC1;ACVRL1;HSP90AA1;IQGAP1;DUSP16;CALM1;FBXO7;PTK2;UNC5C;ITGB1;PLCG2;ROR2;NBEA;EEF2;CSPG4;CAV2;DAB2IP;RPS7;RPS3;RACK1;RPS19;BMPR2;PKD1;TRIB2;LIMS1;GCH1;TRIM14;RPS6;HSPB1;BCAR1;CIT;ADCY4;AP2A2;WARS1;IKBKB;RHOB;HDAC5;MTCP1;FERMT2;PTPRC;CCDC88A;FAF1;CAVIN2;BCL2L1;GSK3B;SPRED2;CEACAM1;ACTA2;CSK;ADD2;KCNQ1;PDCD10;EMP2;RYR2;CHEK2;SRCIN1;RHOA;APPL1;PAK2;MAP3K1;APC;YWHAG;CDKN1B;MAP2K7;SLC12A4;STAT3;ATF4;PTPN1;DUSP8;CRK;PIH1D1;DUSP3;CEP68;HINT1;USP37;PTPN23;DNM1;MSH2
prerank,small GTPase binding (GO:0031267),-0.26706605980115083,-1.1288150739118048,0.18791946308724833,0.6580342907713257,1.0,51/170,21.93%,UNC13B;FGD5;CAV1;FGD6;TBC1D30;IQGAP1;EXOC4;SH3BP4;ARHGDIB;RABGAP1L;NCKAP1;RIN3;FLNA;YBX3;EHD1;SOD1;PEX5L;SGSM1;PAK1;CYRIB;EPS8;EXOC5;PAK2;RANBP1;KCTD13;EVI5;MYO5A;RANGAP1;WHAMM;ARHGEF2;MLPH;PPP6R1;CDC42EP5;RCC2;DMXL2;BICDL1;RAF1;TRIP11;BICD1;RABGAP1;RTKN;KIF3B;CDC42EP2;RABGGTB;IFT20;PEX5;ARFIP2;RABGGTA;RAB8A;RAP1GAP;EXOC8
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2676701320452963,1.1270277251135248,0.1618705035971223,0.8128874844146351,1.0,93/597,14.06%,CREB5;SOX5;MAF;TCF4;TCF7L2;OSR1;ARNT2;ZIC1;HLF;HOXC4;HOXB4;ESRRG;ARID5B;CUX1;SMAD6;PRDM5;DMRT1;NR1I2;ASCL2;SOX6;TBL1XR1;ZBTB20;NFYB;ZIC5;BBX;PKNOX2;VSX2;NFAT5;HOXA7;ASH2L;NFIB;TEAD1;ELF4;ARID4A;TEF;GMEB1;IRF8;ZNF250;GLI3;ZBTB32;TCF7L1;BCOR;ZNF23;XRCC5;SMAD3;EN1;NR6A1;GABPB1;GABPB2;TCF12;PER3;ARNT;KDM5B;CEBPG;NFYC;HOXB6;CREB3L2;IRF3;MBD4;ZSCAN29;IRX1;ABL1;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;ZNF568;RXRA;NPAS2;ZBTB37;ZNF177;ORC2;SOX13;GMEB2;HSF1;PSPC1;AR;HIVEP1;KLF5;HOXD4;NFATC4;TSPYL2;HOXA6;NONO;NR1I3;FOXK2;SNAI1;HOXB9;CLOCK;SRF;DMRTA2;BATF
prerank,beta-tubulin binding (GO:0048487),0.40245114428290596,1.1260890705425826,0.30975143403441685,0.8098391467060189,1.0,2/31,1.94%,GJB6;EML4
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.47415799951744175,1.1213603636151588,0.3493975903614458,0.8179264960773366,1.0,1/13,0.83%,AGPAT4
prerank,endopeptidase activity (GO:0004175),0.28423004447531697,1.120488225502361,0.2408660351826793,0.8146078796987423,1.0,26/257,8.96%,ADAMTS12;ADAMTS9;TRABD2B;CORIN;ADAMTS5;THSD4;ADAMTS10;KLK2;ADAMTS15;CTSH;USP11;MMP2;PCSK9;ACE;TPP1;ADAMTS7;MMP19;PSMA2;NRDC;PSMA3;MMP9;USP24;ADAMTSL4;USP25;USP7;USP34
prerank,GTPase inhibitor activity (GO:0005095),-0.4591244714150322,-1.119411965370602,0.33659491193737767,0.6783446785800905,1.0,2/13,2.13%,SLIT2;IQGAP1
prerank,protein heterodimerization activity (GO:0046982),0.2977852855754049,1.117579903789266,0.23654390934844194,0.8167780492489796,1.0,25/178,11.42%,ATP1A2;BMP6;TCF4;ARNT2;EPAS1;NPAS3;BDKRB2;TPM1;BCL2;IRAK2;TOP2B;ZHX2;PAFAH1B3;ITGA3;ALG2;ARNT;PAFAH1B1;BCL2L2;PGLYRP3;MICU1;NEUROD2;UBA3;TFAP2B;FXR1;ERBB2
prerank,CoA hydrolase activity (GO:0016289),0.46502914969164183,1.1173583409299475,0.3405940594059406,0.8116253385786147,1.0,8/16,23.12%,ACOT4;ACAA2;ACOT1;HIBCH;NUDT7;ACOT11;ACOT13;ACOT6
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.5176861399669711,1.1162943813695536,0.3470715835140998,0.8089730536703705,1.0,5/10,13.92%,MGME1;DCLRE1A;DCLRE1B;TATDN1;APEX1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.43810679375220085,1.1150873903797953,0.30831643002028397,0.8069329818716244,1.0,3/18,7.08%,TGFBR3;SMAD6;SMAD3
prerank,manganese ion binding (GO:0030145),0.3596382564376746,1.114631242629824,0.2889273356401384,0.802514298548092,1.0,16/48,19.30%,LARGE1;PPM1M;B4GALT1;TDP2;MPPED2;HMGCL;NEK4;XYLT2;ABL1;PRIMPOL;WRN;POMGNT1;XPNPEP3;XXYLT1;PCK2;GALNT3
prerank,glutamate receptor activity (GO:0008066),-0.4210490875632532,-1.1135180355173113,0.30278884462151395,0.6891944736917237,1.0,7/19,21.18%,GRM3;GRM7;GRIK4;GRM8;GRIA2;GRIK2;GRID2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.47104070249053154,-1.1111055083412777,0.3467153284671533,0.6907990157278023,1.0,4/11,24.62%,MAP3K5;MAP3K1;MAP3K6;MAP3K15
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5020156667455767,1.1108262830055737,0.33401639344262296,0.8082104418361351,1.0,3/10,13.64%,DUOX2;NCF2;DUOX1
prerank,solute:anion antiporter activity (GO:0140323),0.4762811579091796,1.1101151069856126,0.3569937369519833,0.8046171226266139,1.0,1/14,0.11%,SLC7A11
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4617250095336152,1.1049927309914065,0.35470941883767537,0.8139527076571331,1.0,4/15,15.33%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3804938353977172,-1.1048222700496488,0.2973523421588595,0.7033648695446766,1.0,7/24,10.92%,RPL41;RPS7;RPL26;RPS14;GNL3;RPL5;RSL1D1
prerank,Toll-like receptor binding (GO:0035325),-0.4691567725107645,-1.1047680046955732,0.3163265306122449,0.698743256296666,1.0,7/11,32.64%,DAB2IP;TOLLIP;TIRAP;MYD88;CD36;TLR6;TLR1
prerank,transforming growth factor beta binding (GO:0050431),-0.3798711415727889,-1.1041048920097072,0.34710743801652894,0.6958664978977698,1.0,8/23,12.03%,LTBP4;THBS1;ACVRL1;ENG;TGFBR2;CD109;LTBP1;NRROS
prerank,lipoprotein particle receptor binding (GO:0070325),-0.36959198220471384,-1.1027611372389565,0.3368200836820084,0.6951617658127807,1.0,8/27,12.65%,DNAJA1;HSP90B1;APBB1;AP2M1;RELN;APBB3;MESD;CLU
prerank,double-stranded DNA binding (GO:0003690),0.2626487630927169,1.1020925454418822,0.19757575757575757,0.816731793968716,1.0,87/531,14.89%,CREB5;MAF;TCF4;OSR1;ARNT2;ZIC1;HLF;HOXC4;RBMS1;HOXB4;ESRRG;CUX1;SATB1;DMRT1;NR1I2;ASCL2;ZBTB20;ZIC5;BBX;RAD51B;PKNOX2;VSX2;NFAT5;HOXA7;NFIB;TEAD1;ELF4;RAD51AP2;TEF;GMEB1;CAMTA1;IRF8;ZNF250;DMC1;DDX60;GLI3;ZBTB32;TCF7L1;ZNF23;XRCC5;EN1;NR6A1;WDR48;TCF12;ARNT;MAU2;KDM5B;CEBPG;HOXB6;IRF3;ZSCAN29;IRX1;ABL1;PRKDC;NEUROD2;TFAP2A;HOXC8;TFAP2B;ZIC4;RXRA;NPAS2;ZBTB37;CRY1;ZNF177;GMEB2;HSF1;HIVEP1;KLF5;CGGBP1;HOXD4;NFATC4;HOXA6;NR1I3;ZBP1;MRE11;SNAI1;HOXB9;CLOCK;SRF;APEX1;DMRTA2;BATF;GLI2;HOXD8;CENPX;KLF13;SOX12
prerank,"DNA binding, bending (GO:0008301)",-0.4372498971417926,-1.100831566228778,0.33984375,0.695850143567891,1.0,3/14,16.86%,LEF1;HHEX;TOP2A
prerank,proton transmembrane transporter activity (GO:0015078),-0.3470934583495803,-1.0998496020215063,0.31516587677725116,0.6938672943272198,1.0,16/39,28.35%,COX4I1;CLCN5;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;UQCRC1;NDUFA4L2;UQCR10;CLCN3;ATP6V1B2;COX15;COX4I2
prerank,G protein-coupled receptor binding (GO:0001664),0.30479481675522097,1.097584272862622,0.2934131736526946,0.8240784517588657,1.0,17/132,7.93%,WNT4;RNF43;WNT6;PRKN;TULP3;GNAS;ADM;NDP;ACE;ZNRF3;TAFA5;ARHGEF11;GNAQ;WNT5B;GRK3;CCL19;RYK
prerank,tau protein binding (GO:0048156),-0.33843994165065905,-1.0967779341340695,0.28708133971291866,0.6977128692592357,1.0,16/40,23.28%,ACTB;HSP90AA1;HSP90AB1;FYN;LGMN;GSK3B;MARK1;BIN1;MARK2;CLU;CDK5;DCTN1;TTBK2;HDAC6;BRSK2;MAP1A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.44951569466795427,-1.096121166571819,0.352165725047081,0.6948501607532643,1.0,5/12,7.62%,PDE4D;PDE3A;PDE8A;PDE2A;PDE8B
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4488989408829399,1.0960800639828938,0.37816764132553604,0.823088940674188,1.0,1/15,0.83%,AGPAT4
prerank,symporter activity (GO:0015293),0.5012925079993631,1.0957605968630213,0.403470715835141,0.8186179543402554,1.0,3/10,12.24%,SLC5A5;SLC28A3;SLC46A2
prerank,WW domain binding (GO:0050699),-0.36662235350421846,-1.0951269310916891,0.3150406504065041,0.6929713240965484,1.0,13/26,37.60%,NDFIP2;TCEAL8;TCEAL9;WBP1;NDFIP1;TCEAL5;PRRG4;TCEAL1;SCNN1A;TCEAL3;TCEAL6;LITAF;NFE2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.48275192974455355,1.0947346500374187,0.3816326530612245,0.8159973110173973,1.0,1/11,0.79%,ITPR1
prerank,protein kinase activator activity (GO:0030295),0.34830752249615876,1.0944761585971512,0.3153310104529617,0.8114959319652155,1.0,6/60,5.14%,PRKAG2;LTF;ALS2;IGF2;FAM20A;RICTOR
prerank,organic anion transmembrane transporter activity (GO:0008514),0.296331154826692,1.0937244585701251,0.25997045790251105,0.8082940063681864,1.0,28/134,12.76%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A9;SLC1A3;PDPN;SLC6A1;SLC25A18;GJA1;SLC38A9;SLCO1B1;SLC2A10;SLC13A5;ABCC2;SLC1A5;SLC25A22;SLC27A1;SLC22A6;SLC19A2;SLC19A1;SLC36A2;SLC35A1;SLC38A7;SLC25A2;SLC38A2;OCA2;SLC25A38
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4462649163993026,1.0912113564627601,0.37422037422037424,0.8097956635135791,1.0,5/15,11.64%,SLC1A3;SLC25A18;SLC1A5;SLC25A22;SLC38A7
prerank,transaminase activity (GO:0008483),0.48548954438422,1.0884740068360939,0.3728448275862069,0.8126040700166012,1.0,1/11,1.55%,ABAT
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4733830172647565,1.0884193567079488,0.3877551020408163,0.8075842023104374,1.0,6/12,21.84%,FRS2;PIK3R1;GAB2;BLNK;SHC1;IRS1
prerank,kinase activity (GO:0016301),-0.27455319664181277,-1.0871680900274543,0.2774725274725275,0.7093850097431652,1.0,37/109,25.12%,DGKH;PSTK;DGKB;PRKD3;NADK;GSK3B;PGM2L1;PIK3C2B;DGKI;NMRK1;MTOR;PAPSS2;CERK;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;MASTL;CKB;RFK;ITPKB;PI4KB;PRKD1;ETNK1;IRAK1;CDK5;PINK1;SEPHS2;PANK2;AKT1;TRIB3;DGKE;DGKQ;IDNK;SEPHS1;SPHK2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3237243867506482,1.085966927919243,0.32142857142857145,0.8092684072982639,1.0,7/73,10.63%,NPR3;LGR4;BDKRB2;KISS1R;PTH2R;GLP1R;NPR1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.454518363824227,-1.0838591865603837,0.35793357933579334,0.7135856027655557,1.0,7/11,15.65%,ITPR2;TRPC3;TRPC6;RPH3A;TRPC4;ITPR3;TRPC1
prerank,Notch binding (GO:0005112),0.4091672240333083,1.0820062052422061,0.3568627450980392,0.8151080145374514,1.0,2/22,3.29%,SNED1;MEGF10
prerank,voltage-gated sodium channel activity (GO:0005248),0.4217846760397401,1.0817126019643537,0.37325349301397204,0.8107423622586347,1.0,1/22,0.09%,SCN7A
prerank,UDP-glycosyltransferase activity (GO:0008194),0.33004282591612116,1.078151590409836,0.343801652892562,0.8155900336966335,1.0,8/70,7.54%,B3GALT1;LARGE1;GXYLT2;B3GNT5;B4GALT1;CHSY1;HAS1;EXTL1
prerank,cholesterol binding (GO:0015485),0.3510094645004126,1.077819722501131,0.35701598579040855,0.8114527696351562,1.0,4/47,4.04%,SIDT1;OSBPL8;GRAMD1C;ABCA1
prerank,transcription coactivator binding (GO:0001223),0.41810910426181563,1.0762059684200018,0.36242884250474383,0.8110394940707938,1.0,4/20,8.04%,RORA;VGLL4;SMAD3;CCNT2
prerank,protein phosphatase regulator activity (GO:0019888),0.34042012161190455,1.075003977139355,0.35344827586206895,0.8092978455203171,1.0,6/53,5.91%,RCAN2;PPP2R2B;PPP4R4;DMPK;PTPA;PTN
prerank,protein kinase inhibitor activity (GO:0004860),-0.3295809876811383,-1.0749229124975623,0.32272727272727275,0.7332155890854107,1.0,19/42,31.43%,RACK1;CIT;NCK1;YWHAB;SPRED2;CDKN1B;SPRY4;IBTK;SMCR8;CAMK2N1;PRKRIP1;CDKN1A;INKA2;SOCS1;SPRY2;RPTOR;GMFB;MAPK8IP1;CEP43
prerank,thyroid hormone receptor binding (GO:0046966),0.39680846727372343,1.0747767111890605,0.3438077634011091,0.8049567948520321,1.0,15/28,25.17%,BRD8;NCOA3;NSD1;MED1;MED13;TACC1;ZNHIT3;TRIP6;NCOR1;HMGN3;TRIP12;THRAP3;GTF2H1;MED24;GTF2B
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.4456866817017903,-1.0743294856924046,0.3939393939393939,0.730264488786405,1.0,5/13,7.87%,PTPRJ;ITGA5;IL1R1;PDGFC;VEGFA
prerank,alanine transmembrane transporter activity (GO:0022858),-0.44095324272958175,-1.0733120673986185,0.3888888888888889,0.7283440644052487,1.0,6/12,16.40%,SLC6A6;SLC38A5;SLC3A2;SLC36A1;SLC1A4;SLC36A4
prerank,phosphatase activity (GO:0016791),0.316743902579209,1.071807385708318,0.35170178282009723,0.8081071256874172,1.0,9/73,8.83%,ATP1A2;PXYLP1;PLPP3;LHPP;DUSP10;EPHX2;ACP3;NT5M;HDHD2
prerank,NADP binding (GO:0050661),0.3813450923462253,1.0709272965010521,0.36869565217391304,0.8057036607671496,1.0,3/32,2.52%,DPYD;GMDS;HSD17B1
prerank,lipase activity (GO:0016298),0.3588462741663943,1.0708769081021463,0.3485915492957746,0.801020427866053,1.0,6/43,7.58%,CEL;LIPA;PLA2G10;LIPH;LIPC;DAGLB
prerank,phosphotyrosine residue binding (GO:0001784),-0.33556079491809643,-1.068773313916797,0.35476718403547675,0.7358741507099059,1.0,10/37,20.43%,BCAR3;SHE;PLCG2;NCK2;CRK;SAMSN1;SHB;YES1;PIK3R3;SHC3
prerank,bHLH transcription factor binding (GO:0043425),0.42337881474874883,1.0686442738576367,0.374749498997996,0.8022997434172946,1.0,4/19,7.97%,FHL2;SCX;SMAD3;TCF12
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.35920734831632223,-1.06622209111596,0.3516483516483517,0.7378122544268599,1.0,8/27,11.79%,SLC12A2;ITPR2;SLC9B2;MAGT1;ATP2A3;SLC4A8;KCNA1;ATP2B1
prerank,methylated histone binding (GO:0035064),0.32527899928343107,1.0660206873926261,0.35303514376996803,0.8043728253312137,1.0,15/62,16.25%,KDM7A;PYGO1;L3MBTL2;DPF2;PHF8;MTF2;CBX8;CBX2;KAT8;MBTD1;RRP8;TRIM24;MORC3;PHF1;PHF2
prerank,semaphorin receptor activity (GO:0017154),0.4828129831824085,1.0653470411077048,0.38865546218487396,0.8013767915266197,1.0,2/11,4.57%,PLXNA2;PLXNC1
prerank,snoRNA binding (GO:0030515),-0.346047499425791,-1.0650925705228882,0.37644341801385683,0.736024693186116,1.0,13/30,28.81%,IMP3;BMS1;NUDT4;DHX37;WDR3;NUDT1;TBL3;NHP2;TSR1;RRP9;NUDT16;BYSL;NOP10
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.4191157561293888,-1.0650848665650785,0.41317365269461076,0.7315740280649664,1.0,12/15,50.88%,GPR34;P2RY12;PTAFR;P2RY1;P2RX5;P2RX7;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,transition metal ion binding (GO:0046914),0.2601467551649404,1.061325313375217,0.3316582914572864,0.8073477310801402,1.0,89/397,16.93%,MOXD1;PAPPA;HEPH;AGMO;KDM7A;PRKN;UPB1;LARGE1;KMT2A;SOD3;ZEB1;PPM1M;LTF;LOXL3;LACC1;B4GALT1;BAZ1B;RNF2;IKZF4;KDM2B;TDP2;SORD;ACE;TET1;ZBTB32;NAPEPLD;ZFP37;PHF8;CXXC5;THAP1;RABIF;ENPP2;MPPED2;SMAD3;NPEPPS;HMGCL;BLM;MMP9;CHD4;NEK4;BBOX1;ZKSCAN5;KDM2A;SLC30A8;SLU7;DPYS;COX17;KDM5B;TRAF7;XYLT2;MDM2;NSD1;CCS;DCT;ABL1;ATP7B;ZNF8;RXRA;ENPP3;MYCBP2;PAM;KMT2B;ITGB1BP2;EEA1;CYLD;RCHY1;S100A9;SHMT1;PRIMPOL;ESCO1;TRIM24;NUDT12;KDM5C;MNAT1;GLI2;BIRC2;ACO2;WRN;SKI;POMGNT1;ZMYM2;NAALADL1;PHF2;SIRT3;SEC24A;XPNPEP3;CBLB;XXYLT1;TYW5
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.35022572896263243,1.0611275453506284,0.38461538461538464,0.8031970557533618,1.0,4/48,4.49%,TRPM3;NALCN;SLC41A1;MMGT1
prerank,protein serine/threonine kinase activity (GO:0004674),0.26532131044569585,1.0607788749898202,0.32871536523929473,0.7994638845749807,1.0,60/335,14.86%,MAPK4;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PDPK1;CAMK1D;BMP2K;MYLK;DMPK;MAP4K5;CDK7;FAM20A;IRAK2;SRPK2;ARAF;MAPK9;SIK1;PRKAA2;LRRK2;PRKCZ;PRKCB;STK17B;TTK;PRKCA;GRK3;PRKAA1;NEK4;NRBP1;GRK5;PKN2;CDK1;CAMK2D;PIK3R4;MAP3K2;NEK10;VRK2;SBK3;LATS1;STKLD1;PRKDC;RPS6KB1;IKBKE;BMPR1A;MAPKAPK2;HIPK3;PRKD2;STK24;TBK1;MAPK1;MAP3K7;NIM1K;CDKL5;NLK;CDK15;PRKCI;CDK4;SIK3
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.22368018555186092,-1.057089584693666,0.21182266009852216,0.7487672786271526,1.0,139/431,25.17%,EEF1A1;MAP3K5;RAP1A;RHOJ;STK38;HSPA8;KRAS;ATP1A1;RPS6KA5;RAC1;ACVRL1;HSP90AA1;HSP90AB1;CDC42BPA;RASL12;PRAG1;RAB31;RAB27A;MINK1;CDK11B;GCH1;TGM2;STK38L;PRPS2;ATP5F1A;RERG;NRAS;RHOB;TUBB3;GBP4;ATP5F1D;GNAI1;RHOT1;ARF5;GNL3;SCG5;WNK3;ARF1;MRAS;MYH9;HNRNPU;DNM2;RAB28;HSPA14;MARK1;PEAK1;RHOA;RAB38;PXK;EIF4G1;BMS1;CDK6;HSPA5;ARHGEF5;RALB;ARL8A;TUBB4B;TUBA1B;GBP5;NDUFA13;RHEB;ATP1A3;ABCD3;GUK1;MSH2;PDK2;MARK2;OAS2;LMTK2;KCNJ8;PFKM;IRAK3;STK36;IDE;GBP3;TUBB2A;SRPK1;TUBA1A;ABCD2;PFKP;SYN2;RABL3;ATL2;CLP1;MTHFD1L;RHOG;RPS6KA4;EIF2B2;WNK2;PEX1;RRAS;TUBB4A;ACVR1;AK6;UBA2;ABCD4;RRAGB;ABCA2;RAB1B;LIG4;MTREX;PINK1;ABCG1;ACLY;TLK2;RAB39A;HSPA9;RIT2;AKT1;MAP3K6;ARFIP2;INSR;MKNK2;NUAK2;RAB8A;UHMK1;SMC4;TUBD1;PYGL;MAST1;BRSK2;KIFC1;TSR1;SIK2;HSPA1B;NEK11;RAB7A;AARS2;ARL4A;GEM;DDX25;SEPHS1;DRG2;TUBB2B;RAB2A;CDC42BPB;RAB14;NUDT16;HRAS
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.427618911576386,1.0570668155225507,0.44061302681992337,0.804365032593983,1.0,4/18,15.04%,HSD17B1;HSD17B10;DHRS11;HSD17B14
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.4072333483615035,-1.056537081998906,0.3895582329317269,0.7457855356997652,1.0,8/16,22.59%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;MTMR1
prerank,GABA receptor activity (GO:0016917),-0.37230594885956336,-1.0550390077514304,0.3892100192678227,0.7455311045370433,1.0,7/21,25.16%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2;GABBR1
prerank,telomeric DNA binding (GO:0042162),0.37688758192418115,1.054083559655452,0.38698010849909587,0.807434265077113,1.0,16/32,24.24%,ACD;XRCC5;BLM;APEX1;WRN;STN1;TELO2;PURA;UPF2;HNRNPA2B1;RAD50;UPF3A;TERF2;SMG1;NCL;KDM1A
prerank,epidermal growth factor receptor binding (GO:0005154),0.39130062122366327,1.0537638461975904,0.3908918406072106,0.8036121281498071,1.0,3/25,3.35%,EFEMP1;FER;FAM83B
prerank,cytochrome-c oxidase activity (GO:0004129),-0.41757459873545305,-1.051562093404493,0.3911290322580645,0.7503578455179648,1.0,8/15,28.35%,COX4I1;NDUFA4;COX6A1;COX8A;COX5A;NDUFA4L2;COX15;COX4I2
prerank,DNA-binding transcription factor binding (GO:0140297),0.2758784512121609,1.0504117876588877,0.358974358974359,0.8079233589913436,1.0,35/189,14.11%,TCF7L2;RBPJ;FHL2;PPARA;PRRX1;RUNX1T1;BCL2;PRDM5;SCX;NFYB;FIZ1;SIK1;TLE3;CXXC5;TTC8;SMAD3;CHD4;RBL2;TCF12;TEAD3;WWP2;LYAR;PIAS1;TLE1;BBS7;HDAC1;GTF2I;AR;CRTC1;CRTC3;CGGBP1;IFI27;SRF;MTDH;CREBBP
prerank,sodium channel activity (GO:0005272),0.35906920517194507,1.0495063252316035,0.3859964093357271,0.805583503739763,1.0,2/37,2.90%,SCN7A;SHROOM2
prerank,protease binding (GO:0002020),0.3013679837142471,1.048902930396283,0.3700159489633174,0.802528053656649,1.0,15/99,8.91%,BDKRB2;TIMP3;STIM1;PRKN;BCL2;ECM1;A2ML1;CCBE1;COL1A2;ITGA3;NOL3;PTEN;ADAMTSL4;AMFR;BRCA2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4624894447537221,-1.0481305669380594,0.43545279383429675,0.7549284364680656,1.0,2/10,1.63%,SHANK3;NSF
prerank,lysophospholipase activity (GO:0004622),-0.37455782490233785,-1.0478753018137983,0.3786008230452675,0.7511651949838318,1.0,6/20,15.14%,MGLL;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3433877094883887,-1.047525623488128,0.4045643153526971,0.7476307477594974,1.0,11/28,32.31%,DAB2IP;EDA;TMBIM1;CASP8AP2;TRAF1;MADD;MYD88;STAT1;BID;FADD;PIDD1
prerank,tubulin binding (GO:0015631),-0.23240324846652594,-1.0465634960333399,0.30864197530864196,0.745826303599321,1.0,90/296,24.41%,DNM3;MTUS1;SGIP1;TTLL7;STARD9;MAP1B;UNC5C;REEP3;REEP1;FYN;MAP4;MID1;RPS3;CLIP1;MAP6;BLOC1S2;CLIP2;CCDC88A;RP1;EML6;PRUNE1;EFHC2;KIF26A;MDM1;CHP1;GAPDH;STMN2;MAP1LC3B;DNM2;PAK1;NAV3;APPL1;APC;KIF1A;ARL8A;RMDN3;GIT1;DNM1;WHAMM;ARHGEF2;RAB11FIP5;STMN1;ALDOA;MTCL1;TOGARAM1;GAS2L3;KIF13A;HOOK1;RCC2;CCDC66;NDE1;CCDC88C;RMDN1;TPPP;KIF21B;STMN4;FHDC1;APC2;TPPP3;RABGAP1;CEP295NL;KIF3B;CCDC69;STMN3;GAS2L1;CDK5;CKAP5;MID2;IRAG2;HAUS6;POLB;KIF15;FMR1;B9D2;NUMA1;GABARAPL1;DCTN1;VAPA;TRIM36;HDAC6;MAST1;SPAG5;KIFC1;TRAPPC14;MAP1A;CLASP2;SPEF1;CEP295;TTLL6;SAXO2
prerank,chloride channel inhibitor activity (GO:0019869),-0.4528193385828608,-1.0461857168258215,0.40601503759398494,0.7424755205060404,1.0,7/10,16.55%,STX7;STX1A;VTI1B;VAMP8;WNK3;CFTR;WNK2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.3470155141015084,-1.0461790982709058,0.4,0.7382201355478017,1.0,12/29,24.99%,GABRB3;GRIK4;GABRB1;GABRG3;GLRA3;GRIA2;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2
prerank,cation channel activity (GO:0005261),0.3036362651071916,1.0461393979252562,0.3716535433070866,0.8050632729982659,1.0,4/94,1.67%,TRPM3;SLC24A3;KCNQ4;NALCN
prerank,actin monomer binding (GO:0003785),-0.36744217187882927,-1.0451915494036852,0.4083333333333333,0.7365469947920961,1.0,3/22,3.94%,TMSB4X;NOS3;TMSB10
prerank,iron ion binding (GO:0005506),0.34429442843115454,1.0444673412280998,0.3978494623655914,0.8051090363879817,1.0,7/48,8.56%,HEPH;AGMO;KDM7A;LTF;TET1;PHF8;PHYH
prerank,mRNA binding (GO:0003729),-0.235380913826469,-1.043802706613826,0.2967032967032967,0.7357731446740279,1.0,78/249,22.30%,RPL41;NOVA2;HNRNPK;TARDBP;ADARB1;RPS7;RPS3;RBFOX1;PKM;IREB2;RPL26;QKI;LUC7L2;RBFOX3;RPS14;HNRNPAB;G3BP1;RBFOX2;RBM47;PABPC1;CALR;YBX3;SRSF1;GNL3;SRRM3;RPL5;PUM2;EIF4G3;RPS2;HNRNPU;PPIE;SF3B1;RBM14;DDX5;SRSF5;ZC3H12C;CPEB1;EIF4G1;ZFP36L1;SSB;EIF3D;RPL7;RSL1D1;YTHDF3;CPSF6;RBM8A;KHDRBS3;RNPS1;SHFL;SRSF6;GRSF1;RPS26;HNRNPA0;RPS5;RPL13A;RIDA;SERBP1;EIF2A;N4BP1;ZC3H12A;CSTF2T;PCBP1;PCF11;CSTF2;YTHDC1;MRPL13;EDC3;PCBP4;HNRNPLL;PTBP1;RPL35;SNIP1;METTL3;FMR1;EIF3A;TRA2B;PUM3;RBM24
prerank,phosphatase binding (GO:0019902),-0.2646329669623204,-1.04151245623799,0.36239782016348776,0.7376512274318542,1.0,30/105,22.65%,MAP3K5;IQGAP1;PTK2;RACK1;PXN;PPME1;NFATC2;CTNNB1;HSP90B1;MET;CEACAM1;FLT4;CHCHD3;CDKN1B;MAP2K7;STAT3;SPTBN4;MTMR9;PPP6R1;JUP;TERF2IP;VRK3;FBXL2;PPP3R1;JAK3;JAK1;CTSC;MAPK3;VCP;ANAPC7
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.28088130425935653,-1.03953196793289,0.353887399463807,0.7391474556652392,1.0,20/74,16.22%,DGKH;PKM;DGKB;NADK;FAM20C;PGM2L1;PIK3C2B;DGKI;HK1;NMRK1;PAPSS2;PIK3CD;PIK3C2A;DGKZ;DGKG;PIK3C3;RFK;PI4KB;CLP1;ETNK1
prerank,solute:sodium symporter activity (GO:0015370),0.3755060311356999,1.0393376369472698,0.3879781420765027,0.8140489395809917,1.0,7/27,13.39%,SLC20A2;SLC13A5;SLC34A3;SLC28A3;SLC4A9;SLC20A1;SLC5A7
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3747069876523891,1.038527900568625,0.42047531992687387,0.8116481791994496,1.0,6/27,13.80%,POLR2D;POLR2A;TENT2;POLR1F;POLR1A;POLR1D
prerank,U6 snRNA binding (GO:0017070),-0.40507841557564994,-1.0375834284352967,0.4163265306122449,0.7399607402329249,1.0,6/14,26.46%,LARP7;DDX39B;PRPF4;EIF5A;RBM22;LSM8
prerank,thioesterase binding (GO:0031996),-0.436788351005883,-1.0374833082763872,0.4142335766423358,0.7361896035270535,1.0,2/11,14.71%,RAC1;TRAF1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3234306684202109,-1.0368369010209086,0.4053452115812918,0.7336708705999639,1.0,13/37,29.62%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.37687556126546967,1.031241247848325,0.42379182156133827,0.8261852704983765,1.0,1/29,0.08%,PRKAG2
prerank,phosphatase activator activity (GO:0019211),-0.4014062860464809,-1.0310846940694112,0.42283298097251587,0.7441166903824027,1.0,7/14,24.06%,CALM1;PPP2R5C;BMP2;CALM2;PPP2R5A;CALM3;PPP1R15A
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.37924939530518004,-1.0275037309582604,0.4373795761078998,0.7492907362399815,1.0,5/18,5.04%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,BMP binding (GO:0036122),-0.4380339972567271,-1.0267029987286622,0.44144144144144143,0.7474232268948447,1.0,2/11,3.91%,ENG;BMPR2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.32327532997653907,-1.0263050255973807,0.4217391304347826,0.7444739945304464,1.0,10/35,20.56%,PTK2;FYN;PTK2B;BMX;CSK;PEAK1;STYK1;YES1;SLA;TXK
prerank,protein phosphatase activator activity (GO:0072542),-0.4109902947571039,-1.0261307785645752,0.4383838383838384,0.7408769617511636,1.0,6/13,24.06%,CALM1;PPP2R5C;CALM2;PPP2R5A;CALM3;PPP1R15A
prerank,pre-mRNA binding (GO:0036002),0.37249753699104715,1.0254338501815086,0.43159922928709055,0.8364239126266728,1.0,1/28,0.17%,CELF2
prerank,ubiquitin binding (GO:0043130),-0.27408282027952097,-1.0253582868164248,0.40591397849462363,0.7388772817367544,1.0,25/73,22.66%,FBXO7;MVB12B;UBXN1;HSPB1;BUB3;UBAP1;FAF1;UCHL1;TOLLIP;NSFL1C;UCHL3;OTUB1;MVB12A;TOP2A;UBAP1L;RNF19B;AUP1;N4BP1;SPRTN;SHARPIN;RNF168;RBCK1;TNFAIP3;USP5;PLAA
prerank,potassium channel regulator activity (GO:0015459),-0.30259356696113515,-1.02531874144135,0.4103896103896104,0.7350555162898853,1.0,12/49,17.13%,ABCC9;NEDD4L;KCNS3;FLNA;KCNAB1;WNK3;CHP1;KCNMB4;ADRB2;KCNIP2;WNK2;SGK1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.39120411783767145,1.0247861965748748,0.44045368620037806,0.8336190361275344,1.0,5/21,14.50%,KL;FGF1;FRS2;FGF9;FGF20
prerank,carboxylic acid binding (GO:0031406),-0.3150108458075068,-1.0246600906114252,0.4135514018691589,0.7326116461588272,1.0,8/38,10.82%,NOS3;SESN3;GRM7;PSAP;GRIN3A;SESN2;GRIN1;NOS1
prerank,sodium channel regulator activity (GO:0017080),0.34927978474464877,1.0235088698412647,0.4221824686940966,0.8325271362956964,1.0,8/37,12.39%,SNTA1;GPD1L;NEDD4;PCSK9;CAMK2D;SCN3B;PTPN3;SCN2B
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3743919932471918,1.0234296534942282,0.4076086956521739,0.8282818970556353,1.0,3/27,3.07%,SLC8A3;SLC41A1;SLC8A1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3623342342880891,-1.0220495649190666,0.4498977505112474,0.7354722408927705,1.0,7/22,12.65%,DNAJA1;HSP90B1;APBB1;AP2M1;APBB3;MESD;CLU
prerank,methylation-dependent protein binding (GO:0140034),0.317769267789812,1.0219029648041018,0.4273927392739274,0.8279635055076818,1.0,14/57,16.25%,KDM7A;PYGO1;L3MBTL2;PHF8;MTF2;CBX8;CBX2;KAT8;MBTD1;RRP8;TRIM24;MORC3;PHF1;PHF2
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.38104519509752033,-1.0218241008016842,0.4376237623762376,0.7322513062733302,1.0,5/18,13.96%,GAS6;SERPINB9;BIRC3;RPS6KA1;MT3
prerank,potassium ion antiporter activity (GO:0022821),0.42455724016491075,1.0210680139499297,0.4267515923566879,0.8258937117720135,1.0,1/15,0.36%,SLC24A3
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.2616419015482615,-1.0196066930501706,0.38095238095238093,0.7340116241082704,1.0,14/100,7.60%,CERT1;HIP1;CYTH3;ARAP2;MYO10;IQGAP1;ARAP3;DAB2IP;DENND1B;CLVS2;CLVS1;FERMT2;RPH3A;HIP1R
prerank,phosphate ion binding (GO:0042301),-0.4435557670022547,-1.0192782069646014,0.46808510638297873,0.7310534448217143,1.0,5/10,36.38%,PDE2A;RPH3A;RELA;CHST14;ADSS1
prerank,death receptor activity (GO:0005035),-0.4324653865397067,-1.019006586468121,0.44866920152091255,0.7281677939354844,1.0,4/11,19.28%,TNFRSF11A;TNFRSF1B;FAS;TNFRSF10B
prerank,filamin binding (GO:0031005),0.4459207672327924,1.0159321255960254,0.4553191489361702,0.8348081607322415,1.0,2/11,3.73%,DPYSL3;NEBL
prerank,adenylate cyclase binding (GO:0008179),0.46925792246086856,1.0136174123867903,0.449901768172888,0.8364431006545853,1.0,1/10,0.40%,ADCY5
prerank,hexosyltransferase activity (GO:0016758),0.2928180189830073,1.0128554600901587,0.4287949921752739,0.8339487839906865,1.0,12/101,8.14%,B3GALT1;TMTC4;LARGE1;TMTC1;B3GNT5;A4GALT;B4GALT1;ALG6;CHSY1;HAS1;EXTL1;ALG9
prerank,GABA-A receptor activity (GO:0004890),-0.3762223481133784,-1.0119875042003827,0.429126213592233,0.7424615918575574,1.0,6/18,24.99%,GABRB3;GABRB1;GABRG3;GABRA5;GABRE;GABRG2
prerank,phosphatidylinositol binding (GO:0035091),-0.26293599204318574,-1.0115720003660806,0.372972972972973,0.7397187931549166,1.0,30/91,21.93%,PITPNC1;HIP1;EPB41;MCF2L;ITPR2;ESYT2;PITPNM2;SCARB1;TNFAIP8L3;DENND1B;CCDC88A;RPH3A;HIP1R;SNX16;APPL1;MTM1;WDFY3;RNF34;ITPR3;PLEKHN1;SNX1;PITPNA;PITPNB;SNAP91;THY1;MREG;SNX2;NUMA1;PLEKHF2;EXOC8
prerank,myosin II binding (GO:0045159),-0.4429685453071365,-1.0107722897334777,0.44385026737967914,0.7378678903985301,1.0,3/10,8.16%,SHROOM4;GSN;SHROOM1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.4096848344863876,-1.010616903366901,0.45366795366795365,0.7345376672361267,1.0,5/12,13.61%,RACK1;NOD1;ATP2A3;CASP8AP2;RPS27L
prerank,SUMO transferase activity (GO:0019789),0.40731682351862764,1.0105457913890805,0.44136460554371004,0.8354141429789067,1.0,5/16,19.01%,PIAS1;MDM2;CBX4;HDAC4;PIAS3
prerank,ATPase regulator activity (GO:0060590),-0.3183770686435175,-1.0105452074249335,0.4590909090909091,0.7310309135309485,1.0,10/38,16.82%,FNIP2;ATP1B1;DNAJA1;BAG1;SIL1;DNAJC1;DNAJC10;ATP5IF1;PLN;DNAJB1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.3773807103188848,-1.0102402996810853,0.4538310412573674,0.7282115594500338,1.0,6/17,19.86%,PTK2B;GRIK4;GRIN3A;GRIN1;GRIA2;GRIK2
prerank,titin binding (GO:0031432),0.4344034314986889,1.008691382446088,0.4431137724550898,0.8357851551260553,1.0,3/13,11.93%,TRIM63;CAMK2D;ACTN2
prerank,peptide hormone receptor binding (GO:0051428),-0.4376790392872675,-1.005554520050813,0.49423076923076925,0.7364952996764427,1.0,6/11,45.19%,PTHLH;GNRH1;ADCYAP1;PSMC5;VIP;UCN2
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.354422692916873,-1.003703492214857,0.45020746887966806,0.7374410392151943,1.0,12/22,30.54%,DUSP16;DUSP8;DUSP3;SBF1;DUSP1;DUSP12;DUSP6;DUSP4;CDKN3;DUSP18;PPM1F;DUSP7
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.38608578891184003,1.0035862950017644,0.4580152671755725,0.8445622267351414,1.0,4/21,6.94%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,hyaluronic acid binding (GO:0005540),0.45534924177406727,1.0031408849323382,0.4543610547667343,0.8414383232035282,1.0,1/10,0.75%,CEMIP
prerank,four-way junction DNA binding (GO:0000400),0.40353609239857624,1.00292795215012,0.4437869822485207,0.8376555442207447,1.0,5/17,15.09%,RAD51B;RAD51C;BLM;ABL1;WRN
prerank,calcium-activated potassium channel activity (GO:0015269),-0.4219917504088262,-1.002631282209825,0.45724907063197023,0.736549806568334,1.0,3/11,12.36%,KCNMA1;KCNMB4;KCNN2
prerank,hexosaminidase activity (GO:0015929),0.44124202500929377,1.002556271490187,0.4682080924855491,0.8343753463564435,1.0,4/12,15.04%,CEMIP;HEXD;SPAM1;HYAL1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.344825993788303,-1.0002607237027992,0.4610526315789474,0.7387251181552481,1.0,9/24,25.05%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.3444043534337863,-0.997934965727044,0.48232848232848236,0.7407449620197083,1.0,9/22,22.29%,OTUD7A;MINDY2;ZRANB1;TAB3;FAAP20;SPRTN;RNF168;OTUD7B;TNFAIP3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.4330073971733923,-0.9955204085588114,0.4828897338403042,0.7427501436567768,1.0,4/10,24.99%,GABRG3;GABRA5;GABRE;GABRG2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.26469096993171926,0.9948030209156722,0.4808823529411765,0.849671659357668,1.0,31/181,13.03%,TCF7L2;ARNT2;RBPJ;PPARA;PRRX1;NR1I2;NCOA2;FIZ1;SETD6;TTC8;NCOA3;SMAD3;CHD4;NCOA7;RBL2;TEAD3;WWP2;PIAS1;ARNT;MED1;BBS7;PARP9;HDAC1;SMARCE1;TACC1;RXRA;CRY1;GTF2I;AR;SMARCB1;IFI27
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.371384209686439,0.9927057983290357,0.4524714828897338,0.850645681690862,1.0,4/23,6.94%,PDE1A;PDE7B;PDE7A;PDE5A
prerank,endopeptidase inhibitor activity (GO:0004866),0.29241348362862507,0.9921000330785645,0.47249190938511326,0.8480071751209689,1.0,7/82,3.76%,TFPI;TIMP3;ITIH2;SERPIND1;LTF;PROS1;A2ML1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.44214610714236535,0.9888663218535263,0.4700854700854701,0.8519496505087178,1.0,2/10,8.36%,DPYSL3;DPYS
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.36228142347211406,0.9888057226124527,0.4695817490494297,0.8479469838367438,1.0,3/26,5.56%,B3GALT1;B3GNT5;CHSY1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.31908985874665974,-0.9883784744591769,0.44731182795698926,0.7566618899279901,1.0,9/32,12.14%,SLC6A6;SLC7A5;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC43A2;SLC36A1;SLC1A4
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.41085335609887064,-0.9872685928462909,0.4838709677419355,0.7556212679077703,1.0,5/12,5.04%,LTBP4;ACVRL1;ENG;BMPR2;TGFBR2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.30161642572227093,-0.986871553917869,0.45739910313901344,0.752947093874957,1.0,11/42,20.43%,BCAR3;SHE;PLCG2;YWHAB;NCK2;CRK;SAMSN1;SHB;YES1;PIK3R3;SHC3
prerank,adenyl nucleotide binding (GO:0030554),-0.4169420888593537,-0.9813337836084527,0.5067961165048543,0.7587176733837687,1.0,2/11,8.66%,BAG1;SIL1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4169420888593537,-0.9813337836084527,0.5067961165048543,0.7587176733837687,1.0,2/11,8.66%,BAG1;SIL1
prerank,mannosyltransferase activity (GO:0000030),0.380783301541507,0.9805042905348957,0.48863636363636365,0.8643296222076112,1.0,5/21,9.84%,TMTC4;TMTC1;ALG2;ALG9;PIGV
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28890770763604756,-0.9774486247466352,0.46808510638297873,0.7643939702360467,1.0,23/49,29.70%,ESYT2;MCTP1;CPNE8;RPH3A;CPNE2;CPNE3;DYSF;C2CD5;SYT10;PCLO;SYT4;PLA2G4A;CPNE9;SYT2;SYT7;SYT15;PLA2G4F;ANXA8;DOC2B;CPNE5;SYT17;SYT1;ESYT3
prerank,platelet-derived growth factor binding (GO:0048407),0.4264533616966202,0.9769566991969797,0.4820627802690583,0.8693481007665057,1.0,3/11,4.40%,PDGFRB;COL1A2;PDGFRA
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3661557822912835,0.9749419111602511,0.49619771863117873,0.8699185168153702,1.0,5/24,11.17%,OSBPL8;GSDMA;PLEKHF1;GSDMD;PLEKHA8
prerank,cAMP binding (GO:0030552),-0.40856184104146454,-0.9747607025388183,0.5120593692022264,0.7670787943659145,1.0,3/11,12.59%,PDE4D;PDE2A;HCN1
prerank,transcription coregulator binding (GO:0001221),0.3121546981569373,0.9720632505915993,0.5103092783505154,0.8730083702090506,1.0,10/50,12.50%,RORA;USP11;VGLL4;SMAD3;MTF2;CCNT2;PER3;CHD6;CNOT2;AR
prerank,receptor tyrosine kinase binding (GO:0030971),-0.2767052639191671,-0.9719637292204037,0.5273159144893111,0.7702433981858978,1.0,14/56,14.69%,GRB14;PITPNM2;PTPN14;GAS6;CBL;RACK1;NCK1;TOB1;SOCS5;CPNE3;PTPN1;DUSP3;PITPNM3;NRG3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.31449482559986974,-0.9718209785924926,0.45790554414784396,0.7669785033821493,1.0,9/30,16.03%,GAS6;CST3;SERPINB9;BIRC3;RPS6KA1;MT3;SPOCK1;PTTG1;CARD16
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3501179097686084,0.9713845484394281,0.47889908256880737,0.8704641728437272,1.0,6/27,13.80%,POLR2D;POLR2A;POLR1F;POLR1A;PRIMPOL;POLR1D
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4367396875284381,0.9704370023668569,0.48893360160965793,0.8687403647128915,1.0,1/11,0.41%,SASH1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.44320592206032594,0.9666933071494781,0.5040322580645161,0.8739546165587637,1.0,4/10,20.66%,ASH1L;NSD1;SETD2;NSD3
prerank,calcium channel activity (GO:0005262),0.28733158696935257,0.9657181644034974,0.48688524590163934,0.872198132676578,1.0,8/84,7.85%,CACNA2D3;SLC24A3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1;MCU
prerank,ATP binding (GO:0005524),0.24756594985619582,0.9637473958318353,0.5297297297297298,0.8729607318445262,1.0,45/266,15.14%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;CLPX;DMPK;MAP4K5;SRPK2;ABCA1;SPHK1;PTPA;SIK1;STK17B;MYO18A;TRNT1;SARS2;BLM;MYO9B;SRR;PMVK;HSPA1L;GALK1;NOL9;LATS1;ABL1;SMARCA5;ATP7B;MYH10;RTEL1;BMPR1A;PRKAG1;ABCB8;PRKACB;PPIP5K2;STK26;NIM1K;CDKL5;NLK;TAP2;PRKCI;HACL1;SIK3;MTHFS
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3094129416735139,-0.963499009850643,0.5045045045045045,0.7832184811859807,1.0,7/32,11.07%,KCNQ3;KCNB2;KCNS3;KCNB1;KCNQ1;KCNA1;KCNQ5
prerank,steroid hydroxylase activity (GO:0008395),0.39263566770722985,0.9634259508081325,0.49902152641878667,0.869786838618997,1.0,1/16,1.11%,CYP27A1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.34734498385545665,-0.9622365265615046,0.5273833671399595,0.7826200151717505,1.0,1/17,0.80%,SLC2A1
prerank,calcium channel regulator activity (GO:0005246),0.3268413484812188,0.9608697556205373,0.5248618784530387,0.8721683129411271,1.0,4/37,4.91%,ITPR1;STIM1;CACNG1;CACNG7
prerank,palmitoyltransferase activity (GO:0016409),-0.3244133058482212,-0.9597338367565832,0.5456475583864119,0.7848650956987744,1.0,11/28,27.61%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;HHAT;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,protein homodimerization activity (GO:0042803),0.22985563185968724,0.9581785515027638,0.5912240184757506,0.8747189707926681,1.0,60/590,8.49%,MAPK4;CPQ;DPYD;NPR3;MTUS2;APPL2;FGFR2;NR2F2;KIT;NADK2;TPM1;UPB1;KMT2A;JAML;FBLN5;SNX6;LHPP;CBS;BCL2;TNNC1;HSD17B1;CRYL1;GSTM2;SOX6;TPST1;TRIM5;ALS2;IRAK2;RBPMS;ZHX2;PAFAH1B3;CRPPA;CBY1;PDGFRA;PTPA;GLIPR2;NDP;LRRK2;SNX9;EPHX2;THAP1;BNIP3;PDCD6;ACP3;HOGA1;PGRMC1;SMAD3;BLM;RPE;NR6A1;KLHL7;NRBP1;SLC30A8;MYO9B;MUC13;CSF1;ZDHHC3;SRR;ARNT;SSBP1
prerank,adenyl ribonucleotide binding (GO:0032559),0.24295401411575812,0.9578225026761263,0.5426666666666666,0.8715264672334361,1.0,49/291,15.14%,PRKAG2;ATP1A2;OXSR1;KSR1;WNK4;DAPK1;PRKAG3;CLPX;DMPK;MAP4K5;SRPK2;ABCA1;SPHK1;PTPA;SIK1;STK17B;MYO18A;TRNT1;MPPED2;SARS2;BLM;RAPGEF4;MYO9B;SRR;PMVK;HSPA1L;GALK1;NOL9;LATS1;ABL1;SLC19A1;SMARCA5;ATP7B;MYH10;RTEL1;BMPR1A;PRKAG1;ABCB8;PRKACB;PPIP5K2;STK26;NIM1K;CDKL5;NLK;TAP2;PRKCI;HACL1;SIK3;MTHFS
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.271695978868379,-0.9577789324954389,0.5320197044334976,0.7859168158587039,1.0,20/55,20.29%,ITPR2;TRPC3;PKD1;ATP2C1;ATP2A2;ATP2A3;RYR2;SLC24A2;GRIN1;ATP2B1;PANX1;CACNB2;TRPV2;SLC24A5;TRPC1;ORAI1;TMEM165;PSEN1;ATP2B2;ATP2B4
prerank,pentosyltransferase activity (GO:0016763),0.3303771165915534,0.954546575067145,0.5038022813688213,0.8754822785379319,1.0,10/36,20.03%,LARGE1;LACC1;PARP4;PARP10;PARP9;UPP2;SIRT3;QPRT;TIPARP;PARP14
prerank,microtubule binding (GO:0008017),-0.22001890216329859,-0.9543316416017578,0.6072874493927125,0.7906422420380131,1.0,79/222,26.90%,DNM3;MTUS1;SGIP1;STARD9;MAP1B;REEP3;REEP1;MAP4;MID1;RPS3;CLIP1;MAP6;CLIP2;CCDC88A;RP1;EML6;KIF26A;MDM1;CHP1;GAPDH;MAP1LC3B;DNM2;NAV3;APC;KIF1A;RMDN3;DNM1;WHAMM;ARHGEF2;MTCL1;TOGARAM1;GAS2L3;KIF13A;HOOK1;RCC2;CCDC66;NDE1;CCDC88C;RMDN1;TPPP;KIF21B;FHDC1;APC2;CEP295NL;KIF3B;CCDC69;GAS2L1;CDK5;CKAP5;MID2;IRAG2;HAUS6;MAPRE1;POLB;KIF15;FMR1;NUMA1;DCTN1;TTBK2;VAPA;HDAC6;KNSTRN;MAST1;SPAG5;KIFC1;MAP1A;CLASP2;SPEF1;CEP295;CAMSAP3;SAXO2;CAMSAP1;KIFC2;REEP2;KIF14;KIF1B;CETN3;EZR;NEFM
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.3182444667076007,-0.9524495307127995,0.5305263157894737,0.791340070162596,1.0,4/29,5.66%,PTPRJ;DUSP16;GCH1;NFATC1
prerank,glycine binding (GO:0016594),-0.3935867765498283,-0.9523331598091648,0.5232558139534884,0.788037179425455,1.0,7/11,31.55%,GRIN3A;GRIN1;GLRA3;GLRA1;GLDC;GNMT;GRIN2B
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3954683831559717,-0.9508994134024561,0.5542406311637081,0.7877714398481297,1.0,5/11,25.11%,NUDT3;NUDT4;NUDT1;DCPS;NUDT16
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3929421723227077,-0.9503698799660234,0.5326732673267327,0.7855514407085689,1.0,7/12,30.54%,DUSP16;DUSP8;DUSP3;DUSP1;DUSP6;DUSP4;DUSP7
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.29806582413831695,-0.9488656958571048,0.5093457943925234,0.7857339990465916,1.0,9/38,14.16%,SERPINE2;SERPINI1;SERPINF1;SERPINB9;APP;A2M;FURIN;SPINT2;SPOCK1
prerank,voltage-gated ion channel activity (GO:0005244),-0.3757175638106527,-0.9485407476533038,0.5433070866141733,0.7830420467774062,1.0,4/14,19.59%,CACNA1E;CACNA1H;HCN1;KCND2
prerank,NAD+ binding (GO:0070403),0.41956940005778554,0.9484670129260464,0.5063559322033898,0.8868118218489,1.0,5/12,23.83%,CRYL1;PARP9;SIRT3;SIRT5;HADH
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.32855343488552363,0.9444286439017705,0.545774647887324,0.8921329573303002,1.0,9/38,15.95%,SNX21;PARD3;SH3PXD2B;WIPI1;PLEKHF1;ZFYVE26;SNX12;RUFY4;DENND1A
prerank,protein kinase C activity (GO:0004697),-0.3724823961636947,-0.939002210727564,0.5555555555555556,0.8012890300887346,1.0,6/14,20.19%,PRKCH;PRKD3;PRKD1;PRKCE;PRKCG;PRKCD
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2959685705263879,-0.9352009547000378,0.5754060324825986,0.8065903862888775,1.0,14/37,18.29%,SLCO1C1;SLCO2A1;SLCO2B1;COX4I1;SLCO3A1;NDUFA4;UQCRH;COX6A1;UQCR11;COX8A;COX5A;UQCRQ;SLCO4A1;UQCRC1
prerank,phosphatase inhibitor activity (GO:0019212),-0.3411622222889912,-0.9347101242091941,0.5564053537284895,0.8040829754582238,1.0,9/20,29.65%,PPME1;PPP1R2;SET;LMTK2;BOD1;MGAT5;URI1;ARPP19;SAG
prerank,actinin binding (GO:0042805),0.3624844057063586,0.9312404024662687,0.5354969574036511,0.9206536894490703,1.0,3/21,4.74%,KCNA5;CSRP3;CACNA1D
prerank,growth factor receptor binding (GO:0070851),0.267219556576928,0.9282632548103739,0.5691823899371069,0.9236789914511443,1.0,15/95,12.50%,EFEMP1;PDGFRB;KL;FER;FAM83B;PDGFRA;PDGFD;FGF1;FRS2;IL6;VEGFB;FGF9;JAK2;TGFA;AREG
prerank,low-density lipoprotein particle binding (GO:0030169),-0.3580365577749212,-0.9275649863140931,0.5714285714285714,0.8164077882778759,1.0,5/16,5.22%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,magnesium ion binding (GO:0000287),0.254430094526218,0.9268465337161482,0.5731166912850812,0.9229063796510999,1.0,31/135,16.88%,OXSR1;EYA2;SRPK2;SPHK1;SIK1;TDP2;LRRK2;EPHX2;PDCD6;HMGCL;SRR;IDH2;XYLT2;LATS1;CLYBL;ABL1;RAP2A;IDH3G;FOXK2;THTPA;PRKACB;NUDT12;STK26;NIM1K;NLK;HACL1;SIK3;WRN;BRSK1;PI4K2A;XXYLT1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2749825958866834,0.9257752750357814,0.5861513687600645,0.9213108462622763,1.0,9/85,7.58%,CEL;LIPA;PLA2G10;PAFAH2;PAFAH1B3;ENPP2;LIPC;H6PD;DAGLB
prerank,exonuclease activity (GO:0004527),0.3020772783841455,0.9242672521065671,0.5604026845637584,0.9209315390458173,1.0,16/46,20.63%,REXO5;APEX2;ENPP2;EXOSC8;DCLRE1B;ENPP3;ISG20L2;MRE11;APEX1;ERI1;WRN;CNOT7;REXO4;EXOSC3;PDE12;RAD50
prerank,myosin binding (GO:0017022),-0.26263169259796687,-0.9241162503210216,0.5707547169811321,0.8209306332910719,1.0,11/55,12.90%,MYRIP;SHROOM4;GSN;RAB3C;NKD2;MYOC;SHROOM1;RHOA;RAB3B;LMTK2;MLPH
prerank,aspartic-type peptidase activity (GO:0070001),-0.39656658160427577,-0.9228109585251147,0.5822050290135397,0.8202829966267338,1.0,3/10,27.35%,CTSD;PSEN1;CTSE
prerank,dynactin binding (GO:0034452),0.3936804736883212,0.9220018414522806,0.5452631578947369,0.9222745206251876,1.0,3/12,13.95%,SNX6;PAFAH1B1;BICD2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.24298020178631904,0.9212302082470324,0.636896046852123,0.9199663225433269,1.0,29/188,13.20%,SOX5;TCF7L2;ARID5B;SMAD6;PRDM5;SOX6;TBL1XR1;ZBTB20;NFYB;ASH2L;ARID4A;BCOR;XRCC5;SMAD3;GABPB1;GABPB2;TCF12;PER3;NFYC;CREB3L2;TFAP2A;ZNF568;RXRA;SOX13;HSF1;PSPC1;AR;NONO;FOXK2
prerank,lipoprotein particle binding (GO:0071813),-0.3366424770165024,-0.9203205645891105,0.6004016064257028,0.8223487621680986,1.0,7/20,12.42%,PLTP;THBS1;SCARB1;SCARF1;STAB1;CDH13;HSPD1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.33511774869362876,0.9192336956647461,0.5660749506903353,0.9205123766465048,1.0,5/27,8.48%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,potassium channel activity (GO:0005267),-0.24062706730204417,-0.9190265192005164,0.6417112299465241,0.821927104676998,1.0,19/89,15.63%,KCNK5;ABCC9;KCNQ3;KCNB2;KCNMA1;KCNS3;KCNB1;GRIK4;KCNK13;KCNQ1;KCNT1;KCNMB4;KCNA1;KCNQ5;KCNN2;HCN1;TMEM38B;KCNQ2;KCNH7
prerank,glucuronosyltransferase activity (GO:0015020),0.36865398005457833,0.9186082206490432,0.5469924812030075,0.9179356969579883,1.0,3/19,7.54%,LARGE1;CHSY1;EXTL1
prerank,FMN binding (GO:0010181),-0.39534086832612375,-0.918486655194674,0.5876494023904383,0.819609292048862,1.0,6/11,32.68%,NOS3;NOS1;PPCDC;PNPO;POR;NOS2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.40122120439266723,0.9183328966968843,0.5690021231422505,0.9146715997734396,1.0,3/12,9.01%,KDM7A;PHF8;KDM3B
prerank,calcium channel inhibitor activity (GO:0019855),0.4040624905509533,0.9175595072810573,0.5428571428571428,0.9124618287684196,1.0,1/11,0.79%,ITPR1
prerank,ligand-gated cation channel activity (GO:0099094),-0.246335632246717,-0.91726524636616,0.6293333333333333,0.8186975003433887,1.0,28/75,34.82%,KCNJ2;PTK2B;GRIK4;GRIN3A;GRIN1;KCNN2;KCNJ8;KCNJ15;GRIA2;TRPM4;GRIK2;KCNH2;CHRNB1;KCNJ6;MCOLN1;TRPM2;KCNJ16;SCNN1A;ASIC1;KCNJ10;GRIA1;GRIN2B;P2RX5;GRIK1;P2RX7;TRPM8;P2RX3;P2RX6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.4083876719493375,0.9171746656240305,0.5663157894736842,0.909452945355969,1.0,1/11,1.77%,AGMAT
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.3772589479743704,0.9146556880518762,0.5364372469635628,0.9114802023195784,1.0,2/15,2.14%,HS3ST3A1;HS3ST3B1
prerank,nuclear receptor binding (GO:0016922),0.2572936298703164,0.9139089902655002,0.6298003072196621,0.9093544296610852,1.0,21/111,11.89%,TCF7L2;BRD8;NR1I2;PPARGC1B;NCOA2;GRIP1;STAT5B;WIPI1;PRKCB;NCOA3;SMAD3;NCOA7;NSD1;MED1;LATS1;MED13;SMARCE1;TACC1;RXRA;CRY1;RNF14
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.24244424820174093,0.913884104025424,0.6433770014556041,0.9055643525773138,1.0,31/173,13.83%,AEBP1;PPARA;ZEB2;KCNIP3;MXI1;SATB1;PRDM5;ZEB1;ASCL2;ZBTB20;VSX2;ZFP90;IRF8;MXD1;ZBTB32;ZFP37;THAP1;EN1;MITF;IRX1;TFAP2A;ZBTB39;ZBTB37;ZNF177;E2F6;SOX13;HSF1;NFATC4;FOXK2;SNAI1;ZNF148
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.29003377594346613,-0.9137832927161884,0.5952380952380952,0.8226446068958129,1.0,9/35,14.10%,GPCPD1;PLCB4;SMPD4;GDPD1;PLCB3;GDPD3;PLCXD3;PLD3;PDE11A
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2829594014331338,0.9131865951480318,0.5789473684210527,0.9032774628519961,1.0,15/69,14.31%,LPGAT1;ZDHHC1;SPHK1;CERS6;CERS5;DBT;ZDHHC3;KAT8;KAT6B;CERS1;SOAT2;ESCO1;PLA2G4C;CREBBP;AWAT2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.36751654660783756,0.9106735140619877,0.5574712643678161,0.9053256096319867,1.0,7/17,24.79%,ACOT4;ACAA2;ACOT1;ACOT11;ACOT13;ACOT6;PPT1
prerank,metallocarboxypeptidase activity (GO:0004181),0.3377029469433351,0.9101193822775915,0.5844402277039848,0.9028399280517058,1.0,3/26,8.19%,AEBP1;AGBL2;CPXM1
prerank,nucleosomal DNA binding (GO:0031492),0.3483030771136246,0.9088391408363031,0.5589430894308943,0.9020251709825378,1.0,7/21,15.41%,RBBP4;HNRNPC;CHD4;HDAC1;SMARCE1;SMARCB1;SMARCC1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.23155114581639655,0.9079855564353194,0.6606145251396648,0.9001271685154135,1.0,44/254,15.32%,TCF4;RBPJ;HLF;PPARA;HOXC4;PRRX1;MEIS1;MYBL1;SCX;NR1I2;HOXB3;NFYB;NFAT5;HOXA7;NFIB;ELF4;GMEB1;RFXAP;SMAD3;TCF12;NFIA;MITF;CEBPG;MDM2;NFYC;IRF3;TFAP2A;TFAP2B;MYB;GTF2I;AR;KLF5;HOXD4;NR1I3;FOXK2;TFDP2;MLXIP;CLOCK;SRF;HOXD8;NKRF;SOX12;BARX2;MEIS2
prerank,NF-kappaB binding (GO:0051059),-0.3066878373205587,-0.9078946104727874,0.6127049180327869,0.8321773712872258,1.0,12/24,35.88%,NFKBIA;FAF1;GSK3B;COMMD7;BRMS1;RNF25;RELA;HDAC3;HIF1AN;NPM1;CDK5RAP3;ANXA4
prerank,ubiquitin-specific protease binding (GO:1990381),0.3572936899293242,0.9035315655802312,0.6003787878787878,0.9065535734260008,1.0,3/19,8.17%,PRKN;PTEN;AMFR
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4015764531616264,0.9035251623261643,0.575107296137339,0.9028156122983052,1.0,1/11,2.04%,PPP1R1A
prerank,tRNA methyltransferase activity (GO:0008175),0.37139412685396933,0.8988875459642993,0.5816733067729084,0.9092832908434755,1.0,4/16,15.01%,TRMT9B;LCMT2;TRDMT1;THUMPD3
prerank,voltage-gated cation channel activity (GO:0022843),0.2622965596373523,0.8968335580111837,0.6076555023923444,0.9102484522120471,1.0,9/97,7.35%,CACNA2D3;KCNQ4;KCNA5;KCND3;CACNA1D;CACNB4;CACNG7;TMC2;CACNA2D1
prerank,neuropeptide receptor activity (GO:0008188),0.31801091848722,0.8967599494263133,0.5841392649903289,0.9067017507377001,1.0,7/29,15.80%,SSTR2;KISS1R;GPR143;NTSR1;TACR3;HCRTR2;NPY2R
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.29955912278073044,0.8962061024756875,0.6200716845878136,0.9042713206217579,1.0,3/46,2.72%,B3GALT1;LARGE1;B3GNT5
prerank,nucleotidyltransferase activity (GO:0016779),0.3572566194542108,0.8953553616287163,0.5501930501930502,0.9025374662335228,1.0,9/19,23.49%,CRPPA;TENT2;REV1;TUT1;MOCS3;TUT4;TUT7;THG1L;PAPSS1
prerank,tau-protein kinase activity (GO:0050321),0.3529110331857855,0.8943021787597996,0.6,0.901138815151679,1.0,1/20,0.39%,ROCK2
prerank,carboxy-lyase activity (GO:0016831),-0.3135886699400379,-0.8942483954159343,0.6425619834710744,0.8587191101493278,1.0,7/23,17.39%,DDC;AMD1;AZIN1;GAD1;PPCDC;UROD;CSAD
prerank,ribonuclease P activity (GO:0004526),-0.373139928191875,-0.8910767879706146,0.6007827788649707,0.8618130781084041,1.0,7/11,34.18%,POP5;POP4;RPP21;RPP30;PRORP;POP7;RPP40
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.34853765608582565,0.8882877858532413,0.6340996168582376,0.910336755250073,1.0,5/21,10.07%,AKAP7;WASF1;WASF3;ARFGEF2;AKAP8L
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.3066961763904442,-0.8879612988656918,0.6224899598393574,0.8650082499291813,1.0,5/23,8.81%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,voltage-gated potassium channel activity (GO:0005249),0.264745404403178,0.8859595952170458,0.6352201257861635,0.9117426802528054,1.0,5/80,4.07%,KCNK2;KCNQ4;KCNA5;KCNT2;KCND3
prerank,G protein-coupled receptor activity (GO:0004930),0.22553433425260686,0.8843807033014237,0.7240398293029872,0.911589678947052,1.0,16/239,8.30%,ADGRV1;NPR3;LGR4;BDKRB2;ADGRL1;LPAR1;CXCR5;PDGFRB;CXCR6;LPAR2;SSTR2;ADRA1D;KISS1R;PTH2R;GPR143;F2RL2
prerank,ion channel inhibitor activity (GO:0008200),0.30435056700059704,0.883550243316971,0.6036697247706422,0.9098494771097312,1.0,8/35,12.63%,ITPR1;WNK4;NEDD4;PCSK9;CAMK2D;SCN3B;STX8;PACSIN3
prerank,cysteine-type peptidase activity (GO:0008234),-0.23870891014830606,-0.8831924686107712,0.714987714987715,0.8716391601006658,1.0,40/73,41.38%,USP38;LGMN;CTSB;CAPN2;USP29;UCHL1;USP50;USP37;CTSZ;CASP8;USP28;USP9X;USP8;ATG4A;CTSL;CTSC;OTUD7B;CASP1;USP5;OTULIN;USP49;USP33;USP2;USP10;USP9Y;BLMH;ATG4D;CTSF;USP35;ESPL1;ATG4B;CASP9;USP40;GGH;USP30;USP26;CTSO;CTSK;ATG4C;TINAGL1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.37903314468127947,-0.8817016521654985,0.6193181818181818,0.867539851485454,1.0,6/10,30.54%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.37903314468127947,-0.8817016521654985,0.6193181818181818,0.867539851485454,1.0,6/10,30.54%,DUSP16;DUSP8;DUSP1;DUSP6;DUSP4;DUSP7
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4041369826372253,0.8815433277513058,0.6,0.9104904056009939,1.0,2/10,12.99%,NAA80;NAA60
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3374693098404519,0.8801862912391605,0.6072144288577155,0.9062843478678716,1.0,5/21,14.82%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3374693098404519,0.8801862912391605,0.6072144288577155,0.9062843478678716,1.0,5/21,14.82%,CDK8;CDK7;CDK1;CDK15;CDK4
prerank,ligand-gated calcium channel activity (GO:0099604),0.35081172125728816,0.8797687272842649,0.6281800391389433,0.9036239374072941,1.0,1/19,0.79%,ITPR1
prerank,nuclear receptor coactivator activity (GO:0030374),0.2806624828765381,0.8788098248484871,0.6348122866894198,0.9021705417408398,1.0,11/52,12.86%,BRD8;PPARGC1B;NCOA2;PRKCB;ZMIZ1;NCOA3;NCOA7;MED1;MED13;TACC1;ZMIZ2
prerank,DNA replication origin binding (GO:0003688),-0.30428529723425013,-0.8775469536751326,0.6334661354581673,0.8726439367678226,1.0,10/23,33.17%,HSPD1;MCM4;MCM8;POLA1;MCM5;MCM10;ORC1;DHX9;MCM6;CDC6
prerank,nuclear localization sequence binding (GO:0008139),-0.32239195202224785,-0.8764761255711158,0.6286836935166994,0.8711600016808057,1.0,9/18,35.09%,NFKBIA;KPNA4;KPNA3;POM121;NUP153;CABP1;TNPO2;KPNA2;IPO4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3273239786384382,0.8764075704861061,0.6372007366482505,0.903972405780408,1.0,4/24,11.81%,DAPK1;CAMK1D;CAMK2D;MAPKAPK2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.34848954582743197,-0.8738440878157016,0.65,0.8731502952000771,1.0,6/14,22.59%,SYNJ1;MTM1;MTMR6;MTMR9;MTMR12;MTMR1
prerank,adenylyltransferase activity (GO:0070566),0.33926033063692285,0.8724263713043512,0.6320939334637965,0.9089272704002486,1.0,7/21,14.43%,NMNAT2;TENT2;ABL1;TUT1;NMNAT1;FLAD1;PAPOLB
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3729727768958375,-0.8722484964015742,0.6247582205029013,0.87298325131296,1.0,2/10,5.60%,ANO1;CLCN5
prerank,zinc ion binding (GO:0008270),0.21885724677846474,0.8720361767527633,0.7744458930899609,0.9063014068995624,1.0,56/293,14.67%,PAPPA;KDM7A;PRKN;UPB1;KMT2A;ZEB1;BAZ1B;RNF2;IKZF4;KDM2B;SORD;ACE;TET1;ZBTB32;NAPEPLD;ZFP37;PHF8;CXXC5;THAP1;RABIF;ENPP2;SMAD3;NPEPPS;BLM;MMP9;CHD4;BBOX1;ZKSCAN5;KDM2A;SLC30A8;SLU7;DPYS;KDM5B;TRAF7;MDM2;NSD1;ZNF8;RXRA;ENPP3;MYCBP2;PAM;KMT2B;ITGB1BP2;EEA1;CYLD;RCHY1;S100A9;SHMT1;PRIMPOL;ESCO1;TRIM24;NUDT12;KDM5C;MNAT1;GLI2;BIRC2
prerank,endopeptidase activator activity (GO:0061133),-0.3819231290143326,-0.8691298713260832,0.6616541353383458,0.8763420090276555,1.0,4/10,28.77%,PSME3;PSME1;VSIR;NLRC4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3080093271224591,-0.8689115115307572,0.6448979591836734,0.8732484256215972,1.0,16/21,56.67%,GRIK2;CHRNB1;P2RX5;P2RX7;P2RX3;P2RX6;CHRNA9;GLRB;CHRNA5;CHRNA4;CHRNA3;P2RX1;CHRNB4;TRPV1;CHRNA1;P2RX2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2715639081081664,-0.8670308106412487,0.6976241900647948,0.8733631847400272,1.0,9/35,24.36%,FOXP1;H3-3A;PIH1D1;RRN3;ZBTB17;TAF4;KLF10;RELA;STAT1
prerank,ribonuclease P RNA binding (GO:0033204),-0.3672395983644555,-0.8642045974806337,0.658203125,0.8756288229428143,1.0,4/10,17.51%,POP5;POP4;RPP21;RPP30
prerank,death domain binding (GO:0070513),-0.36381428754803546,-0.863903058188238,0.6536964980544747,0.8727076893768742,1.0,4/11,14.00%,RACK1;DAPL1;BCL2L1;DAP
prerank,H4 histone acetyltransferase activity (GO:0010485),0.4016222382663552,0.862007302394759,0.6314699792960663,0.9237837361683747,1.0,5/10,21.83%,KAT8;BRCA2;NAA60;MSL3;NAA50
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3817131113354897,0.8616948459715522,0.6063157894736843,0.9209635546151551,1.0,2/10,4.86%,CACNA1D;CACNB4
prerank,nucleotide diphosphatase activity (GO:0004551),0.3742935628356264,0.8600538837899907,0.623046875,0.9207525579451888,1.0,4/14,13.81%,FHIT;NUDT13;NUDT6;NUDT12
prerank,RNA polymerase binding (GO:0070063),0.34579519686375304,0.860042715387604,0.625,0.9172834855715676,1.0,4/18,8.59%,NEDD4;CCNT2;CCNT1;PKN2
prerank,ATPase activator activity (GO:0001671),-0.3122320530489651,-0.857175882861042,0.6719681908548708,0.8823939160253813,1.0,7/20,25.93%,ATP1B1;DNAJA1;DNAJC1;DNAJC10;DNAJB1;DNAJA2;DNAJB6
prerank,phospholipase C activity (GO:0004629),-0.2915222759913553,-0.8563836266595444,0.6862348178137652,0.8804244782942156,1.0,5/25,8.81%,EDNRA;PLCG2;PLCB4;CHRM3;PLCB3
prerank,tRNA binding (GO:0000049),-0.25499530439282503,-0.8561446770763134,0.7146282973621103,0.8774511579090561,1.0,17/43,30.10%,EEF1A1;PSTK;SARS1;SSB;RPUSD4;ALKBH8;EIF2A;DALRD3;ELP5;TRMT10C;AARS2;MRPS27;YRDC;CARS1;KARS1;PUS1;TRNAU1AP
prerank,retinoic acid receptor binding (GO:0042974),-0.3226715268949487,-0.855413457003144,0.7006109979633401,0.8754488566078985,1.0,4/17,16.90%,ACTN4;ARID5A;NRIP1;NR4A2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.36148067705563347,0.8495193502429333,0.6317907444668008,0.9357297479490593,1.0,5/14,18.54%,DUOX2;NCF2;DUOX1;CYB5R4;AIFM1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3196875774409601,0.8476386418737186,0.6711026615969582,0.9360941653437087,1.0,2/25,2.11%,PLEKHA2;ADAP2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.31411733923672486,0.8473807736871521,0.6640776699029126,0.9331001989806047,1.0,5/28,10.77%,MAP2K6;PRKAA2;LRRK2;TTK;RPS6KB1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3484974231256513,0.8463659125876845,0.6239669421487604,0.9317909677717436,1.0,2/14,4.07%,KCNA5;KCND3
prerank,peptidase activator activity (GO:0016504),-0.297204373637044,-0.8460017574120207,0.7074688796680498,0.889600501054837,1.0,8/22,24.17%,CAV1;MAL;PSME3;CASP8AP2;PSME1;PINK1;VCP;VSIR
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.3411176065319138,-0.8447853131985641,0.6863117870722434,0.888523055347578,1.0,3/14,5.19%,ATXN3;MINDY2;MINDY1
prerank,protein phosphatase 2A binding (GO:0051721),-0.28959485545468333,-0.8421079959625851,0.7248459958932238,0.8899863888401034,1.0,7/23,18.21%,DAB2IP;PPME1;GRIN3A;FOXO1;MASTL;BOD1;SMG5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3618293547470607,-0.8415110175164233,0.6779324055666004,0.8876894740651854,1.0,6/10,31.42%,ADARB2;GDA;CDA;ADA;DCTD;CDADC1
prerank,voltage-gated anion channel activity (GO:0008308),-0.31974199521002716,-0.8408419013953052,0.6998050682261209,0.8856046099538676,1.0,2/15,5.60%,ANO1;CLCN5
prerank,1-phosphatidylinositol binding (GO:0005545),-0.32744850430715067,-0.8398285552323628,0.6896551724137931,0.8841634389520483,1.0,2/15,2.50%,EPB41;SCARB1
prerank,galactosyltransferase activity (GO:0008378),0.3681071948517183,0.8395424878219682,0.6303418803418803,0.9424542220615404,1.0,4/11,12.58%,A4GALT;B4GALT1;B3GALT6;B4GALT2
prerank,serine-type endopeptidase activity (GO:0004252),0.24836889688721064,0.8388275882479928,0.7228525121555915,0.9403878904701167,1.0,5/80,3.79%,CORIN;KLK2;CTSH;MMP2;PCSK9
prerank,ferrous iron binding (GO:0008198),-0.30484068287809596,-0.8378665039390896,0.6858316221765913,0.8844976021283666,1.0,5/21,12.25%,FTH1;FTL;EGLN3;ISCU;EGLN2
prerank,protein kinase C binding (GO:0005080),-0.2514778969217171,-0.8345250329654748,0.7417218543046358,0.8873947238736976,1.0,17/43,24.50%,RACK1;HSPB1;ADCY4;HDAC5;CCDC88A;CAVIN2;YWHAG;HINT1;PICK1;TOP2A;ADAM9;DSP;TIRAP;HDAC7;HDAC9;DACT2;DACT3
prerank,kinase inhibitor activity (GO:0019210),-0.2622572504455575,-0.8329146017786088,0.7145877378435518,0.8869018772185752,1.0,12/33,30.50%,WARS1;NCK1;YWHAB;CDKN1B;SPRY4;SMCR8;PRKRIP1;CDKN1A;SOCS1;GMFB;AHSG;MAPK8IP1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.3041321202619287,-0.8298852266130219,0.7016129032258065,0.8887490240155372,1.0,11/19,35.17%,GRIK4;GABRG3;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2;GRIK1;GRID1;GABRG1
prerank,mRNA methyltransferase activity (GO:0008174),-0.3416126229130788,-0.8283016665315914,0.705765407554672,0.8884867997306789,1.0,5/12,23.62%,TRMT61B;METTL3;CMTR2;TRMT10C;PCIF1
prerank,DNA polymerase binding (GO:0070182),-0.30844016021027276,-0.8261135982095352,0.703187250996016,0.8893177869246869,1.0,2/18,2.37%,HSP90AA1;HSP90AB1
prerank,DNA secondary structure binding (GO:0000217),0.2914102215916723,0.824231403597042,0.6968576709796673,0.9655624319689604,1.0,6/31,10.44%,KMT2A;RAD51B;RAD51C;BLM;CLSPN;ABL1
prerank,pseudouridine synthase activity (GO:0009982),-0.33154247274731014,-0.8221947659791025,0.7263969171483622,0.8927776174824998,1.0,7/13,29.60%,RPUSD4;RPUSD1;TRUB2;PUS7;PUSL1;RPUSD2;PUS1
prerank,lysine N-methyltransferase activity (GO:0016278),0.3164107566403736,0.8176144664981713,0.6994328922495274,0.9747256280301362,1.0,3/20,9.77%,SETD6;SETD7;EEF1AKMT1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.36651520433058005,0.8120414244613472,0.6659877800407332,0.9820168277055932,1.0,1/11,6.09%,SLC2A10
prerank,ion channel activity (GO:0005216),0.24124495269882024,0.808859965689742,0.8060200668896321,0.9847967963425507,1.0,2/80,1.67%,TRPM3;NALCN
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3514180504438059,0.8040835535262713,0.6708074534161491,0.990174419286376,1.0,6/11,25.53%,AMFR;UBE4A;PPIL2;UBE4B;UBE2K;PRPF19
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.27806972340157804,0.8020600834658783,0.7438330170777988,0.9902571024400093,1.0,5/33,8.48%,PPARA;PRKN;RNF217;SIAH2;RNF180
prerank,signal sequence binding (GO:0005048),-0.2520554105146437,-0.8010530979593885,0.7657266811279827,0.9250861844933276,1.0,19/35,35.09%,NFKBIA;TOMM20;PEX5L;AP2M1;KCNIP2;KPNA4;AP2B1;PEX5;TIMM22;KPNA3;POM121;KDELR3;NUP153;CAT;CABP1;SEC61A2;TNPO2;KPNA2;IPO4
prerank,growth factor activity (GO:0008083),0.24256202996404513,0.7960920288177527,0.8144499178981938,0.997667433731254,1.0,12/74,12.83%,DKK1;IGF2;ARTN;FGF1;PTN;IL6;CSF1;VEGFB;FGF9;TGFA;AREG;GDNF
prerank,single-stranded RNA binding (GO:0003727),-0.23896388271813782,-0.7958443395965435,0.8142201834862385,0.9299442081728946,1.0,22/43,35.89%,ADARB2;HNRNPU;STRBP;SNRPC;EIF4H;IFIH1;POLR2G;EXOSC10;PTBP1;AGO3;FMR1;EIF4B;HNRNPF;TLR7;CNBP;PUS1;ZFR;JMJD6;DHX9;RBM11;HNRNPA1;TLR8
prerank,microtubule motor activity (GO:0003777),0.2572247015546381,0.7950980179819312,0.7684563758389261,0.9958369561283774,1.0,5/51,7.06%,KIF13B;KIF2A;KIF6;DNAH2;KIF27
prerank,endodeoxyribonuclease activity (GO:0004520),-0.29123477308646806,-0.7938709144965063,0.7752577319587629,0.9297076333606932,1.0,9/20,33.40%,RPS3;EXOG;RBBP8;APLF;EXO1;ERCC5;DNA2;DCLRE1C;FEN1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.30627603584048235,-0.7929390621860319,0.751503006012024,0.9278806427320737,1.0,7/16,32.08%,PIR;ALOX12;ETHE1;HGD;ADI1;ALOXE3;HAAO
prerank,MAP kinase kinase activity (GO:0004708),0.32763069302634884,0.7895020425458954,0.7049180327868853,1.0,1.0,2/15,5.48%,MAP2K6;LRRK2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.26987817748661785,0.7884417480561805,0.763302752293578,1.0,1.0,12/38,20.27%,SORBS1;GRIP1;LRRK2;FRS2;PIK3R1;MAGI2;GAB2;AXIN1;BLNK;PTPN11;SHC1;LAT
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.34216036481225826,0.7877705579278333,0.6964285714285714,0.9980991171825119,1.0,3/10,16.02%,USP27X;CYLD;DESI2
prerank,cholesterol transfer activity (GO:0120020),-0.3015882104826483,-0.7854869371181217,0.79,0.9362522153060828,1.0,6/16,23.65%,PLTP;GRAMD1A;STARD5;MTTP;ABCG1;NPC2
prerank,motor activity (GO:0003774),0.24602353913575095,0.7851109987281224,0.8218954248366013,0.9989819772350763,1.0,6/60,7.06%,KIF13B;KIF2A;KIF6;DYNC2H1;DNAH2;KIF27
prerank,chemokine receptor binding (GO:0042379),0.27113892602160405,0.7830143781930834,0.7563636363636363,0.9989168104994351,1.0,7/35,18.00%,CXCL13;CCL19;ITCH;CCL4;CKLF;CX3CL1;CCL28
prerank,adrenergic receptor binding (GO:0031690),0.3184866959045542,0.7821334417735045,0.7385496183206107,0.9969786229955511,1.0,5/16,15.91%,GNAS;NEDD4;DLG4;MAGI2;GRK2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.28624331824791743,-0.7797692059061231,0.7784810126582279,0.9410953942954758,1.0,3/18,10.32%,STXBP6;BAIAP2L1;PPP1CA
prerank,sterol transfer activity (GO:0120015),-0.29330155204730385,-0.7796004359304267,0.7935871743486974,0.9379297572757627,1.0,6/17,23.65%,PLTP;GRAMD1A;STARD5;MTTP;ABCG1;NPC2
prerank,nucleotidase activity (GO:0008252),-0.29908773893908297,-0.7752370639560571,0.7996031746031746,0.9410161674208316,1.0,5/15,19.89%,NT5C2;NT5C;BPNT2;NT5E;NT5DC1
prerank,ligand-gated channel activity (GO:0022834),-0.25562974166111196,-0.7744266506608488,0.811965811965812,0.9388854694061737,1.0,8/29,22.89%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.3003522474707744,-0.7732012028446085,0.7557692307692307,0.9375016801135487,1.0,7/14,26.32%,SPOCK2;NGF;SPOCK1;TIMP2;BST2;SPOCK3;TIMP1
prerank,ATP hydrolysis activity (GO:0140603),-0.23426048815391504,-0.7726499018395473,0.8486238532110092,0.9348799516099238,1.0,12/41,16.69%,HSP90AA1;SMCHD1;KIF26A;ABCB10;TOR1B;TOR3A;ATP2B1;CLU;ABCD2;CFTR;RUVBL1;ABCA3
prerank,serine-type peptidase activity (GO:0008236),0.2222294990110214,0.7724112821645293,0.8775510204081632,1.0,1.0,7/96,7.32%,CORIN;KLK2;CTSH;MMP2;PCSK9;TPP1;MMP9
prerank,ligand-gated ion channel activity (GO:0015276),-0.2507899938991974,-0.765367692864856,0.823404255319149,0.9418948116288783,1.0,8/30,22.89%,GRIK4;GABRB1;GRIN3A;GRIN1;GRIA2;GRIK2;GRID2;CHRNB1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3180267081770282,-0.7649441001903439,0.7782026768642447,0.9391788430742377,1.0,2/12,8.61%,PAN2;CNOT6L
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2760353422565139,0.7598078907449054,0.7992633517495396,1.0,1.0,8/29,15.85%,MGAM;HEXD;GANC;CTBS;GBA2;MOGS;PGGHG;GLA
prerank,calcium-release channel activity (GO:0015278),0.3032614708368064,0.7582872816111568,0.7621832358674464,1.0,1.0,1/17,0.79%,ITPR1
prerank,chemoattractant activity (GO:0042056),-0.25384925042640116,-0.7554841386707339,0.8179959100204499,0.9485912025455794,1.0,11/26,35.25%,VEGFA;FGF7;SCG2;MIF;BMP4;CXCL10;FGF2;NTF3;VEGFC;GPNMB;CCL5
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.24732969800450041,0.7538572169593969,0.833904109589041,1.0,1.0,8/44,11.77%,KMT2A;ASH2L;SETD7;SETD1A;ASH1L;NSD1;SMYD3;KMT2B
prerank,CXCR chemokine receptor binding (GO:0045236),0.34089550337790764,0.7534623259702189,0.7327586206896551,1.0,1.0,2/11,9.79%,CXCL13;ITCH
prerank,SH2 domain binding (GO:0042169),0.2650446682619421,0.7528084613329095,0.801094890510949,1.0,1.0,8/31,16.21%,AFAP1;SH3PXD2B;ABL1;JAK2;PAG1;NLK;RUFY1;BLNK
prerank,microtubule plus-end binding (GO:0051010),0.2983834838462116,0.7524852044525832,0.7865612648221344,1.0,1.0,3/20,8.84%,STIM1;MAPRE2;PAFAH1B1
prerank,chemokine activity (GO:0008009),0.2695279096815767,0.750231523949127,0.8183556405353728,1.0,1.0,6/31,18.00%,CXCL13;CCL19;CCL4;CKLF;CX3CL1;CCL28
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.21532897288242153,-0.7495773626956546,0.9195121951219513,0.9532131096741024,1.0,15/54,23.56%,ACER3;ACER2;GLS;TGM2;HDAC5;HINT1;SIRT4;HDAC11;NIT1;HINT3;SIRT7;HDAC9;HDAC6;AMDHD2;SIRT6
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.2525346420176852,-0.7435140464599745,0.8484848484848485,0.9577029072114628,1.0,7/26,20.06%,PPME1;PPP1R2;SET;PPP1R14A;LMTK2;BOD1;MGAT5
prerank,carboxypeptidase activity (GO:0004180),0.2618956519686457,0.7434851154312988,0.8327067669172933,1.0,1.0,4/35,8.19%,AEBP1;SCPEP1;AGBL2;CPXM1
prerank,protein kinase regulator activity (GO:0019887),0.21354143302874756,0.7396561085449659,0.8901639344262295,1.0,1.0,10/95,12.89%,PRKAG2;PRKAG3;MBIP;CCNT2;CCNT1;GPRC5C;PARVA;PRKAG1;CCNE1;GPRC5B
prerank,channel activity (GO:0015267),-0.22497640350227385,-0.7364635192054357,0.8878718535469108,0.9636139639105271,1.0,11/41,23.79%,AQP4;AQP11;TMEM266;PANX1;TRPV2;MCUB;TMEM120A;SLC14A1;TRPA1;CHRNB1;BAX
prerank,Hsp70 protein binding (GO:0030544),0.26510137144287127,0.7352444286091881,0.8067542213883677,1.0,1.0,2/31,4.20%,PRKN;HDAC8
prerank,ribosomal small subunit binding (GO:0043024),-0.274967391559311,-0.7335064124272971,0.8272921108742004,0.9638921492425699,1.0,11/17,39.25%,EIF1B;ERAL1;EIF4H;EIF1;DHX29;EIF4B;MTIF3;NME1;NPM1;PIM1;UNG
prerank,RNA polymerase II complex binding (GO:0000993),0.2588018792088739,0.7315717520513335,0.8180039138943248,1.0,1.0,14/32,23.72%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;SCAF1;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC;BRD4
prerank,phospholipase A2 activity (GO:0004623),0.26821768797725115,0.7300405078935783,0.8078358208955224,1.0,1.0,4/26,15.33%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.2834094234653521,0.7289668517089635,0.80078125,1.0,1.0,3/22,8.05%,RBMS3;CPEB2;EXOSC8
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.32151850837590595,0.7258919359958861,0.7861635220125787,1.0,1.0,2/11,12.99%,NAA80;NAA60
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.33408365843436505,0.7256489664256938,0.7900677200902935,1.0,1.0,2/10,12.18%,CASP12;CFLAR
prerank,neuropeptide hormone activity (GO:0005184),-0.2527929192677486,-0.7231762203939537,0.854,0.9728727540924201,1.0,16/22,56.40%,SPX;NPY;PNOC;ADCYAP1;PENK;NMB;VIP;CRH;GAL;PPY;CALCB;UCN;NPPA;GHRH;HCRT;QRFP
prerank,NADPH binding (GO:0070402),-0.28987347896051574,-0.7195706453622553,0.8187134502923976,0.9737005376116166,1.0,3/13,15.96%,KCNAB1;LBR;QDPR
prerank,methyl-CpG binding (GO:0008327),0.27578008302566165,0.7192291804561822,0.8370786516853933,1.0,1.0,6/22,23.33%,TET1;CXXC5;ZBTB38;CXXC4;TET3;LRWD1
prerank,sequence-specific mRNA binding (GO:1990825),-0.3103193137063678,-0.718575329552991,0.8317214700193424,0.9714683278804199,1.0,6/10,31.96%,SSB;SHFL;FMR1;RBM24;ETF1;DHX9
prerank,phosphatidate phosphatase activity (GO:0008195),0.30340644378069426,0.7165737188160508,0.8012820512820513,1.0,1.0,1/13,1.84%,PLPP3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.2980986688590533,0.7129370391861894,0.8142292490118577,1.0,1.0,3/15,13.12%,SH3PXD2B;PLEKHF1;VEPH1
prerank,water transmembrane transporter activity (GO:0005372),0.31735425474368484,0.712482568237446,0.8004434589800443,1.0,1.0,1/11,3.58%,PDPN
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.27479487102085265,-0.7091875557845412,0.8598326359832636,0.9784632243489654,1.0,9/14,46.80%,CMPK1;AK5;NME2;AK9;NME1;NME6;DTYMK;AK1;NME3
prerank,alpha-actinin binding (GO:0051393),0.2653681839124837,0.7082611019206576,0.8342857142857143,1.0,1.0,7/24,19.87%,KCNA5;CACNA1D;PKD2;PALLD;PDLIM5;DAG1;PKD2L1
prerank,antiporter activity (GO:0015297),0.2744545181438333,0.7052807394662702,0.8387096774193549,1.0,1.0,7/20,17.56%,SLC25A11;SLC35E2B;SLC35E2A;SLC35A1;CLCN4;TMEM241;SLC35D2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.29374314800918966,-0.7051394025660538,0.8414872798434442,0.9793365055671295,1.0,5/11,22.47%,RPS3;NEIL1;NEIL3;NTHL1;APLF
prerank,SUMO binding (GO:0032183),0.2966226463522401,0.7022102908179998,0.8122448979591836,1.0,1.0,5/13,19.64%,USP25;SIMC1;CBX4;PML;USPL1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3037414468421927,0.7015849999508208,0.8249496981891348,1.0,1.0,1/13,1.22%,SLC38A3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.24462872794900986,0.6993029578859512,0.883629191321499,1.0,1.0,14/33,22.88%,NCOA3;RPRD1B;AGO2;RPRD2;CDC73;AR;CTR9;RECQL5;ELP2;PAF1;AGO1;DRAP1;SUPT4H1;WAC
prerank,vitamin D receptor binding (GO:0042809),0.2954857203024246,0.6970927873923983,0.8137254901960784,1.0,1.0,3/14,11.41%,MED1;MED13;RXRA
prerank,cyclic nucleotide binding (GO:0030551),-0.25074238998296283,-0.6938312664090148,0.8877755511022044,0.9878622303476424,1.0,4/21,14.10%,PDE4D;PDE2A;HCN1;PDE11A
prerank,5'-nucleotidase activity (GO:0008253),-0.2773651940783914,-0.6933898567728243,0.8568627450980392,0.9849765347558198,1.0,7/13,35.22%,NT5C2;NT5C;NT5E;NT5DC1;NT5C1A;NT5DC2;NT5DC3
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.21352622556386955,0.6928703486393112,0.9308681672025724,1.0,1.0,13/75,14.16%,CRYL1;EHHADH;SORD;HSD17B10;PTGR1;H6PD;BDH1;DHRS3;UGDH;DHDH;ME3;DHRS11;BDH2
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2458753385105934,0.6913118471091844,0.8834244080145719,1.0,1.0,6/31,17.43%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.23808921311798284,0.6908239995661541,0.8795620437956204,1.0,1.0,11/35,24.47%,TRMT9B;LCMT2;TRDMT1;DUS2;DTWD1;GATC;AARS1;TARS2;ELAC2;DUS1L;GATB
prerank,cardiolipin binding (GO:1901612),0.31386542247287685,0.6893882246037499,0.8311688311688312,1.0,1.0,3/10,13.28%,GSDMD;GSDME;NME4
prerank,3'-5' DNA helicase activity (GO:0043138),0.27902440625668673,0.6887596266145338,0.8389662027833003,1.0,1.0,6/16,20.56%,BLM;HELQ;WRN;MCM2;MCM7;RECQL5
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.2397673004325579,0.686221125698639,0.8970588235294118,1.0,1.0,9/34,20.66%,SETD6;SETD7;CAMKMT;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4;NSD3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.30727080350298486,0.6827231881338746,0.8237885462555066,1.0,1.0,2/11,12.18%,CASP12;CFLAR
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.28600191744154396,0.6822225199175599,0.8491735537190083,1.0,1.0,1/14,2.68%,CAPN9
prerank,nuclease activity (GO:0004518),0.21785802765807646,0.6744566953089283,0.9481605351170569,1.0,1.0,10/52,16.82%,REXO5;RNASEL;SND1;ISG20L2;MRE11;APEX1;WRN;PARN;REXO4;RNASEH2A
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.22472387203537164,0.6698288526889767,0.9184060721062619,1.0,1.0,11/40,17.83%,METTL4;METTL8;PRMT7;DPH5;AS3MT;RRP8;LRTOMT;THUMPD3;N6AMT1;ASMT;NNMT
prerank,RNA stem-loop binding (GO:0035613),0.29583194154040426,0.6685107982451365,0.842,1.0,1.0,3/12,11.58%,RC3H2;MYH10;LARP6
prerank,ribosomal large subunit binding (GO:0043023),0.3019663146254545,0.6682530010119315,0.8313725490196079,1.0,1.0,3/11,13.46%,CPEB2;LTN1;NEMF
prerank,RNA polymerase core enzyme binding (GO:0043175),0.23264501725932596,0.6677453105376796,0.9135338345864662,1.0,1.0,13/33,22.88%,NCOA3;RPRD1B;AGO2;RPRD2;ERBB2;CDC73;CTR9;RECQL5;ELP2;PAF1;AGO1;SUPT4H1;WAC
prerank,protein phosphatase 1 binding (GO:0008157),-0.23734652288952976,-0.6641354391407928,0.9184890656063618,1.0,1.0,3/21,7.61%,PPP1R16B;AKAP11;KCNQ1
prerank,CCR chemokine receptor binding (GO:0048020),0.23989982920701217,0.6614076250526766,0.9018867924528302,1.0,1.0,3/28,10.07%,CXCL13;CCL19;CCL4
prerank,retinoid X receptor binding (GO:0046965),-0.278756089243963,-0.6575027376482566,0.8771929824561403,1.0,1.0,3/11,16.90%,ARID5A;NRIP1;NR4A2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2136814055737791,-0.6545543554802593,0.9436936936936937,1.0,1.0,13/28,34.18%,POP5;POP4;RPP21;RPP30;EDC3;AGO3;PRORP;NUDT16;EXO1;POP7;DROSHA;FEN1;RPP40
prerank,endoribonuclease activity (GO:0004521),0.22808268575181653,0.653488047160751,0.9236234458259325,1.0,1.0,6/32,15.24%,RNASEL;ZC3H12B;SND1;AGO2;DICER1;NYNRIN
prerank,O-methyltransferase activity (GO:0008171),0.28784249425857755,0.6532435422439375,0.8758029978586723,1.0,1.0,3/10,17.30%,FTSJ3;LRTOMT;ASMT
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2258093363597419,0.6522872356094361,0.9100917431192661,1.0,1.0,13/33,24.65%,ERI3;ERI2;DCP2;ERI1;PARN;CNOT8;CNOT7;EXOSC3;PDE12;XRN1;DIS3L;EXOSC4;DIS3
prerank,histone methyltransferase activity (GO:0042054),-0.20924937159506282,-0.6516311994607771,0.9416846652267818,1.0,1.0,12/32,34.64%,PRMT8;KMT2E;MEN1;FBL;SMYD1;EHMT2;DOT1L;EED;SUZ12;KMT5A;TTLL12;SMYD2
prerank,I-SMAD binding (GO:0070411),0.28108075783343134,0.6506121584796332,0.8626262626262626,1.0,1.0,4/13,15.67%,SMAD6;SMAD3;AXIN1;SMAD4
prerank,alpha-tubulin binding (GO:0043014),-0.20834661577348104,-0.6429559554063655,0.9603340292275574,1.0,1.0,4/31,10.56%,TTLL7;FYN;EFHC2;ARL8A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.23562882366215693,0.6385754162862349,0.9382470119521913,1.0,1.0,10/25,25.61%,PARP4;PARP10;PARP9;SIRT3;TIPARP;PARP14;SIRT5;TNKS2;ART4;PARP2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.27951416532040313,-0.6374037390601834,0.9094412331406551,1.0,1.0,4/10,30.59%,CDKN1B;CDKN1A;CDKN2D;INCA1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.21244802920956518,-0.6349860854980374,0.9580573951434879,1.0,1.0,8/28,24.99%,GRIK4;GABRG3;GRIK2;GABRA5;GRID2;GABRE;CHRNB1;GABRG2
prerank,cysteine-type endopeptidase activity (GO:0004197),0.18846113300546338,0.6333769340833939,0.9798994974874372,1.0,1.0,8/78,8.96%,CAPN9;CTSH;USP11;CASP12;USP24;USP25;USP7;USP34
prerank,GABA receptor binding (GO:0050811),0.2788631259691519,0.6320188157142166,0.8723404255319149,1.0,1.0,3/11,15.35%,ARFGEF2;TRAK1;TRAK2
prerank,cGMP binding (GO:0030553),0.2716423940282906,0.6268137713875944,0.8757763975155279,1.0,1.0,4/11,21.34%,PDE5A;CNGA3;CNGB3;RAPGEF2
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.2703873438382823,0.6256368283291379,0.9047619047619048,1.0,1.0,12/12,72.98%,GPR88;OPN1MW;OPN1MW3;RRH;OPN4;GNAT2;OPN1SW;OPN5;RHO;ELOVL4;GPR52;OPN3
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.1867237549947965,-0.61810116264625,0.9707865168539326,1.0,1.0,20/42,42.36%,CCNY;CDKN1B;CCNYL1;CCNF;CCNL2;CCNG2;CDKN1A;CDKN2D;CCNB2;CKS2;CCNQ;INCA1;CDK5R2;CCND1;CCND3;CCNA2;CKS1B;CCNB1;CCNC;CDKN2C
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.2571658201879403,-0.6170510680570422,0.9254302103250478,1.0,1.0,2/11,17.87%,HCN1;HCN2
prerank,aminopeptidase activity (GO:0004177),0.22811151676105657,0.6154856387981533,0.9312839059674503,1.0,1.0,6/26,22.20%,CTSH;NPEPPS;NAALADL1;XPNPEP3;MMP14;MMP17
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.2638537694858212,0.6148309388280535,0.8924949290060852,1.0,1.0,4/12,19.01%,AGO2;EIF4E3;LARP1;GEMIN5
prerank,methyltransferase activity (GO:0008168),0.19999585504666173,0.6137035773165657,0.9714795008912656,1.0,1.0,12/46,18.46%,METTL4;FTSJ3;PRMT7;EEF1AKMT1;AS3MT;RRP8;LRTOMT;METTL27;N6AMT1;ASMT;NNMT;NSUN3
prerank,phospholipase activity (GO:0004620),0.19140677486545823,0.6126710717974725,0.9689542483660131,1.0,1.0,11/67,15.33%,PLA2G10;FAM83B;NAPEPLD;ENPP2;LIPH;LIPC;PLA2G4B;PLA2G4C;PLCL1;PLCE1;PLA2G12A
prerank,muscle alpha-actinin binding (GO:0051371),-0.23575627096955076,-0.6109030291217031,0.9412955465587044,1.0,1.0,2/15,9.04%,PDLIM7;LDB3
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.21037714259066775,0.6087937055440661,0.9485815602836879,1.0,1.0,6/34,17.43%,UBE2E2;UBE2L3;BIRC6;UBE2A;UBE2H;UBE2E1
prerank,R-SMAD binding (GO:0070412),0.2472197511813738,0.6075859748055238,0.9322381930184805,1.0,1.0,6/18,20.61%,SMAD6;SMAD3;LDLRAD4;SMAD4;PMEPA1;SMAD2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2290829145728644,0.6053721386539475,0.9447619047619048,1.0,1.0,21/21,77.12%,CHRNE;CHRNB2;ANXA9;CHRNA7;CHRFAM7A;DRD4;CHRNA2;CHRNA6;DRD1;CHRNA1;DRD5;GRM5;CHRNB3;CHRNB4;CHRNA3;CHRNG;CHRNA4;CHRNA5;GRM1;GRIA1;CHRNB1
prerank,N-methyltransferase activity (GO:0008170),-0.21630312141312802,-0.6052275391413467,0.9491525423728814,1.0,1.0,2/20,6.67%,TFB2M;TRMT11
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.24312474511605311,-0.6031509159472864,0.9227799227799228,1.0,1.0,4/13,23.66%,SREBF2;MIF;IDI1;DDT
prerank,exopeptidase activity (GO:0008238),-0.1765399500484204,-0.6016071183760856,0.9926829268292683,1.0,1.0,22/50,40.36%,FAP;NAALAD2;DPP4;ACE2;CTSZ;PRCP;RCE1;ENPEP;NUDT16;LTA4H;JMJD7;DPP9;BLMH;CPB1;PM20D2;CPA2;DPEP1;KDM8;GGH;DPP10;DPEP3;DPP6
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.248153404049065,-0.5980337709815747,0.9446564885496184,1.0,1.0,6/11,39.92%,RPA1;TERF2IP;RPA2;HNRNPA1;TERF1;CTC1
prerank,endonuclease activity (GO:0004519),0.19201665206366453,0.5884958497300339,0.9878472222222222,1.0,1.0,10/49,16.68%,RNASEL;ZC3H12B;MBD4;SND1;AGO2;MRE11;DICER1;APEX1;NYNRIN;REXO4
prerank,mannose binding (GO:0005537),-0.24560993392100333,-0.5883335256377825,0.9577464788732394,1.0,1.0,4/12,27.68%,LMAN2;LMAN2L;CLN5;ACR
prerank,ribonuclease activity (GO:0004540),0.18893872875517925,0.5878088926923272,0.9864176570458404,1.0,1.0,16/56,21.79%,RNASEL;ZC3H12B;EXOSC8;SND1;AGO2;DICER1;NYNRIN;CNOT7;RNASEH2A;EXOSC3;NOB1;SAMHD1;AGO1;PIWIL4;PPP1R8;ELAC2
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.24755675651442866,0.5842194406238839,0.9393346379647749,1.0,1.0,2/14,5.99%,RPP14;TSEN34
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.21043154284357657,-0.5838840091370853,0.9713114754098361,1.0,1.0,6/20,26.34%,EIF3F;USP50;OTUB1;USP9X;YOD1;SENP5
prerank,gamma-tubulin binding (GO:0043015),0.22207428629766846,0.5798243471299148,0.9584158415841584,1.0,1.0,7/22,20.29%,TUBGCP6;BRCA2;TUBGCP2;OFD1;BRSK1;DDX3X;CENPJ
prerank,single-stranded DNA helicase activity (GO:0017116),-0.21608581821069855,-0.5795842493429225,0.9762376237623762,1.0,1.0,10/19,36.53%,WRNIP1;POLQ;MCM5;RFC5;DHX9;MCM6;DNA2;PIF1;HELB;RFC2
prerank,5'-3' exonuclease activity (GO:0008409),0.24888004515020026,0.5792639796898547,0.9290187891440501,1.0,1.0,4/14,13.43%,DCLRE1A;DCLRE1B;DCP2;MRE11
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.26900663281017057,0.5791126316077431,0.921875,1.0,1.0,3/10,15.81%,RPE;RENBP;DSEL
prerank,histone deacetylase activity (GO:0004407),-0.20804385986078217,-0.5681133837435206,0.9567901234567902,1.0,1.0,9/19,35.79%,HDAC5;HDAC11;SIRT7;HDAC9;HDAC6;SIRT6;HDAC3;MIER1;HDAC10
prerank,miRNA binding (GO:0035198),-0.18745683802573787,-0.5664942973930227,0.9808102345415778,1.0,1.0,8/30,23.63%,PUM2;YBX1;ZC3H7A;SOX2;ZC3H12A;AGO3;FMR1;ZNF346
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.2057164790929061,-0.564399353149342,0.970276008492569,1.0,1.0,8/17,39.38%,CMPK1;CLP1;AK5;NME2;AK9;NME1;NME6;DTYMK
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.2476964990481095,0.5642781230815085,0.9168399168399168,1.0,1.0,1/11,4.07%,KCND3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.23374682531562102,-0.5640621667880392,0.9441233140655106,1.0,1.0,3/12,24.36%,H3-3A;RELA;STAT1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.23439069902355636,-0.555574994074608,0.9624505928853755,1.0,1.0,7/11,54.22%,CHRNB1;CHRNA9;CHRNA5;CHRNA4;CHRNA3;CHRNB4;CHRNA1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.19248882465965408,0.5536745307935156,0.9795918367346939,1.0,1.0,12/34,24.65%,ERI3;ERI2;CNOT2;ERI1;PARN;CNOT8;CNOT7;EXOSC3;PDE12;DIS3L;EXOSC4;DIS3
prerank,telomerase RNA binding (GO:0070034),-0.1903542957232746,-0.5522546210345816,0.973630831643002,0.998239253680966,1.0,8/22,30.96%,PINX1;HNRNPU;SMG5;EXOSC10;NHP2;SMG6;NOP10;TENT4B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.24483908939444388,0.5465375913673395,0.9529652351738241,1.0,1.0,4/12,19.66%,TENT2;TUT1;PAPOLB;PAPOLG
prerank,neuropeptide receptor binding (GO:0071855),0.2346163366517464,0.5464378824078032,0.9493670886075949,1.0,1.0,2/14,11.05%,AGRP;APLN
prerank,snRNA binding (GO:0017069),-0.1643773735421519,-0.5464024057545942,0.9954233409610984,0.996921655576995,1.0,8/42,20.49%,HNRNPU;LARP7;DDX39B;MEPCE;SNRPC;PRPF4;EIF5A;RBM22
prerank,3'-5' exonuclease activity (GO:0008408),0.1756312175027258,0.5355443133742506,0.9927927927927928,1.0,1.0,14/45,20.63%,ERI3;ERI2;TATDN1;MRE11;APEX1;ERI1;WRN;PARN;CNOT8;CNOT7;REXO4;EXOSC3;PDE12;RAD50
prerank,damaged DNA binding (GO:0003684),0.17680325988892837,0.5309793733731911,0.9788732394366197,1.0,1.0,10/44,17.36%,DDB2;AUNIP;DCLRE1A;DCLRE1B;CUL4B;MPG;APEX1;CREBBP;RAD18;XPC
prerank,solute:proton symporter activity (GO:0015295),-0.20158147619857925,-0.5224528525746864,0.9917355371900827,1.0,1.0,6/16,29.59%,SLC39A8;SLC36A1;SLC25A3;SLC2A9;SLC15A4;SLC2A13
prerank,neuropeptide binding (GO:0042923),0.20412585446287015,0.5216752432329764,0.9770354906054279,1.0,1.0,1/18,5.45%,SSTR2
prerank,sulfuric ester hydrolase activity (GO:0008484),0.22751669496104865,0.5173101147516511,0.9793388429752066,1.0,1.0,4/12,21.32%,SULF1;ARSG;ARSK;GALNS
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.22988505882076193,0.5141998971626737,0.9653679653679653,1.0,1.0,2/11,12.51%,PRMT7;FBXO11
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.21950147548188625,0.5129567607210338,0.9818181818181818,1.0,1.0,14/14,78.07%,DHRS3;RDH11;SDR16C5;ADH1A;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;DHRS9;RDH12;RDH10;AKR1A1
prerank,deoxyribonuclease activity (GO:0004536),-0.19984711817182582,-0.49756282290688064,0.9825242718446602,1.0,1.0,1/14,3.54%,RPS3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.20957314585471992,-0.4974672211110854,0.9841269841269841,0.9992791874585183,1.0,4/11,30.47%,RDH14;DHRS13;AKR1A1;RDH12
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.21515570065293813,0.4959606147584969,0.9690522243713733,1.0,1.0,13/13,78.50%,ZGRF1;DICER1;DNASE1L3;FAN1;SLX4;DNASE1L2;DNASE1;ENDOV;DNASE1L1;FEN1;DNA2;EXO1;GEN1
prerank,RNA cap binding (GO:0000339),0.19799290967052577,0.49246383956616285,0.986,1.0,1.0,5/16,19.29%,AGO2;EIF4E3;LARP1;GEMIN5;LSM1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.19704265303011953,-0.49220846811157865,0.9898167006109979,0.9969932854381659,1.0,3/13,22.90%,TRMT11;TRMT10C;METTL1
prerank,regulatory RNA binding (GO:0061980),0.1662158705107504,0.4888536647681228,0.9907749077490775,1.0,1.0,11/38,21.92%,ZC3H7B;AGO2;DICER1;RBM10;TUT4;HNRNPA2B1;RBM4;AGO1;ELAVL1;PIWIL4;TUT7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.19644199300522855,-0.4776447158557739,0.9860834990059643,0.9961088321304219,1.0,4/12,30.07%,NDUFS7;DCXR;CBR1;NQO2
prerank,nuclear import signal receptor activity (GO:0061608),0.19251538364937815,0.4636032806589553,0.9849137931034483,1.0,1.0,15/15,80.77%,TNPO1;IPO9;KPNB1;TNPO3;HIKESHI;RANBP6;KPNA6;IPO5;KPNA7;KPNA1;IPO4;KPNA2;TNPO2;KPNA3;KPNA4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.1755399812993057,0.4630411599643595,0.9981818181818182,1.0,1.0,8/24,22.24%,PMVK;NME4;PPIP5K2;ITPKA;AK8;IP6K2;AK4;AK3
prerank,nuclear export signal receptor activity (GO:0005049),-0.19139136715404195,-0.46258760242073144,0.9861660079051383,0.9949005193567002,1.0,6/11,44.55%,CSE1L;NUP42;XPO6;RAN;XPO1;XPO7
prerank,acetylcholine receptor activity (GO:0015464),0.17240678656234096,0.4563360478627009,0.9883040935672515,1.0,1.0,1/22,4.61%,CHRNE
prerank,aspartic-type endopeptidase activity (GO:0004190),0.1926674618620125,0.4410712850130564,0.9938775510204082,1.0,1.0,12/12,80.75%,BACE1;SPPL3;DDI2;PGC;BACE2;ASPRV1;NAPSA;SPPL2A;SPPL2B;HM13;CTSE;PSEN1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.17599382077734682,0.403301163991263,0.9918200408997955,1.0,1.0,3/12,18.36%,BABAM2;TRAP1;TRAF6
prerank,exoribonuclease activity (GO:0004532),0.17838226568835497,0.3985273201182766,0.9959100204498977,1.0,1.0,4/12,23.34%,EXOSC8;CNOT7;EXOSC3;EXOSC4
prerank,metalloaminopeptidase activity (GO:0070006),0.15577386773759166,0.3760226103594456,1.0,0.9990836880347392,1.0,4/16,22.20%,NPEPPS;XPNPEP3;MMP14;MMP17
